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The present invention provide S caliX pyrrole, 
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derivatives, conjugates, multimers, and Solid Supports 
thereof. Such macrocycles have proved to be effective and 
Selective ion- and neutral molecule-binding agents forming 
Supramolecular ensembles, and ion- and neutral molecule 
Separation agents. The macrocycles are fully meso-non 
hydrogen-Substituted porphyrinogens, a few molecules of 
which were previously known but not recognized as pos 
Sessing anion- or molecule-binding properties. The binding 
mode is noncovalent, primarily that of hydrogen-bonding, 
thereby providing a new mode for liquid chromatography, 
that of Hydrogen Bonding Liquid Chromatography. Further 
useful applications of the macrocycles provided herein 
include environmental remediation by removal of undesired 
ions or neutral molecules, and removal of phosphate for 
kidney dialysis. 
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FIELD OF THE INVENTION 
The present invention relates generally to the fields of 
Separation technology, environmental remediation, and bio 
medical applications Such as dialysis and drug delivery. 
More particularly, it concerns ion- and neutral molecule 
binding, ion- and neutral molecule-separation or ion- and 
neutral molecule-detection, using calixnpyrrole, calixm 
pyridinonpyrrole, or calixmpyridine macrocycles. A new 
type of liquid chromatography is provided herein, that of 
Hydrogen Bonding Liquid Chromatography, that is based on 
noncovalent interactions and provides efficient and effective 
Separation of heretofore difficult-to-Separate anions and 
molecules. 
BACKGROUND OF THE INVENTION 
Anions play essential roles in biological processes; 
indeed, it is believed that they participate in 70% of all 
enzymatic reactions. There is, therefore, intense effort being 
devoted to the problem of anion complexation and recog 
nition. In the molecular recognition arena, a number of 
research groups have followed Nature's lead and have 
designed and Synthesized receptors that use hydrogen bonds 
alone, or in concert with electrostatic interactions, to coor 
dinate to anions. Nonetheless, there remains at present a 
critical need for additional anion complexing agents that are 
either easy to make or inherently Selective in their Substrate 
binding properties. 
Additionally, the Separation of anionic mixtures using 
chromatographic techniques involving anion binding inter 
actions is a little Studied area of chemistry. Current tech 
niques for purification of anions Such as oligonucleotide 
fragments, polyphosphate-containing molecules Such as 
ATP, ADP and AMP, carboxylates, or N-protected amino 
acids involve derivatization prior to Separation, leading to 
decreased yields and cumberSome methodology, or involve 
a Salt-Separation Step following chromatography. This is a 
very important area to both Scientists and clinicians as both 
mono- and di-nucleotides, natural and Synthetic oligonucle 
otides play critical roles in modern biotechnology as well as 
medicine. Oligonucleotides are used, for instance, as hybrid 
ization probes in blot analyses, primers for PCR 
amplification, and for Site-specific mutage nesis. 
Furthermore, in Some areas, oligonucleotide-derived prod 
ucts are currently being used as probes for the detection of 
genetic diseases and for proviral HIV, the causative agent of 
Acquired Immunodeficiency Syndrome (AIDS). Oligo 











theraputic agents, both directly, i.e., in gene therapy, and in 
an antisense fashion. 
The above-mentioned applications require oligonucle 
otide materials of impeccable purity (often greater that 
>99.99%). Such purity, however, is not readily obtained 
using existing technology. Presently, gene products and 
other oligonucleotide-type materials are purified using poly 
acrylamide gel electrophoresis (PAGE). This approach Suf 
fers from the requirement of using toxic materials and is 
painfully manpower-demanding and low-yielding. 
Liquid chromatographic techniques, in particular, high 
performance liquid chromatography (HPLC) and High Per 
formance Affinity Chromatography (HPAC) employing spe 
ciality Silica gels are currently used to Separate biological 
molecules. Indeed, Silica gel phases with bonded groups, 
Such as linear hydrocarbons, amino groups, cyano-groups, 
carboxylic amides and amino acids, are all known. 
Unfortunately, few, if any, of these phases are efficacious for 
the efficient, high-yielding Separation of nucleotides and 
oligonucleotides. Those that work best for this purpose are 
ion eXchange columns which, on a limited basis, can Some 
times Separate oligonucleotides containing 40 or fewer resi 
dues. However, this technique still suffers from several 
limitations, including the requirement for Severe conditions, 
Such as elution at pH 2.7, for routine operation. The use of 
high concentration buffers (greater than 1 M) and gradients 
that often include formic acid or formamide, also limits the 
half-lives of ion exchange columns. Reverse phase columns 
use column media, Such as Silica gel with appended groups 
Such as alkyl chains, that Separate Species on the basis of 
hydrophobic effects. Reverse phase columns may be used at 
pressures up to 5000 psi. However, in order to separate 
Species Such as oligonucleotides on this type of column, 
protecting groups must first be appended to the 
oligonucleotide, and ion-pairing reagents must be used, 
requiring an additional purification Step after the chromato 
graphic Separation. 
A type of Stationary phase has been previously described 
in which purine and pyrimidine bases are bonded to Silica 
gel. With this Support, base-pairing interactions between the 
nucleic acid base pairs and the modified Silica gel were 
expected to improve the resolution obtained in nucleic acid 
Separation procedures. Although Such Stationary phases 
were used to Separate nucleic acid-free bases, purine 
alkaloids, nucleosides, and mono- and oligonucleotides, this 
approach unfortunately has demonstrated the least Success in 
the case of oligonucleotide Separation, which is the most 
important area. Thus, prior to the present invention, there 
remained a critical need for improved Solid Supports that 
would effectively Separate nucleotides and oligonucleotides. 
Additionally, Sapphyrin (an expanded porphyrin known to 
bind anions) has been attached to a functionalized Silica gel. 
The Separatory properties of this material were not Sufficient 
to Separate oligonucleotides Successfully due to broad peaks 
observed for (3- to 9-mer) oligonucleotide mixtures. 
Furthermore, Synthetic challenges are associated with pre 
paring the requisite functionalized Sapphyrins since they 
require over 20 Synthetic Steps to produce. 
Current technology for dialysis in medical applications 
relies on membranes, Such as microfiltering cellophane, to 
filter anions Such as chloride anion or phosphate-containing 
US 6,262,257 B1 
3 
anions from the blood stream. Aluminum hydroxide or 
calcium carbonate cocktails must be consumed by the dialy 
sis patient in order to bind the anionic species. A major 
drawback of this technology is that aluminum builds up in 
cellular membranes to toxic levels over time causing ail 
ments including dementia and death. Calcium carbonate 
offers a less toxic Substitute, however, it is less efficient and 
is associated with hypercalcemia. 
Water-Soluble anion binding agents are desired as drug 
delivery agents. For example, many anti-Viral drugs only 
show activity when phosphorylated. However, many phos 
phorylated drug derivatives are too polar to pass through cell 
wall membranes. A water-Soluble anion binding agent may 
be able to encapsulate the negative charge and So allow the 
drug to pass though cell walls. 
The Synthesis of new molecular devices designed to Sense 
and report the presence of a particular Substrate is an area of 
analytical chemistry that is attracting attention. The detec 
tion of anionic Species is a particular challenge, as anions are 
difficult to bind and are generally larger than cations leading 
to a Smaller charge-to-radius ratio. 
Molecular recognition of neutral compounds presents a 
challenge in the area of Supramolecular chemistry. Binding 
of Substrates, Such as short-chain alcohols and Simple 
monoamides, is particularly difficult because these mol 
ecules have few functionalized Sites available for hydrogen 
bonding, and they lack the large hydrocarbon Surfaces 
necessary to participate in efficient hydrophobic or JC-TL 
Stacking interactions. ASSociation constants for neutral 
Substrate-synthetic receptor complexes are thus generally 
modest, even though the architectural complexity of the 
receptorS is often high. 
Cation binding agents may be useful as Sensors for 
particular cations or as Sequestering agents. Additionally, 
particular cation-complexes may be useful in medicine as 
imaging agents or in the treatment of disease. 
One aspect of the present invention involves calixpyr 
roles. Calixpyrroles represent a Subset of a class of macro 
cycles that was previously termed porphyrinogens. Porphy 
rinogens are non-conjugated macrocyclic Species composed 
of four pyrrole rings linked in the C-position via sphybrid 
ized carbon atoms. Porphyrinogens that carry meso 
hydrogen atoms are prone to oxidation to the corresponding 
porphyrins. Fully meso-non-hydrogen-Substituted porphy 
rinogens are generally stable crystalline materials. The first 
Such macrocycle, meso-octamethylcalix4pyrrole, was 
reported over a century ago by Baeyer (Ber. Disch. Chem. 
Ges. 1886, 19, 2184) using a condensation between acetone 
and pyrrole catalyzed by hydrochloric acid, however, the 
structure of the molecule was not elucidated. This method 
was reportedly refined by Dennstedt and Zimmerman (Ber. 
Disch. Chem. Ges. 1887, 20, 850) by replacing the hydro 
chloric acid catalyst with “chlorZink” (presumably zinc 
chloride) and heating the reaction. Chelintzev and Tronov 
reportedly produced calix4pyrroles by the method of con 
densing acetone and pyrrole, methylethyl ketone and 
pyrrole, methylhexylketone and pyrrole and a mixture of 
acetone and methylethylketone with pyrrole (J. Russ. Phys. 
Chem. Soc. 1916, 48, 1197: Chem Abstr. 1917, 11, 1418). 
Chenlintzev, Tronov and Karmanov reported further pro 
duction of calixpyrroles by condensing cyclohexanone with 
pyrrole and a mixture of acetone and cyclohexanone with 











Rothemund and Gage reportedly refined Dennstedt and 
Zimmerman's method by replacing the acid catalyst with 
methanesulfonic acid (J. Am. Chem. Soc. 1955, 77,3340). 
Brown, Hutchinson and MacKinnon (Can. J. Chem. 1971, 
49, 4017) reportedly repeated the synthesis of meso 
tetracyclohexylcalix4pyrrole and assigned a tetrameric 
macrocyclic Structure. J.-M. Lehn and co-workers have 
reportedly Synthesized meso-octa-3-chloropropylcalix4 
pyrrole by an unpublished procedure and converted it to 
meso-octa-3-cyanopropylcalix4pyrrole (B. Dietrich, P. 
Viout and J.-M. Lehn in Macrocyclic Chemistry, VCH 
Publishers, Weinheim, 1993, pg. 82). The metal cation bind 
ing of deprotonated calix4pyrrole macrocycles has been 
studied by Floriani and co-workers (Chem. Commun. 1996, 
1257). Floriani has reportedly developed a method for 
expanding the pyrrole rings of metal-bound deprotonated 
calix4pyrroles forming calix1pyridino.3pyrroles and 
calix(2pyridino 2pyrroles (J. Am. Chem. Soc. 1995, 117, 
2793). A further prior art method reports using pyrrole, a 
C-C Saturated alicyclic ketone and an acid containing 
Vinyl groups or triple bonds to form a polymerized resin 
(WO 93/13150). In this case, the resulting products are 
undefined since it appears to be unknown where the modi 
fying group is attached to the product. 
While the term porphyrinogen is now widely accepted in 
the literature, the present inventors believe the fully meso 
non-hydrogen-Substituted Systems are misnamed. They are 
not bona fide precursors of the porphyrins and might, 
therefore, be better considered as being calixpyrroles rather 
than porphyrinogens. Such a renaming has precedent in the 
chemistry of other heterocyclic ring Systems. Interestingly, 
while related functionalized calixarenes, a class of mol 
ecules containing phenol (as opposed to pyrrole) Subunits 
have been shown to be capable of binding anions, unmodi 
fied calixarene frameworks show no affinity for anionic 
guests, demonstrating that the anion-binding properties are 
not an inherent part of the calixarene ring Structure. 
While a few other fully meso-non-hydrogen-substituted 
porphyrinogens are known, no one prior to the present 
inventors recognized their properties and consequent uses as 
described herein. 
SUMMARY OF THE INVENTION 
The present invention results from the inventors discov 
ery that calix4pyrrole macrocycles bind anions in the Solid 
State. That discovery led the present inventors to Synthesize 
novel calixnpyrroles, calixmpyridinonpyrroles or calix 
mpyridine macrocycles, to develop new methods of mak 
ing Said macrocycles, and to demonstrate methods of using 
Said macrocycles as presented herein. 
“Calixnpyrrole,” as used herein, means a macrocycle 
having “n” pyrrole rings linked in the C. positions via Sp 
hybridized meso-carbon atoms that are not bound to hydro 
gen (protium), deuterium or tritium atoms. This is a Subset 
of a class of molecules that was previously termed porphy 
rinogens. “Calixmpyridinonpyrrole,” as used herein, 
means a macrocycle having “m’ pyridine rings and “n” 
pyrrole rings linked in the C. positions via sphybridized 
meso-carbon atoms that are not bound to hydrogen 
(protium), deuterium or tritium atoms. “Calixmpyridine,” 
as used herein, means a macrocycle having “m’ pyridine 
rings linked in the C. positions via sp. hybridized meso 
carbon atoms that are not bound to hydrogen (protium), 
deuterium or tritium atoms. 
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A “calixnpyrrole”, “calixmpyridinonpyrrole” or 
“calixmpyridine' is different from a porphyrinogen Since a 
porphyrinogen has one or more sphybridized meso-carbon 
atoms bound to a hydrogen (protium), deuterium or tritium 
atom. A “calixnpyrrole”, “calixmpyridinonpyrrole” or 
“calixmpyridine' is different from a porphomethene Since 
a porphomethene contains three sp hybridized meso 
carbons and one sp hybridized meso-carbon. A "calixn) 
pyrrole”, “calixmpyridinonpyrrole” or “calixm 
pyridine' is different from a phlorin Since a phlorin contains 
one sphybridized meso-carbon and three sp’ hybridized 
meso-carbons. A "calixnlpyrrole”, “calixmpyridinon 
pyrrole” or “calixmpyridine” is different from a porphyrin 
since a porphyrin contains four sphybridized meso-carbons 
and is aromatic. A "calixnpyrrole”, “calixmpyridinon 
pyrrole” or “calixmpyridine” is different from an expanded 
porphyrin Since an expanded porphyrin contains at least one 
sp’ hybridized meso-carbon. 
Macrocycles of the present invention have unexpected 
properties that make them particularly useful. Calixn 
pyrroles and calixmpyridinonpyrroles bind anions and 
neutral molecular species in Solution and in the Solid State in 
Such an effective and Selective way that the anions or neutral 
molecular species can be separated from other anions and 
neutral molecular species. Calixmpyridinonpyrroles and 
calixmpyridines can also be used to bind and separate 
cations. Further, the affinity a macrocycle has for a particular 
Species can be “tuned by Strategic choice of electron 
donating or electron-withdrawing peripheral Substituents for 
Synthesis of the macrocycle. Additionally, the affinity a 
calixmpyridinonpyrrole or calixmpyridine has for a 
particular Species can be “tuned' by N-protonation or quat 
ernization by N-alkylation. Applications of these properties 
for removal of biological ions or neutral molecule Species 
for medical uses, or removal of undesirable ions or neutral 
molecule Species from environmental Sources provide only 
a few of the practical and important uses for the present 
molecules. 
A calixnlpyrrole, calixmpyridinonpyrrole, or calix 
Impyridine macrocycle noncovalently-complexed to a 
molecular or ionic Species is an embodiment of the present 
invention. When the macrocycle is a calix4pyrrole the 
ionic Species is other than a metal cation. The term “n” refers 
to the number of pyrrole rings in the calixpyrrole macro 
cycle and, for molecules of the present invention, is 4, 5, 6, 
7, or 8. The term “m+n” refers to the number of pyridine and 
pyrrole rings in the calixpyridinopyrrole macrocycle respec 
tively and, for molecules of the present invention, is 4, 5, 6, 
7, or 8. The term “m” refers to the number of pyridine rings 
in the calixpyridine macrocycle and, for molecules of the 
present invention, is 4, 5, 6, 7, or 8. “Noncovalently 
complexed to a molecular or anionic species,” as used 
herein, means that bound molecules are held to the core of 
a macrocycle by noncovalent binding to one or more pyr 
rolic N-H or pyridino N-H groups thus forming a 
Supramolecular ensemble. “Noncovalent binding” includes 
intermolecular interactions Such as hydrogen bonds, dipole 
dipole interactions, dipole-induced dipole interactions, ion 
dipole interactions, ion pairing, Van der Waals interactions, 
London dispersion forces, JC-TC Stacking interactions, edge 












interactions, or entropic, hydrophobic or Solvophobic 
effects. In a preferred embodiment of the invention, the ionic 
Species is an anionic Species. 
“Supramolecular” as used herein describes the chemistry 
of complexes, that is molecular ensembles containing more 
than one atomic, ionic, or molecular component. Thus 
complexes of the macrocycles of the present invention and 
an ion or neutral molecule are considered to be Supramo 
lecular complexes or ensembles. 
A calixnpyrrole, calixmpyridinonpyrrole or calixm 
pyridine macrocycle attached to a Solid Support, where m, 
m+n and n are defined as herein above, is a particularly 
useful embodiment of the present invention. Due to the 
effective and Selective Separation of a variety of molecules 
by calixnlpyrrole-derivatized Solid Supports as described in 
the examples herein, the present inventors have developed a 
new type of liquid phase chromatography termed 
“Hydrogen-Bonding Liquid Chromatography.” The bases of 
the chromatography are noncovalent interactions, primarily 
hydrogen bonding. 
A calixnpyrrole, calixmpyridinonpyrrole or calixm 
pyridine macrocycle having a first conformation in a Solid 
State when unbound to a molecular or anionic Species and 
having a Second conformation in a Solid State when bound to 
a molecular or anionic Species where n is 4, 5, 6, 7, or 8 is 
another embodiment of the present invention. In particular, 
the present inventors have observed an unbound 1,3- 
alternate “first conformation, and a bound cone or 1,2- 
alternate “second conformation for calix4pyrrole macro 
cycles. 
Exemplary calixnlpyrrole macrocycles for anion and 
neutral molecular species binding, for Solid Supports, for 
derivatives, for multimers, for conjugates and the like, have 
Structure I. 
For Structure I, when n is 4, p=q=r=S=0, R-R are 
independently Substituents as listed in paragraph i) below, 
and RA-R are independently Substituents as listed in para 
graph ii) below. When n is 5, p=1, q=r=s=0, R to Ro are 
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independently Substituents as listed in paragraph i) below, 
and RA-R are independently Substituents as listed in para 
graph ii) below. When n is 6, p=q=1, r=s=0, R to R2 are 
independently Substituents as listed in paragraph i) below, 
and RA-R are independently Substituents as listed in para 
graph ii) below. When n is 7, p=q=r=1, S=0, R to Rs are 
independently Substituents as listed in paragraph i) below, 
and RA-R are independently Substituents as listed in para 
graph ii) below. When n is 8, p=q=r=s=1, R to R are 
independently Substituents as listed in paragraph i) below, 
and RA-R are independently Substituents as listed in para 
graph ii) below; 
i) hydrogen, halide, hydroxyl, alkyl, alkenyl, alkynyl, 
aryl, alkylary 1, nitro, phospho, formyl, acyl, 
hydroxyalkyl, alkoxy, hydroxyalkoxy, hydroxyalkenyl, 
hydroxyalkynyl, Saccharide, carboxy, carboxyalkyl, 
carboxyamide, carboxyamidealkyl, amino, amido, 
aminoalkyl, phosphoalkyl, alkyl Sulfoxide, alkyl 
Sulfone, alkyl Sulfide, tetrahydropy ran, 
tetrahydrothiapyran, thioalkyl, haloalkyl, haloalkenyl, 
haloalkynyl, alkyl ester, a Site-directing molecule, a 
catalytic group, a reporter group, a binding agent, or a 
couple that is coupled to a site-directing molecule, to a 
catalytic group, to a reporter group, or to a binding 
agent, 
ii) hydrogen, alkyl, aminoalkyl, carboxy alkyl, carboxya 
mide alkyl, phospho alkyl, alkyl Sulfoxide, alkyl 
sulfone, alkyl sulfide, halo alkyl, aryl, N-oxide, 
dialkylamino, carbamate, or arylsulfonyl. 
Alternatively, at least two Substituents attached to a pyrrole 
B-carbon, a meso-carbon or a pyrrole nitrogen are coupled 
to form a bridged Structure, and when coupled to form a 
bridged Structure, nonbridged Substituents are as defined 
herein in paragraph i) or ii). Odd-numbered R-Substituents 
are other than hydrogen for macrocycles having Structure I. 
A meso-Substituted calixnpyrrole, where n is 4, 5, 6, 7, 
or 8, and where the meso-Substitution is an oxygen-, Sulfur-, 
or alkenyl-containing Substituent is an embodiment of the 
present invention. Oxygen-, or Sulfur-containing Substitu 
ents are particularly useful for giving the macrocycle a 
functionality that can be further derivatized for uses 
described herein. A "monohook calixnpyrrole having an 
oxygen-containing carboxyl group has been found to poS 
SeSS Self-assembly properties as shown in FIG. 4. A calix 
npyrrole having a vinyl Substituent as an example of an 
alkenyl group is particularly useful for forming a polymer of 
defined linkage and structure. Such a polymer is useful for 
a Selective electrode as described herein. 
A further aspect of the present invention is a P-substituted 
calixnpyrrole. Exemplary f-substituted calixnpyrrole 
macrocycles have Structure I as described herein wherein at 
least one even-numbered R substituent is other than hydro 
gen. Substitution on a B-carbon of a pyrrole ring provides 
even further flexibility in the design of macrocycles of the 
present invention for the various uses described herein. 
A calixmpyridinonpyrrole macrocycle having struc 












The term “m' designates a number of pyridines, and the 
term “n” designates a number of pyrroles, in macrocycle II, 
m+n=4, and m is other than 1 or 2. When m is 4; n=0, p=1, 
and q=0, Rio to Rios and Rol to R2 are independently 
Substituents as listed in paragraph i) above, and Ro-Ro. 
are independently Substituents as listed in paragraph ii) 
above. When m is 3; n=1, p=0, q=1, Rio to Rios and Rao 
to R are independently Substituents as listed in paragraph 
i) above, and Ro-Ro are independently Substituents as 
listed in paragraph ii) above. Ro-Ros are other than 
hydrogen. When Ro-Roa is other than a lone pair of 
electrons, Z=1, that is, the pyridine nitrogen atom is posi 
tively charged. When Ro-Ro is a lone pair of electrons 
Z=0, that is, the pyridine nitrogen atom is neutral. 
Further aspects of the present invention include calixm 
pyridinonpyrrole macrocycles where m and n designate a 
number of pyridines and pyrroles in the macrocycle, 
respectively, m and n are other than 0, and m+n=5, 6, 7, or 
8. Each pyridine or pyrrole C-carbon is bound to another 
pyridine or pyrrole C-carbon via one non hydrogen-linked 
sp-hybridized meso-carbon; each sp hybridized meso 
carbon is further independently bonded to a group charac 
terized in paragraph i) above with the exception of hydro 
gen; each pyridine B carbon, pyrrole B carbon and pyridine 
Y carbon is independently bonded to a group characterized in 
paragraph i) above; each pyridine or pyrrole nitrogen is 
bound to a group characterized in paragraph ii) above. In a 
further embodiment, at least one sp meso-carbon, pyridine 
B-carbon, pyrrole B-carbon, pyridine Y-carbon, pyrrole 
nitrogen, or pyridine nitrogen is coupled to form a bridged 
structure to itself or to another sphybridized meso-carbon, 
pyridine 3-carbon, pyrrole B-carbon, pyridine Y carbon, 
pyrrole nitrogen, or pyridine nitrogen; and when coupled to 
form a bridged Structure, non-bridged atoms are as defined 
for an Sphybridized meso-carbon, pyridine f-carbon, pyr 
role B-carbon, pyridine Y carbon, pyrrole nitrogen, or pyri 
dine nitrogen. 
A calixmpyridine macrocycle having structure III 
wherein m is 4, 5, 6, 7, or 8 is a further aspect of the present 
invention. 
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III 
When m is 4, p=q=r=S=0. Rio to R2 and Rao to Ros 
are independently Substituents as listed in paragraph i) 
below, and Ro-Ro are independently Substituents as 
listed in paragraph ii) above. When m is 5, p=1, q=r=s=0. 
Rio to Rs and Rao to Rao are independently Substituents 
as listed in paragraphi) above, and Rao-Rios are indepen 
dently Substituents as listed in paragraph ii) above. When m 
is 6, p=q=1, r=S=0, Rio to Rs and Rao to R22 are 
independently Substituents as listed in paragraph i) above, 
and Ro-Roe are independently Substituents as listed in 
paragraph ii) above. When m is 7, p=q=r=1, S=0. Rio to 
R2 and Rao to R2 are independently Substituents as 
listed in paragraph i) above, and Ro-Ro, are indepen 
dently Substituents as listed in paragraph ii) above. When m 
is 8, p=q=r=S=1, Rio to R12 and Rao to R2s are inde 
pendently Substituents as listed in paragraph i) above, and 
Ro-Rios are independently Substituents as listed in para 
graph ii) above. Ro-R are other than hydrogen. When 
Ro-Ro, are other than a lone pair of electrons, Z=1, that 
is the pyridine nitrogen atom carries a positive charge. When 
Ro-Ro, are a lone pair of electrons Z=0, that is the 
pyridine nitrogen atom is neutral. In a further embodiment 
at least two Substituents are coupled to form a bridged 
Structure, and when coupled to form a bridged Structure, 
nonbridged Substituents are as defined in paragraphi) or ii) 
above. 
A calixnpyrrole where n is 5, 6, 7, or 8 is another 
embodiment of the present invention. Calixnpyrroles hav 
ing a number of pyrrole rings greater than four have not been 
previously known. An advantage of the larger macrocycles 
over those having four pyrroles is that they are expected to 







and have the property of binding more than one anion 
Simultaneously. 
A chiral calixnpyrrole, calixmpyridinonpyrrole, or 
calixmpyridine where m and n are defined herein above, is 
a further embodiment of the present invention. A chiral 
calixpyrrole, calixpyridinopyrrole or calixpyridine is 
expected to have different binding properties for each of a 
pair of enantiomeric Species, thus allowing preferential 
binding of a particular enantiomer. 
The present invention provides a number of different 
novel methods of making calixnpyrrole, calixmpyridino 
npyrrole, and calixmpyridine macrocycles. A first 
method of making embodiment is a method of making a 
calixnpyrrole where n is 4, 5, 6, 7, or 8, the calixnlpyrrole 
having an ester Substituent, comprising reacting an ester 
functionalized ketone, pyrrole and a ketone to produce a 
calixnpyrrole having an ester Substituent. 
A Second method of making embodiment is a method of 
making a calixnlpyrrole where n is 4, 5, 6, 7, or 8, the 
calixnpyrrole having an acid Substituent, comprising react 
ing an ester-functionalized ketone, pyrrole and a ketone to 
produce a calixnpyrrole ester derivative; and 
de-esterifying the ester derivative to produce a calixn 
pyrrole monoacid derivative. 
A method of making a f-substituted calixnpyrrole where 
n is 4, 5, 6, 7, or 8 comprising activating a calixnlpyrrole 
where n is 4, 5, 6, 7, or 8; and reacting the activated 
calixnpyrrole with an electrophile is a third method of 
making embodiment of the invention. 
A fourth synthetic method embodiment of the invention is 
a method of making a f-Substituted calixnlpyrrole where n 
is 4, 5, 6, 7, or 8 comprising reacting a B-Substituted pyrrole 
and a ketone to produce a f-substituted calixnpyrrole. 
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A method of making a f-substituted calixnpyrrole where 
n is 4, 5, 6, 7, or 8 comprising producing a calixnlpyrrole 
radical where n is 4, 5, 6, 7, or 8; and reacting the radical 
with a radical acceptor molecule is a fifth Synthetic method 
embodiment of the invention. 
A method of making a calixnpyrrole wherein n is 5, 6, 
7, or 8 comprising reacting a pyrrole and a ketone in the 
presence of a Lewis acid is a Sixth Synthetic method embodi 
ment of the invention. 
A Seventh method of making embodiment is a method of 
making a calixnlpyrrole wherein n is 4, 5, 6, 7, or 8 
comprising reacting a pyrrole and a ketone in the presence 
of a heterogenous catalyst. 
An eighth synthetic method embodiment of the invention 
is a method of making a calixnpyrrole wherein n is 4, 5, 6, 
7, or 8 comprising the steps of a) reacting a ketone 
functionalized pyrrole and an alkyl metal to form a pyrrole 
alcohol, b) condensing the pyrrole alcohol to form a cycliz 
able pyrrole oligomer, and c) repeating step b) at least n 
minus 2 times to form a calixnpyrrole. 
A ninth synthetic method embodiment of the invention is 
a method of making a calixnpyrrole wherein n is 4, 5, 6, 
7, or 8 comprising reacting a pyrrole and a ketone in the 
presence of an anion template. 
A method of making a Solid-Supported calixnpyrrole, 
Solid-supported calixmpyridinonpyrrole, or Solid 
Supported calixmpyridine comprising attaching a calixn 
pyrrole, a calixmpyridinonpyrrole, or a calixmpyridine 
having a functionalized group to a Solid Support, the Solid 
Support reactive with the functionalized group, or to a 
tether-functionalized Solid Support, the tether reactive with 
the functionalized group is a tenth Synthetic method embodi 
ment of the present invention. 
A method of making a calixpyridinopyrrole comprising 
adding halocarbene to a calixpyrrole in a cycloaddition 
reaction, thereby converting a pyrrole to a pyridine and 
forming a calixpyridinopyrrole is an eleventh Synthetic 
embodiment of the present invention. Preferably, the halo 
carbene is chlorocarbene and most preferably, is dichloro 
carbene. 
A method of making a calixpyridine comprising: adding 
halocarbene to calixpyrrole or to calixpyridinopyrrole in a 
cycloaddition reaction So as to convert pyrrole to pyridine to 
form a calixpyridine is a twelth synthetic method embodi 
ment of the present invention. The halocarbene is as 
described herein. 
A thirteenth method of making embodiment or Synthesis 
embodiment is a method of making a calixnpyrrole where 
n is 5, 6, 7, or 8, the calixnpyrrole having different 
Substituents at meso-carbon atoms, comprising reacting pyr 
role and at least two ketone molecules to produce a calix 
npyrrole having different Substitutents at meso-carbon 
atOmS. 
A method of making a calixnpyrrole comprising react 
ing a cyclic ketone template having in ketone groups and 
pyrrole or f3-Substituted pyrrole to produce a calixnpyrrole 
is a fourteenth method of making embodiment of the inven 
tion. 
A further composition of matter of the present invention 
is a calixnlpyrrole, a calixmpyridinonpyrrole, or a calix 
mpyridine made by one of the first through fourteenth 
synthetic method embodiments provided herein. 
A method of forming a complex of a calixnlpyrrole or a 
calixmpyridinonpyrrole, and an ion or a neutral molecule 
comprising contacting the calixnlpyrrole or the calixm 
pyridinonpyrrole with the ion or neutral molecule under 
conditions effective to allow the formation of the complex is 












Another aspect of the invention is a method for Separating 
a first molecule, a first anion or a first cation from a mixture 
of a first molecule, a first anion or a first cation and other 
Species, comprising obtaining a calixnpyrrole-, a calixm 
pyridinonpyrrole- or a calixmpyridine-derivatized Solid 
Support; and contacting the Solid Support with the mixture to 
Separate the first molecule, the first anion or the first cation. 
Another method of Separating includes batch processing 
where a macrocycle or macrocycle of the present invention 
attached to a Solid Support is added to a mixture containing 
the ion or molecule to be separated, and Separating the 
macrocycle-molecule, macrocycle-ion, Solid Support 
macrocycle-ion or Solid Support-macrocycle-molecule com 
plex. Macrocycles provided herein are particularly effective 
as Separation media as described in the present examples. 
A method of transporting a molecular or ionic Species 
through a membrane comprising incorporating a calixn 
pyrrole or a calixmpyridinonpyrrole into the membrane; 
and contacting the membrane with the molecular or ionic 
Species in the presence of a gradient of the molecular or 
ionic Species or counter gradient of another back-transported 
Species is an embodiment of the invention. Thus, the present 
invention maybe used to facilitate the transport of ionic or 
neutral Substrates in both a Support or antiport Sense. 
A further embodiment of the present invention is an 
electropolymerizable calixnpyrrole, calixmpyridinon 
pyrrole, or calixmpyridine, which macrocycles, are useful 
for constituting modified electrodes for the detection of ionic 
or molecular species. 
A further embodiment of the present invention is an 
anion-, cation-, or neutral molecule-Selective electrode com 
prising a conductive body, a polymer, and a calixnlpyrrole, 
a calixmpyridinonpyrrole, or a calixmpyridine. The 
calixnpyrrole, the calixmpyridinonpyrrole, or the calix 
mpyridine may be electropolymerized and form the con 
ductive body. 
A method of electrochemical detection of an anion, a 
cation, or a neutral molecule comprising assembling an 
anion-, cation-, or neutral molecule-Selective electrode and 
contacting the electrode with a Solution of the anion, the 
cation, or the neutral molecule, and detecting the presence or 
absence of the anion, the cation, or the neutral molecule is 
an embodiment of the present invention. 
A method of binding a cation comprising contacting the 
cation with a calixnpyrrole or calixmpyridinonpyrrole 
having a cation-binding functionality, or with a calixm 
pyridine is also an aspect of the invention. 
A method of removal of pertechnetate from pertechnetate 
containing nuclear waste comprising contacting the waste 
with a calixnlpyrrole or a calixmpyridinonpyrrole to 
form a calixnpyrrole- or a calixmpyridinonpyrrole 
pertechnetate complex, and removing the complex from the 
waste is also an aspect of this invention. 
A method of removal of an environmental pollutant from 
an environmental Source, comprising contacting the envi 
ronmental Source with a calixnlpyrrole or a calixm 
pyridinonpyrrole to form a calixnpyrrole- or a calixm 
pyridinonpyrrole-pollutant complex, and removing the 
complex from the environmental Source is also an aspect of 
this invention. 
Further embodiments of the invention include a chroma 
tography column or a Sensor comprising a Solid Support 
bound to a calixnpyrrole where n is 4-8, to a calixm 
pyridinonpyrrole where m+n=4-8 and m is not 1 or 2, or 
to a calixmpyridine where m is 4-8. Use of a calixn 
pyrrole, a calixmpyridinonpyrrole, or a calixmpyridine 
in the preparation of a pharmaceutical composition for use 
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in in vivo or ex vivo treatment of body tissues is another 
embodiment of the invention. The treatment may involve 
binding, transport, and/or removal of ions or neutral molecu 
lar species for conditions Such as gout, for kidney dialysis, 
for removal of viruses, for introduction of antiviral drugs, or 
the like. A method, therefore, includes administering to a 
patient in need thereof a therapeutically effective amount of 
a calixnpyrrole, a calixmpyridinonpyrrole, or a calix 
Impyridine. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The following drawings form part of the present Specifi 
cation and are included to further demonstate certain aspects 
of the present invention. The invention may be better 
understood by reference to one or more of these drawings in 
combination with the detailed description of the Specific 
embodiments presented herein. 
FIG. 1A illustrates the X-ray crystal structure of meso 
octamethylcalix4pyrrole, 1, adopting a 1,3-alternate con 
formation. Thermal ellipsoids are at 30% probability level. 
FIG. 1B illustrates the X-ray crystal structure of meso 
tetraspirocyclohexylcalix4pyrrole, 2, adopting a 1,3- 
alternate conformation. Thermal ellipsoids are at the 30% 
probability level. 
FIG. 2A illustrates the X-ray crystal structure of meso 
octamethylcalix4pyrrole tetra-butylammonium chloride 
complex, 1.Cl. The meso-octamethylcalix4pyrrole adopts 
a cone conformation wherein all four pyrrole NH groups are 
hydrogen-bonded to the bound chloride anion. The counter 
cation is omitted for clarity. Thermal ellipsoids are at the 
30% probability level. 
FIG. 2B illustrates the X-ray crystal structure of meso 
tetraspirocyclohexylcalix4pyrrole tetrabutylammonium 
chloride complex, 2. Cl. The meso 
tetraspirocyclohexylcalix4pyrrole adopts a cone confor 
mation wherein all four pyrrole NH groups are hydrogen 
bonded to the bound chloride anion. The counter cation is 
omitted for clarity. Thermal ellipsoids are at the 30% prob 
ability level. 
FIG. 3A illustrates the X-ray crystal structure of meso 
octamethylcalix4pyrrole bis-methanol complex, 1.2 
MeOH. The meso-octamethylcalix4pyrrole adopts a 1,3- 
alternate conformation wherein two NH groups bind to each 
methanol. Thermal ellipsoids are at the 30% probability 
level. 
FIG. 3B illustrates the X-ray crystal structure of meso 
octamethylcalix4pyrrole bis-dimethylformamide complex, 
1.2 DMF. The meso-octamethylcalix4pyrrole adopts a 
1,2-alternate conformation wherein two NH groups bind to 
each dimethylformamide. Thermal ellipsoids are at the 30% 
probability level. 
FIG. 3C illustrates the X-ray crystal structure of meso 
octamethylcalix4pyrrole dimethylsulfoxide complex, 
1. DMSO. The meso-octamethylcalix4pyrrole adopts a 1,3- 
alternate conformation wherein one NH group binds to a 
dimethylsulfoxide. Thermal ellipsoids are at the 30% prob 
ability level. 
FIG. 4 illustrates the X-ray crystal structure of tetrabuty 
lammonium Salt of calix4pyrrole, 4. Calix4pyrrole 
anions Self-assemble in the Solid State forming dimerS. 
Thermal ellipsoids are at the 30% probability level. Counter 
cations are omitted for clarity. 
FIG. 5 illustrates the X-ray crystal structure of a meso 
octabenzylcalix4pyrrole acetone complex, 6.3(acetone). 











mation wherein one NH group binds to an acetone. An 
unbound acetone molecule in the crystal lattice is omitted 
for clarity. Thermal ellipsoids are at the 30% probability 
level. 
FIG. 6 illustrates the X-ray crystal structure of meso 
tetrakis-tetrahydrothiopyranylcalix4pyrrole, 7, adopting a 
1,3-alternate conformation. Thermal ellipsoids are at the 
30% probability level. 
FIG. 7 illustrates an X-ray crystal structure of 
f-octabromo-meso-octamethylcalix4pyrrole, 14, adopting 
a 1,3-alternate conformation. Thermal ellipsoids are at the 
30% probability level. 
FIG. 8 illustrates an X-ray crystal structure of a meso 
tetramethylcalix4pyrrole-p-tert-butylcalix4arene pseudo 
dimer, 15. Thermal ellipsoids are at the 30% probability 
level. 
FIG. 9 illustrates a "H NMR of a meso-tetramethylcalix 
4pyrrole-p-tert-butylcalix4arene pseudo dimer in 
CDC1. 
FIG. 10 illustrates a sodium chloride complex of calix4 
pyrrole-crown ether conjugate, 32. 
FIG. 11A illustrates a cyclic voltammogram of 
compound, 33, conducted in dichloromethane at a Scan rate 
of 100 mV/sec. Working electrode: platinum disk, counter 
electrode: platinum wire, reference electrode: Ag/AgCl. 0.1 
M tetrabutylammonium hexafluorophosphate as base elec 
trolyte. Scale equals 2 microamps. 
FIG. 11B illustrates a cyclic voltammogram of 
compound, 34, conducted in dichloromethane at a Scan rate 
of 100 mV/sec. Working electrode: platinum disk, counter 
electrode: platinum wire, reference electrode: Ag/AgCl. 0.1 
M tetrabutylammonium hexafluorophosphate as base elec 
trolyte. Scale equals 2 microamps. 
FIG. 12A illustrates a cyclic voltammogram of solutions 
of compound, 33, and 2 equivalents of tetrabutylammonium 
fluoride (1), tetrabutylammonium chloride (2), and tetrabu 
tylammonium dihydrogenphosphate (3) conducted in 
dichloromethane at a scan rate of 100 mV/sec. Working 
electrode: platinum disk, counter electrode: platinum wire, 
reference electrode: Ag/AgCl, 0.1 M tetrabutylammonium 
hexafluorophosphate as base electrolyte. Scale equals 5 
microamps. 
FIG. 12B illustrates a cyclic voltammogram of solutions 
of compound, 34, and 2 equivalents of tetrabutylammonium 
fluoride (1), tetrabutylammonium chloride (2), and tetrabu 
tylammonium dihydrogenphosphate (3) conducted in 
dichloromethane at a scan rate of 1200 mV/sec. Working 
electrode: platinum disk, counter electrode: platinum wire, 
reference electrode: Ag/AgCl, 0.1 M tetrabutylammonium 
hexafluorophosphate as base electrolyte. Scale equals 5 
microamps. 
FIG. 13 illustrates a calix4)pyrrole-R-(+)-a- 
methylbenzylamine conjugate, 40, -fluoride complex repre 
Sented as a diastereomeric mixture. 
FIG. 14 illustrates the hydrogen bond donating capabili 
ties of a meso-mono-butylamidotrispirocyclohexylcalix4 
pyrrole, 28, complexed to an anion. 
FIG. 15A illustrates mesosubstituted-calix 4-pyrrole Sub 
Stituted Silica gel, M. 
FIG. 15B illustrates B-substituted-calix4pyrrole substi 
tuted Silica gel, B. 
FIG. 16 illustrates the separation of phenyl arsenate (1), 
benzene Sulfonate (2), benzoate (3), and phenyl phosphate 
(4) on a meso-Substituted calix4pyrrole column: mobile 
phase, 50 mM phosphate buffer, pH=7.0; flow rate 0.3 
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mL/min.; column temperature 25 C.; detection 254 nm 
(0.100 AUFS). 
FIG. 17 illustrates the separation of 5'-adenosine mono 
phosphate (1), 5'-adenosine diphosphate (2), and 
5'-adenosine triphosphate (3) on a meso-Substituted calix4 
pyrrole column: mobile phase 250 mM phosphate buffer, 
pH=7.0; flow rate 0.3 mL/min.; column temperature 25 C.; 
detection 254 nm (0.100 AUFS). 
FIG. 18 illustrates the separation of 5'-adenosine mono 
phosphate (1), 5'-adenosine diphosphate (2), and 
5'-adenosine triphosphate (3) on a f-substituted calix4 
pyrrole column: mobile phase 105 mM phosphate buffer, 
pH=7.0; flow rate 0.20 mL/min.; column temperature 25 
C.; detection UV at 254 nm (0.100 AUFS). 
FIG. 19 illustrates the separation of uridine (1), phenol 
(2), aniline (3), benzene (4), and 4-iodo-nitrobenzene (5) on 
a meso-Substituted calix4pyrrole column: mobile phase 
60% water/40% acetonitrile (v/v); flow rate 0.3 mL/min.; 
column temperature 25 C.; detection 254 mm (0.100 
AUFS). 
FIG. 20 illustrates the separation of Cbz-N-protected 
Serine (1), glutamine (2), alanine (3), phenylalanine (4), 
tryptophan (5), aspartate (6), and glutamate (7) on a meso 
substituted calix 4-pyrrole column: mobile phase 70%. 30 
mMacetate buffer, pH=7.0/30% CHCN (v/v); flow rate 0.3 
mL/min.; column temperature 25 C., detection 254 nm 
(0.100 AUFS). 
FIG. 21 illustrates the separation of Cbz-N-protected 
Serine (1), leucine (2), alanine (3), phenylalanine (4), tryp 
tophan (5), aspartate (6), and glutamate (7) on a 
B-substituted calix4pyrrole column: mobile phase 75/25 
30 mM acetate buffer, pH=7.0/acetonitrile; flow rate 0.20 
mL/min.; column temperature 25 C.; detection UV at 254 
nm (0.100 AUFS). 
FIG.22 illustrates the separation of 4-fluorobiphenyl (1), 
4,4'-difluorobiphenyl (2), 2,2',3,3',5,5", 6,6',- 
octafluorobiphenyl (3), and perfluorobiphenyl (4) on a 
meso-substituted calix4pyrrole column: mobile 60% 
water/40% acetonitrile (v/v); flow rate 0.3 mL/min.; column 
temperature 25° C.; detection 254 nm (0.100 AUFS). 
FIG. 23 illustrates the separation of 4-fluorobiphenyl (1), 
4,4'-difluorobiphenyl (2), 2,2',3,3',5,5", 6,6',- 
octafluorobiphenyl (3), and perfluorobiphenyl (4), on a 
B-substituted calix 4-pyrrole column: mobile 76% water/ 
24% acetonitrile (v/v); flow rate 0.2 mL/min.; column 
temperature 25° C.; detection 254 nm (0.100 AUFS). 
FIG. 24 illustrates the separation of a mixture of 
poly deoxythymidilates oligomers containing between (12) 
and (18) base pairs on a meso-Substituted calix4pyrrole 
column: mobile phase 50/50 acetonitrile/50 mM phosphate, 
250 mM chloride buffer, pH=6.8 (v/v); flow rate 0.4 
mL/min.; column temperature 25 C.; detection UV at 265 
. 
FIG. 25 illustrates the separation of a mixture of 
poly deoxythymidilates oligomers containing between (12) 
and (18) base pairs on a f-substituted calix4pyrrole col 
umn: mobile phase 40/60 acetonitrile/40 mM phosphate, 50 
mM chloride buffer, pH=7.0 (v/v), flow rate 0.25 mL/min...; 
column temperature 25 C.; detection UV at 262 nm (0.100 
AUFS). 
FIG. 26 illustrates the separation of TCTAGA, (1), 
GCATGC, (2), and CCCGGG, (3), on a meso-substituted 
calix 4-pyrrole column: mobile phase 50/50 acetonitrile/50 
mM sodium phosphate, pH=7.0 (v/v); flow rate 0.4 
mL/min.; column temperature 25 C.; detection UV at 265 











DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENTS 
The present invention provides ?-Substitued calixn 
pyrroles, calixmpy ridines, calixnpyrrole-anion 
complexes, calixmpyridinonpyrrole-anion complexes, 
calixnpyrrole-neutral molecule complexes, calixm 
pyridinonpyrrole-neutral molecule complex, calixm 
pyridinonpyrrole-cation complexes, calixmpyridine 
cation complexes, calixmpyridine-neutral molecule 
complexes and certain meso-Substituted calix4pyrroles, 
meso-Substituted calixnpyrroles where n is 5, 6, 7, or 8, 
certain calixmpyridinonpyrroles, where m+n=4, and 
calixmpyridinonpyrroles where m+n=5, 6, 7, or 8 as new 
compositions of matter. 
Specific anions bound by macrocycles of the present 
invention include, but are not limited to, halide anions, 
carboxylates, phosphates, Sulfates, oxalates, terephthalates, 
phospholipids, nucleotides, oligonucleotides, DNA, RNA, 
anionic polyoxometalates, or oxoanions Such as pertechne 
tate as demonstrated in the examples herein, Size and charge 
of the anion appear not to be limiting factors in the type of 
anion that may be bound Since oligonucleotides are able to 
be separated on calix4pyrrole modified HPLC columns. 
The term "molecular species” as used herein, means a 
neutral molecule, and represents a variety of classes of 
molecules Since the macrocycles of the present invention 
provide different sizes of cavities and varieties of donor and 
acceptor Sites. Specific neutral molecules include, but are 
not limited to, alcohols, polyalcohols, ketones, polyketones, 
phenols, polyhydroxylated aliphatic and aromatic 
compounds, amino compounds, amino acids, urea, 
guanidine, Saccharides, biologically important polymers like 
proteins derivatives, and the like. Additionally, neutral mol 
ecules include, but are not limited to, ion pairS Such as NaCl, 
CSI, or any grouping of ions which is neutral overall, or 
Zwitterionic Species Such as amino acids and the like. 
Specific cations include, but are not limited to, Group 1 
metals, Group 2 metals, transition metals, post-transition 
metals, lanthanides, actinides, ammonium, alkylammonium, 
arylammonium, hydroxonium and guanidinium. 
Carbon atoms in pyrrole rings are referred to as C. or f3, C. 
carbons are adjacent to the NH group and 3-carbons are 
adjacent to the C-carbons (see IV). In an alternative 
designation, the nitrogen atom is labelled 1 and the other 
atoms are numbered Sequentially starting from an adjacent 
carbon atom. Thus, the C-carbons are also referred to as 
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Similarly, carbon atoms in pyridine rings are referred to as 
C, B or y; C. carbons are adjacent to the Natom, B-carbons 
are adjacent to the C-carbons and the Y-carbon is adjacent to 
the two f-carbons (see V). In an alternative designation, the 
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nitrogen atom is labelled 1 and the other atoms are numbered 
Sequentially Starting from an adjacent carbon atom. Thus, 
C-carbons are also referred to as atoms 2 and 6, B-carbons 
as atoms 3 and 5, and the y-carbon as atom 4. 
AS used herein, “a non-C, non-meSO, macrocyclic carbon' 
means a B or a Y carbon; and "macrocyclic nitrogen' means 
a pyrrole or pyridine nitrogen. 
Substituents for Macrocycles of the Present 
Invention 
Representative examples of alkanes useful as alkyl group 
Substituents of the present invention include Straight-chain, 
branched or cyclic isomers of propane, butane, pentane, 
hexane, heptane, octane, nonane, and decane, with methane, 
ethane, propane, and cyclohexane being preferred. Alkyl 
groups having up to about thirty, or up to about fifty carbon 
atoms are contemplated in the present invention. Represen 
tative examples of Substituted alkyls include alkyls Substi 
tuted by two or more functional groups as described herein. 
Representative examples of alkenes useful as alkenyl 
group Substituents include ethene, Straight-chain, branched 
or cyclic isomers of propene, butene, pentene, hexene, 
heptene, octene, nonene, and decene, with ethene and pro 
pene being preferred. Alkenyl groups having up to about 
thirty or fifty carbon atoms, and up to about five double 
bonds, or more preferably, up to about three double bonds 
are contemplated in the present invention. 
Representative examples of alkynes useful as alkynyl 
group Substituents include ethyne, Straight-chain, branched 
or cyclic isomers of propyne, butyne, pentyne, heXyne, 
heptyne, octyne, nonyne, and decyne, with ethyne and 
propyne being preferred. Alkynyl groups having up to about 
thirty, or up to about fifty carbon atoms, and having: up to 
about five or up to about three triple bonds are contemplated 
in the present invention. 
The aryl may be a compound whose molecules have the 
ring Structure characteristic of benzene, naphthalene, 
phenanthrene, anthracene, and the like, i.e., either the 
6-carbon ring of benzene or the condensed 6-carbon rings of 
the other aromatic derivatives, or a compound whose mol 
ecules have the ring Structure characteristic of pyridine i.e., 
a 5-carbon-1-heteroatom ring, or pyrrole i.e., 4-carbon-1- 
heteroatom ring Such as, but not limited to, pyrrole, furan, or 
thiophene or the condensed 5-or 6-atom rings of the other 
aromatic derivatives. For example, an aryl group may be 
phenyl or naphthyl, and the terms used herein include both 
unsubstituted aryls and aryls Substituted with one or more 
nitro, carboxy, Sulfonic acid, hydroxy, oxyalkyl or halide 
Substituent. Purine or pyrimidine molecules are included as 
“aryl” molecules. In this case, the Substituent on the phenyl 
or naphthyl may be added in a Synthetic Step after the 
condensation Step which forms the macrocycle. 
Among the halide Substituents, chloride, bromide, fluo 
ride and iodide are contemplated in the practice of this 
invention. Representative examples of haloalkyls used in 
this invention include halides of methane, ethane, propane, 
butane, pentane, hexane, heptane, octane, nonane and 
decane, with halides, preferably chlorides or bromides, of 
methane, ethane and propane being preferred. Representa 
tive examples of haloalkenyls used in this invention include 
halides of methene, ethene, propene, butene, pentene, 
hexene, heptene, octene, nonene and decene, with halides, 
preferably chlorides or bromides, of methene, ethene and 
propene being preferred. Representative examples of 
haloalkynyls used in this invention include halides of 











heptyne, octyne, nonyne and decyne, with halides, prefer 
ably chlorides or bromides, of methyne, ethyne and propyne 
being preferred. 
“Hydroxyalkyl” means alcohols of alkyl groups. Pre 
ferred are hydroxyalkyl groups having one to twenty, more 
preferably one to ten, hydroxyls. “Hydroxyalkyl” is meant to 
include glycols and polyglycols, diols of alkyls, with diols 
of C1-10 alkyls being preferred, and diols of C1-3 alkyls 
being more preferred; and polyethylene glycol, polypropy 
lene glycol and polybutylene glycol as well as polyalkylene 
glycols containing combinations of ethylene, propylene and 
butylene. 
Representative examples of alkoxys include the alkyl 
groups as herein described having ether linkages. "Alkoxy” 
is meant to include polyethers with one or more functional 
groups. The number of repeating alkoxys within a Substitu 
ent may be up to 200, preferably is from 1-20, and more 
preferably, is 1-10, and most preferably is 1-5. A preferred 
alkoxy is O(CH2CH2O)CH where X=1-100, preferably 
1-10, and more preferably, 1-5. 
“Crown ether” means a cyclic polyether with repeating 
alkoxy groups. They are named according to the number of 
atoms and the number of oxygens in the cycle. S-crown-T is 
a cyclic polyether containing S atoms and T oxygen atoms. 
Preferred are crown ethers containing one to twenty oxygen 
atoms, more preferably one to ten. Representative examples 
include, but are not limited to, 12-crown-4, 15-crown-5, 
benzo-15-crown-5, 18-crown-6, benzo-18-crown-6, 
21-crown-7, 24-crown-8, dibenzo-18-crown-6 and function 
alized derivatives thereof. 
“Hydroxyalkenyl' means alcohols of alkene groups. Pre 
ferred are hydroxyalkenyl groups having one to twenty, 
more preferably one to ten, hydroxyls. 
“Hydroxyalkynyl' means alcohols of alkyne groups. Pre 
ferred are hydroxyalkenyl groups having one to twenty, 
more preferably one to ten, hydroxyls. 
“Hydroxyalkoxy' means alkyl groups having ether or 
ester linkages, hydroxyl groups, Substituted hydroxyl 
groups, carboxyl groups, Substituted carboxyl groups or the 
like. 
Representative examples of thioalkyls include thiols of 
ethane, thiols of Straight-chain, branched or cyclic isomers 
of propane, butane, pentane, heXane, heptane, octane, 
nonane and decane, with thiols of ethane (ethanethiol, 
CHSH) or propane (propanethiol, CH,SH) being pre 
ferred. Sulfate-substituted alkyls include alkyls as described 
above Substituted by one or more Sulfate groups, a repre 
Sentative example of which is diethyl Sulfate ((CH3)2SO). 
“Alkylsulfoxide” means alkyl groups having S=O 
groupS. Preferred are alkylsulfoxide groups having one to 
twenty, more preferably one to ten, Sulfoxides. Alkylsulfox 
ide is meant to include cyclic alkyl groups containing 
Sulfoxide moieties. 
“Alkylsulfone” means alkyl groups having S(=O). 
groupS. Preferred are alkylsulfone groups having one to 
twenty, more preferably one to ten, Sulfones. Alkylsulfone is 
meant to include cyclic alkyl groups containing Sulfone 
moieties. 
“Alkylsulfide” means alkyl groups having S groupS. Pre 
ferred are alkylsulfide groups having one to twenty, more 
preferably one to ten, Sulfides. Alkylsulfide is meant to 
include cyclic alkyl groups containing Sulfide moieties Such 
as tetrahydrothiopyran derivatives. 
Representative examples of phosphates include phosphate 
groups, polyphosphate groups, DNA, RNA, oligonucle 
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otides and nucleotides. Representative examples of 
phosphate-Substituted alkyls include alkyls as described 
above Substituted by one or more phosphate or polyphos 
phate groups. Representative examples of phosphonate 
substituted alkyls include alkyls as described above substi 
tuted by one or more phosphonate groups. 
Representative examples of carboxy groups include car 
boxylic acids of the alkyls described above as well as aryl 
carboxylic acids Such as benzoic acid and derivatives 
thereof. Representative examples of carboxyamides include 
peptides, proteins, primary carboxyamides (CONH2), Sec 
ondary (CONHR') and tertiary (CONR'R") carboxyamides 
where each of R' and R" is a functional group as described 
herein. 
Representative examples of useful amines include a 
primary, Secondary or tertiary amine of an alkyl or aryl as 
described herein. 
“Carboxyamidealkyl means alkyl groups with Secondary 
or tertiary amide linkages or the like. “Carboxyalkyl” means 
alkyl groups having hydroxyl groups, carboxyl or amide 
Substituted ethers, ester linkages, tertiary amide linkages 
removed from the ether or the like. 
The term "saccharide' includes oxidized, reduced or 
Substituted Saccharide; heXOSes Such as D- or L-glucose, D 
or L-mannose or D- or L-galactose, pentoses Such as D- or 
L-ribose or D- or L-arabinose, ketoses Such as D- or 
L-ribulose or D- or L-fructose; disaccharides Such as 
Sucrose, lactose, or maltose, derivatives Such as acetals, 
amines, and phosphorylated Sugars, oligosaccharides or 
polysaccharides, Such as aliginic acid as well as open chain 
forms of various Sugars, and the like. Examples of amine 
derivatized Sugars are galactosamine, glucosamine, Sialic 
acid and D- and L-glucamine derivatives Such as 1-amino 
1-deoxysorbitol. 
By “reporter group' is meant a Substituent that is 
fluorescent, chromophoric, electropolymerizable, redox 
active, or optically active. Examples of a fluorescent reporter 
group include, but are not limited to, ruthenium (II) bipy 
ridyl complexes, acetylnaphthalene, 9-aminoacridine, 
9-phenylanthracene, benzimidazole, N-methylbenzob 
carbazole, 2-phenylbenzoxazole, 1,1'-binaphthyl, fluorene, 
fluoresce in dianion, inde no 2, 1-alindene, 2,5- 
diphenylfuran, perylene, 2-aminopurine, p-quatephenyl, 
4,4'-diphenylstilbene, Sapphyrins and texaphyrins. 
Examples of a chromophoric reporter groups include isoS 
ulfan blue, fluoroscein, 2,7'-dichlorofluoroscein, 
rhodamine, carboxyrhodamine, dialkylaminocoumarin, 
erythrosin, pyrene, 9-(diethylamino)-5-octadecanoylimino 
5 H-benzoaphenoxazine, 5-octadecanoyloxy-2-(4- 
nitrophenylazo)phenol, 9-(diethylamino)-5 -(2- 
naphtoy limino)-5 H-benzoaphenoxazine, 4',5'- 
dibromoflurescein octadecyl ester, 2-(4-nitrophenylazo) 
chromotropic acid disodium Salt, 2-(phenylazo) 
chromotropic acid disodium Salt, 4.5-dihydroxynaphtalene 
2,7-disulfonic acid disodium salt, , 5,7-dihydroxyflavone, 
5,7-dinitro-8-hydroxy-2-naphthalenesulphonic acid, 6,6'- 
(3,3'-dimethyl1,1'-biphenyl)4,4'-diyl)bis(azo)bis 4 
amino-5-hydroxy-1,3-naphthalene disulfonic acid 
tetrasodium salt, 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5', 
7"-tetraiodospiro isobenzofuran-1 (3H).9'-9Hxanthen-3- 
one dipotassium salt, 3.7-bis(dimethylamino)phenothiazin 
5-ium chloride, 3,6-bis(dimethylamino) acridine 
hydrochloride zinc chloride double salt (Acridine Orange), 
Sapphyrins and texaphyrins. By “electropolymerizable' is 
meant a moiety that will polymerize when Subjected to a 











potential. Examples of an electropolymerizable group 
include, but are not limited to, C-free pyrroles, C.-free 
thiophenes, anilines or vinyl groups. By “redox-active' is 
meant a moiety which can undergo an oxidation or a 
reduction process. Examples of a redox-active group 
include, but are not limited to, ferrocene, cobaltocenium, 
ruthenium (II) bipyridyl complexes, transition metals, 
fullerenes, porphyrins, expanded porphyrins and pyrroles. 
In one embodiment of the present invention, a calixn 
pyrrole, calixmpyridinonpyrrole or calixmpyridine is 
further coupled to a site-directing molecule. “Site-directing 
means having Specificity for targeted Sites. “Specificity for 
targeted sites' means that upon contacting the calixn 
pyrrole-, calixmpyridinonpyrrole- or calixmpyridine 
conjugate with the targeted Site, for example, under physi 
ological conditions of ionic Strength, temperature, pH and 
the like, Specific binding will occur. The interaction may 
occur due to Specific electroStatic, hydrophobic, or other 
interaction of certain residues of the conjugate with Specific 
residues of the target to form a stable complex tinder 
conditions effective to promote the interaction. 
Exemplary Site-directing molecules contemplated in the 
present invention include but are not limited to: polydeOX 
yribonucleotides, polyribonucleotides, oligodeoxyribo 
nucleotides, oligoribonucleotides, polyamides, including 
peptides having affinity for a biological receptor, and pro 
teins Such as antibodies, Steroids and Steroid derivatives, 
hormones Such as estradiol, or histamine, hormone mimics 
Such as morphine; and further macrocycles Such as 
teXaphyrins, Sapphyrins or rubyrins. 
Representative examples of useful Steroids include a 
Steroid hormone of the following five categories: progestins 
(e.g. progesterone), glucocorticoids (e.g., cortisol), miner 
alocorticoids (e.g., aldosterone), androgens (e.g., 
testosterone) and estrogens (e.g., estradiol). 
The term “a peptide having affinity for a biological 
receptor” means that upon contacting the peptide with the 
biological receptor, for example, under appropriate condi 
tions of ionic Strength, temperature, pH and the like, Specific 
binding will occur. The interaction may occur due to specific 
electroStatic, hydrophobic, entropic or other interaction of 
certain amino acid or glycolytic residues of the peptide with 
Specific amino acid or glycolytic residues of the receptor to 
form a stable complex under the conditions effective to 
promote the interaction. The interaction may alter the three 
dimensional conformation and the function or activity of 
either or both the peptide and the receptor involved in the 
interaction. A peptide having affinity for a biological recep 
tor may include an endorphin, an enkephalin, a growth 
factor, e.g. epidermal growth factor, poly-L-lysine, a 
hormone, a peptide region of a protein and the like. A 
hormone may be estradiol, for example. 
Representative examples of useful amino acids of pep 
tides or polypeptides include amino acids with Simple ali 
phatic side chains (e.g., glycine, alanine, Valine, leucine, and 
isoleucine), amino acids with aromatic side chains (e.g., 
phenylalanine, tryptophan, tyrosine, and histidine), amino 
acids with oxygen-, and Sulfur-containing side chains (e.g., 
Serine, threonine, methionine, and cysteine), amino acids 
with Side chains containing carboxylic acid or amide groups 
(e.g., aspartic acid, glutamic acid, asparagine, and 
glutamine), and amino acids with side chains containing 
Strongly basic groups (e.g., lysine and arginine), and proline. 
Representative examples of useful peptides include any 
naturally occurring or Synthetic di-, tri-, tetra-, pentapeptides 
or longer peptides derived from any of the above described 
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amino acids (e.g., endorphin, enkephalin, epidermal growth 
factor, poly-L-lysine, or a hormone). Representative 
examples of useful polypeptides include both naturally 
occurring and Synthetic polypeptides (e.g., insulin, 
ribonuclease, and endorphins) derived from the above 
described amino acids and peptides. 
The term “binding agent’ means that upon contacting the 
binding agent with a guest Species for binding under appro 
priate conditions of ionic strength, temperature, pH and the 
like, Specific binding will occur. The interaction may alter 
the three-dimensional conformation and the function or 
activity of either or both the bound species and the receptor 
involved in the interaction. Preferred binding agents include 
a calixnlpyrrole, a calixmpyridinonpyrrole, a calixm 
pyridine, a calixarene, a cation-binding functionality, a 
crown ether, a chelating group, a porphyrin, or an expanded 
porphyrin Such as Sapphyrin, rosarin, rubyrin, texaphyrin, 
amethyrin or turcasarin, or oligopyrroles. 
Texaphyrin compounds, methods for making and methods 
for using them are described in U.S. Pat. Nos. 4,935,498, 
5,162,509, 5,252,720, 5,272,142, 5,256,399, 5,292,414, 
5,432,171, 5,439,570, 5,475,104, 5,451,576, 5,457,183, 
5,369,101, 5,569,759, 5,559,207, 5,587,463, 5,594,136, and 
5,599,923; in pending application U.S. Ser. No. 08/484,551; 
and in PCT publications WO 90/10633, WO 93/14093, WO 
94/29316, and WO 96/38461; each patent, application, and 
publication is incorporated by reference herein. 
Rubyrins are disclosed in U.S. Pat. No. 5,410,045, and 
turcasarins are disclosed in PCT publication WO 96/21665; 
the patent and PCT publication are incorporated by refer 
ence herein. 
Sapphyrins are disclosed in U.S. Pat. Nos. 5,041,078; 
5,159,065; 5,120,411; 5,302,714; 5,457,195; 5,530,123; 
5,543,514; and 5,587,478; each patent is incorporated by 
reference herein. 
A “catalytic group, as used herein, means a chemical 
functional group that may act as a general acid, Brönsted 
acid, Lewis acid, general base, Brònsted base, Lewis base, 
nucleophile, or any other means by which an activation 
barrier to reaction is lowered or the ground State energy of 
a Substrate is increased. Exemplary catalytic groups con 
templated include, but are not limited to, imidazole, guani 
dine; Zinc coordinated to a nitrogen containing macrocycle, 
EDTA complexes, DTPA compleses, substituted Saccharides 
Such as a D-glucosamine, D-man no Samine, 
D-galactosamine, D-glucamine, and the like, amino acids 
Such as L-histidine and L-arginine, derivatives of amino 
acids Such as histamine; polymers of amino acids Such as 
poly-L-lysine, (LySAla), (LySLeu Ala), where n is from 
1-30 or preferably 1-10 or more preferably 2-7 and the like. 
The catalytic group may be attached either directly to the 
calixnlpyrrole, calixmpyridinonpyrrole or calixm 
pyridine or via a linker or couple of variable length. 
A couple may be described as a linker, i.e. the covalent 
product formed by reaction of a reactive group designed to 
attach covalently another molecule at a distance from the 
calixnlpyrrole, calixmpyridinonpyrrole or calixm 
pyridine macrocycle. Exemplary linkers or couples are 
amides, amine, disulfide, thioether, ether, ester, or phosphate 
covalent bonds. 
In most preferred embodiments, conjugates and appended 
groups are covalently bonded to the calixnpyrrole via a 
carbon-carbon, carbon-nitrogen, carbon-Sulfur, or a carbon 
oxygen bond, more preferably a carbon-carbon, carbon 
oxygen or a carbon-nitrogen bond. 
Preferred embodiments of the present invention include a 











where m+n is 4-8; other than when each of m and n is 2, and 
other than when m is 1 and n is 3; or calixmpyridine where 
n is 4-8; where at least one Substituent attached to a 
meso-carbon is carboxy or carboxyalkyl, or at least one 
SubSituent attached to a B- or Y-carbon is other than 
hydrogen, or at least one Substituent attached to a B- or 
Y-carbon is carboxy, carboxyalkyl, ester or carboxyamide. 
Further preferred embodiments of the present invention 
include a calixnpyrrole; a calixmpyridinonpyrrole 
where n is 4-8 other than when each of m and n is 2, and 
other than when m is 1 and n is 3; or calixmpyridine where 
m is 4-8; where at least one of the nitrogen atoms is bound 
to hydrogen. A calix4pyrrole where all pyrrole nitrogen 
atoms are bound to hydrogen, where meso-carbons are 
bound to methyl, and one B-substituent is (CH),COOH 
where 1sts 10. Another preferred calix4pyrrole has each 
of three meso-carbons bridged to itself in a Spirocyclohexyl 
Substituent, one meso-carbon is bonded to a methyl group 
and to a -CHCH-CHCOOH group, B-subsituents are 
hydrogen and pyrrolic nitrogens are bound to hydrogen. 
Most preferred macrocycles of the present invention are 
as follows. 
Com 















15 meso-p-tert-butyl-calixarene-tetramethylcalix4pyrrole pseudo 
dimer 









29 mono-meso-butylamido-heptamethylcalix 4-pyrrole 
30 mono-f-octadecyl-meso-octamethylamidocalix4pyrrole 
31 propyl bridged f-amido-meso-octamethylcalix4pyrrole dimer 







glucopyranosecalix4pyrrole conjugate (chiral) 
37 2-amido-2-deoxy--D-glucopyranosecalix4pyrrole conjugate 
(chiral) 
38 meso-tetraspiro-4-cholesten-3-onylcalix4pyrrole (chiral) 
39 meso-tetrabinaphthal-meso-tetramethylcalix 4-pyrrole (chiral) 





Most preferred are macrocycles 3, 4, 10, 12 and solid 
supported materials Gel M and Gel B. 
While the cited calixnpyrroles, calixmpyridinon 
pyrroles or calixmpyridines are presently preferred for use 
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in the present invention, the invention is not limited thereto 
and any calixnpyrrole, calixmpyridinonpyrrole or calix 
Impyridine may be used. 
Synthetic Methods for Macrocycles of the Present 
Invention 
The present disclosure provides a number of different 
methods for making macrocycles of the present invention. 
The following preferred embodiments are described. 
Calixnpyrroles having an ester functionality at a meso 
carbon. A method of making a calixnpyrrole having an 
ester functionality at a meso-carbon comprises reacting a 
ketone having one or more ester functionalities with a 
pyrrole in the presence of a Brønsted acid. The method of 
invention additionally compriseS reacting a mixture of 
ketones containing one or more ester functionalities and 
ketones not containing ester functionalities with a Brónsted 
acid to provide a range of ester functionalities. Examples of 
ketones having one or more ester functionalities include, but 
are not limited to, methylacetylbutyrate, acetylpropionate 
and acetylpentanoate. Examples of pyrroles include, but are 
not limited to, pyrrole, 3,4-diethylpyrrole, 3,4- 
dimethoxypyrrole or 3-butylpyrrole. Examples of Bronsted 
acids include, but are not limited to HCl, methanesulfonic 
acid, toluenesulfonic acid, benzenesulfonic acid, HCIO, 
formic acid, acetic acid, Sulfuric acid or phosphoric acid. 
AS demonstrated in Example 2, methylacetylbutyrate was 
reacted with pyrrole and cyclohexanone in the presence of a 
Brónsted acid to form a macrocyclic Structure comprised of 
in pyrrole units, where n is 4, 5, 6, 7, or 8 and the number of 
ester functionalities is equal to 1 to n. 
Calixnpyrroles having an acid functionality at a meso 
carbon. This method embodiment for making calixn 
pyrroles having an acid functionalities at a meso-carbon 
comprises de-esterifying an ester-functionalized calixn 
pyrrole where n is 4, 5, 6, 7 or 8. De-esterifying may be 
accomplished by heating the ester-functionalized calixn 
pyrrole in a water/ethanol Solution in the presence of Sodium 
hydroxide and Subsequent acidification and extraction of the 
calixpyrrole acid. 
Addition of an electrophile to a calixnlpyrrole to form a 
B-substituted calixnpyrrole. This method embodiment 
comprises activating a calixnpyrrole, where n is 4, 5, 6, 7 
or 8 and reacting the activated calixnpyrrole with an 
electrophile to make a f-substituted calixnlpyrrole. 
Examples of activation include, but are not limited to, 
deprotonation with a Brónsted base Such as n-butyl lithium, 
tert-butyl lithium, or phenyl lithium, or a Brønsted base in 
conjunction with a complexing agent Such as tetramethyl 
ethylenediamine. Examples of electrophiles include, but are 
not limited to, ethylbromoacetate, methylbromoacetate, 
acrylonitrile, methyl acrylate, acyl chloride, alkyl halide, 
functionalized alkyl halides or carbon dioxide. An exem 
plary method is found in Example 3. 
f-Substituted calixnlpyrroles. A method of making a 
B-subtituted calixnpyrrole where n is 4, 5, 6, 7, or 8 
comprises reacting a 3-Substituted pyrrole with a ketone in 
the presence of a Brønsted acid to produce a B-Substituted 
calixnpyrrole where n is 4, 5, 6, 7 or 8. Examples of 
B-Substituted pyrroles include, but are not limited to, 3,4- 
dimethoxypyrrole, 3,4-diethyl pyrrole 3,4-dimethylpyrrole, 
3,4 diphenylpyrrole, or 3-butylpyrrole. Examples of ketones 
include, but are not limited to, acetone, pentan-3-one, diben 
Zyl acetone, 5-nonone, 4-heptanone, cyclohexanone, or 
cyclopentanone. Examples of Brønsted acids have been 











npyrrole where n is 4, 5, 6, 7, or 8 comprising producing 
a calixnpyrrole radical where n is 4, 5, 6, 7, or 8; and 
reacting the radical with a radical acceptor molecule Such as 
iodine, methyl acrylate or iodoacetamide. An exemplary 
method is described in Example 3. 
Lewis acid condensation. A pyrrole and a ketone are 
reacted in the presence of a Lewis acid to form a calixn 
pyrrole where n is 5, 6, 7, or 8. Examples of ketones and 
pyrroles have been described herein. Examples of Lewis 
acids include, but are not limited to, electron pair acceptors 
containing empty orbitals. Such as aluminum trichloride, 
boron trifluoride, gallium trichloride, or high Valent metals 
Such as titanium (IV), Vanadium (V), tin (IV), manganese 
(III), or UO.". Exemplary methods include the methods 
described in Example 5. 
Heterogeneous condensation. A Synthetic method for het 
erogeneous condensation to form calixnpyrroles where n is 
4, 5, 6, 7 or 8 comprises reacting a pyrrole and a ketone in 
the presence of a heterogeneous catalyst. Examples of 
pyrroles and ketone have been described herein. Examples 
of heterogeneous catalysts include, but are not limited to, 
montmorrilonite, Zeolite, Silica gel, alumina, or a cation 
eXchange Solid Support. Exemplary methods include those 
methods found in Example 5. 
Calixnpyrroles from pyrrole alcohols. A method of 
Synthesis of calixnpyrroles using pyrrole alcohols com 
priseS reacting a ketone-functionalized pyrrole with an alkyl 
metal or aryl metal to form a pyrrole alcohol; condensing the 
pyrrole alcohol with a Lewis acid, a Brónsted acid or a 
heterogeneous catalyst to form a cyclizable pyrrole oligo 
mer; and repeating the condensing n-2 times to form a 
calixnpyrrole. Examples of pyrrole ketones include, but 
are not limited to, 2-acetyl-3,4-diethylpyrrole, 
2-acetylpyrrole, 2-acetyl-3,4-dimethylpyrrole, 
2-alkylacetyl-3,4-disubstituted pyrrole, 2-alkylacetyl-3- 
Substituted pyrrole, or 2-alkylacetyl-4-Substituted pyrrole. 
Examples of alkyl metals include, but are not limited to, 
alkyllithium, Grignard reagent, oroanocuprates, organoZincs 
or organotin compounds. Examples of aryl metals include, 
but are not limited to, phenyllithium. 
Using 2-acetylpyrrole and an alkyl lithium to illustrate the 
method described herein, 2-acetylpyrrole is reacted with 
butyl lithium to produce 1-butyl-1-methyl-1-(2-pyrrolo) 
methanol. 1-Butyl-1-methyl-1-(2-pyrrolo) methanol is con 
densed with 2-acetylpyrrole in the presence of a Brønsted 
acid. The reaction is repeated twice to form a calix4 
pyrrole. 
Non-Covalent Template synthesis. This synthetic method 
embodiment comprises reacting a ketone and pyrrole in the 
presence of a Lewis acid, a Brönsted acid or a heterogeneous 
catalyst in the presence of a template. Examples of pyrroles, 
ketones, Lewis acids, Brønsted acids, and heterogeneous 
catalysts have been given herein. Examples of templates 
include, but are not limited to, tetraphenylporphyrin, hydro 
gen bonding neutral molecules, Such as Sugars, 
cyclodextrins, alcohols or amines or anionic Species Such as, 
halides, carboxylates, Sulfonates or phosphates. 
Using halides to illustrate, but not limit, the methods of 
template Synthesis of calixnpyrroles, pyrrole and acetone 
would be condensed using a Brønsted acid, a Lewis acid or 
a homogeneous catalyst in the presence of a halide. By 
varying the size of the halide, it would be possible to “tune” 
the size of calixnpyrrole where n is 4, 5, 6, 7, or 8. 
Pyrrole Ring Expansion. This synthetic method embodi 
ment compriseS reacting a calixpyrrole or calixpyridinopy 
rrole with a halocarbene in a cycloaddition reaction, con 
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Verting a pyrrole to a pyridine and forming a 
calixpyridinopyrrole or a calixpyridine. Exemplary proce 
dures for this cycloaddition are found herein in Example 6. 
Dihalocarbenes can also be generated from chloroform or 
bromoform in the presence of a strong base (e.g. tert-BuOK) 
or under phase transfer catalysis conditions (e.g. in the 
presence of triethylbenzylammonium bromide) in chloro 
form or bromoform with a concentrated sodium hydroxide 
solution (50%). 
Calixnpyrroles having different Substituents at meso 
carbons. A method of Synthesizing a calixnpyrrole where 
n is 5, 6, 7, or 8 having different Substituents at a meso 
carbon comprises reacting at least two ketones with a 
pyrrole in the presence of a Lewis acid. Examplary ketones 
and Lewis acids are described herein. 
Covalent Template Synthesis. A method of Synthesizing a 
calixnpyrrole where n is 4, 5, 6, 7, or 8 comprising reacting 
pyrrole or a 3-Substituted pyrrole with an n-fold cyclic 
ketone template having in ketone groups is a further embodi 
ment of this invention. n-Fold cyclic ketone templates 
include, but are not limited to, calixnarenes, resorcinn 
arenes, CTV, and cyclic SugarS Such as the C, 3- or 
Y-cyclodextrins. Alternatively, benzene rings Substituted 
with ketone groups, or azacrown ethers with N-pendant 
ketone moieties may serve as templates in the Synthesis of 
the present invention. In one aspect of the invention, it is 
preferred that the ketone groups of the template all be 
pointing in the Same direction. For example, in the case of 
calixarenes, the calixarene is in a cone conformation. 
One skilled in the art of organic Synthesis, in light of the 
present disclosure, could extend and refine the referenced 
basic Synthetic chemistry to produce calixnpyrroles having 
various Substituents. For example, polyether-linked polyhy 
droxylated groups, Saccharide Substitutions in which the 
Saccharide is appended via an acetal-like glycosidic linkage, 
an oligosaccharide or a polysaccharide may be similarly 
linked to a calixnlpyrrole. A carboxylated calixnpyrrole, 
calixmpyridinonpyrrole or calixmpyridine in which the 
acid groups are linked to the calixnpyrrole, calixm 
pyridinonpyrrole or calixmpyridine core via aryl ethers 
or functionalized alkyl Substituents could be converted to 
various amido products wherein the amide linkages Serve to 
append further Substituents. Saccharide moieties may be 
appended via amide bonds. 
Calixarene-calixpyrrole Pseudo Dimers, Multimers 
and Polymers 
Calixnarenes are macrocyclic molecules composed of 
phenol rings linked by methylene groups. According to one 
aspect of the present invention, calixnpyrroles are useful as 
anion binding agents. A method of the invention comprises 
reacting a cyclic ketone-containing compound with pyrrole. 
The number of ketones and the number of pyrroles will be 
equal to n. The cyclic ketone-containing compound acts as 
a template upon which the calixpyrrole is formed, after 
which the synthesized calixpyrrole may be detached from 
the ketone-containing template. Alternatively, where the 
template is a calixarene, the resulting cylindrical calixn 
arene-calixnpyrrole pseudo dimer may be kept intact. 
The cyclic ketone-containing compound may be Selected 
from any cyclophane molecule having in ketone groups. 
Examples of Such molecules include, but are not limited to, 
calixnarenes, resorcinarenes, CTV, and cyclic SugarS Such 
as the cyclodextrins. Alternatively, benzene rings Substituted 
with ketone groups, or azacrown ethers with N-pendant 











the present invention. In one aspect of the invention, it is 
preferred that the ketone groups of the template all be 
pointing in the Same direction. For example, in the case of 
calixarenes, the calixarene is in a cone conformation. 
In order to detach a templated calixnpyrrole, a cleavable 
group is present between the template and the ketone. This 
cleavable group may be covalently linked or non-covalently 
linked. The cleavage group may be, for example, an ester 
that can be Subsequently hydrolyzed, or a benzyl group that 
can be hydrogenated or removed with a de-benzylating 
agent Such as MeSi. Non-covalent interactions may also be 
employed, Such as carboxylic acid dimerization or metal 
complexation between the template and the ketone. 
In the Synthesis, the pyrrole condensation must be acid 
catalysed; the acid may be Selected from a Brónsted acid, 
such as methanesulfonic acid, HCl, HClO, HSO, HNO, 
TFA, HCOH, HPO, a Lewis acid such as VOCl, 
Mn(OAc), SnCl, AlCls, or UO(OAc); and a clay Such as 
montmorrilonite. The Synthesis is carried out in an organic 
Solvent that is compatible with the particular ketone 
containing template utilized. Solvents Such as chloroform, 
dichloromethane, acetonitrile, carbontetrachloride, toluene, 
benzene, and mixtures of these Solvents with methanol, 
ethanol, propanol, and the like may be used. The linker to the 
ketone could also be changed to include any Spacer Such as 
benzyl groups, alkynes, alkenes, ethers, polyethers, 
thioethers, bipyridyl, phenanthroline, anthracene, 
naphthalene, any polyaromatic, quinone, ferrocene, cobal 
tocenium or other metallocene, and the like. 
Using calixarenes to illustrate the method of the present 
invention, the calix4arene skeleton is used as a template, 
around which a calix4pyrrole forms. Although calixarene 
linked and calixarene-capped porphyrins as well as calix 
arenes linked to pyrrole groups are known, to the best of the 
present inventors knowledge, compound 15 represents the 
first example of a calixarene-capped calixpyrrole. 
Calixnpyrroles Derivatives, Multimers, and 
Conjugates 
Example 8 provides for the synthesis of different and 
exemplary derivatives, multimers or conjugates of calixn 
pyrroles. With use of either the meso-"monohook' acid 4 or 
the B-"monohook' acid 12 there exist possibilities of Sub 
Stitution through various functional groups. Formation of an 
amide bond, for example, could lead to attachment of natural 
nucleotides as well as the "unnatural nucleotide analogues. 
Using nucleotide-functionalized calixpyrroles, it may be 
possible to do through-membrane transport of nucleotide 
analog drugs Such as AZT, acyclovir, and the like (Example 
11). Using the case of calix4pyrrole by way of illustration, 
one skilled in the art in light of the present invention would 
appreciate that in addition to one “hook', one may add two, 
three, four, five, Six, Seven, or eight “hooks' at the meso- or 
B-positions of the calixpyrrole. Arrays of calixpyrroles Span 
ning membranes and acting as anion channels analogous to 
cation channels are contemplated by the present inventors. 
By using poly-amine-containing compounds, dimers, trim 
erS and tetramers of calixpyrrole could be used as carriers for 
transporting polyanionic Species through aliphatic mem 
branes. Through NMR work and work with HPLC, it has 
been determined that calix4pyrroles show a higher affinity 
for phosphate anions than other oxyanions. With this in 
mind, arrays of calixpyrroles could be used to encircle RNA 
and DNA molecules, thus providing anti-Viral activity. 
Specificity of binding could be gained by attaching specific 
nucleotides to the calixpyrrole oligomer. Attachment of 
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known nucleotide cleaving agents Such as Fe-EDTA could 
facilitate the site directed cleavage of RNA. Calix4pyrrole 
also binds to carboxylic acid groups by HPLC and could be 
used for extraction of pesticide and herbicide metabolites. 
Additionally, with the addition of a cation-binding 
functionality, amino acid recognition and transport are poS 
Sible. A Solid Silica-Supported calix4pyrrole has shown 
selectivity of various N-benzyl protected amino acids. This 
could lead to specific binding of proteins and interuption of 
enzymatic pathways. The attachment of Sugars, and mono 
and polysaccharides to the calixpyrrole could allow for 
recognition of compounds Such as glucose-6-phosphate. 
By attachment of a redox-active reporter group, calixn 
pyrrole, calixmpyridinonpyrrole or calixmpyridine 
macrocycles may function as potentiometric or amperomet 
ric Sensors for cations, anions, or neutral molecules. 
By attachment of a fluorophoric reporter group, calixn 
pyrrole, calixmpyridinonpyrrole or calixmpyridine 
macrocycles may function as fluorescent Sensors for cations, 
anions, or neutral molecules. 
By attachment of a chromophoric reporter group, calix 
npyrrole, calixmpyridinonpyrrole or calixmpyridine 
macrocycles may function as chromophoric Sensors for 
cations, anions, or neutral molecules. 
Calixnpyrroles, Calixmpyridinonpyrroles and 
Calixmpyridines as Separation Media 
Separation of closely similar molecules from highly com 
plex mixtures requires high resolution techniques. Ion 
eXchange, affinity chromatography, reverse phase 
chromatography, and gel filtration represent current types of 
Separation techniques. The present macrocycles provide a 
new type of Separation media due to non-covalent, primarily 
hydrogen bonding, interaction between the macrocycle and 
a guest. 
In ion exchange, Separation is based on charges carried by 
the Solute molecules. An ion eXchanger includes an 
insoluble matrix or Solid Support to which charged groups 
have been covalently bound. The charged groups are asso 
ciated with mobile counterions. The counter ions can be 
reversibly exchanged with other ions of the same charge 
without altering the matrix. It is possible to have both 
positively and negatively charged exchangers. Positively 
charged exchangers have negatively charged ion (anions) 
available for exchange and are So termed cation exchangers. 
Negatively charged exchangers have positively charges 
counterions and are termed cation eXchangers. The matrix 
may be based on inorganic compounds, Synthetic resins, 
polysaccharides, Silicas, aluminas, or polymeric Supports. 
The nature of the matrix determines its physical properties, 
Such as its mechanical Strength and flow characteristics, its 
behavior towards test Samples, and to Some extent, its 
capacity. 
Affinity chromatography is a type of adsorption chroma 
tography in which the molecule to be purified is specifically 
and reversibly adsorbed by a complementary binding Sub 
stance (ligand) immobilized on an insoluble Support 
(matrix). Cyanogen bromide activation has been the most 
common method for coupling ligands to a matrix. A Suc 
cessful Separation requires that a ligand is available and that 
it can be covalently attached to a chromatatographic bed 
material. It is also important that the immobilized ligand 
retain its specific binding affinity for the Substance of interest 
and that methods are available for selectively desorbing the 












Reverse phase chromatography relies on hydrophobic 
Surfaces, especially silylated alkyl (R,R,R, SiO), on the 
solid support to bind hydrophobic molecules. More polar 
molecules pass through the column unimpeded. The hydro 
phobic media may include aromatic molecules, long chain 
aliphatic hydrocarbons, or cyclic hydrocarbons. 
Separation in gel filtration depends on the different abili 
ties of the various Sample molecules to enter pores in a 
Stationary phase. As a Solute passes down a chromatographic 
bed, its movement depends upon the bulk flow of the mobile 
phase and upon the Brownian motion of the Solute mol 
ecules which causes their diffusion into and out of the 
Stationary phase. Very large molecules that never enter the 
pores move through the chromatographic bed fastest. 
Smaller molecules that can enter the gel pores move more 
Slowly through the column Since they spend a proportion of 
their time within the pores. Molecules are, therefore, eluted 
in the order of decreasing molecular size. 
In contrast to the known methods of chromatography, the 
macrocycles of the present invention provide new principles 
for Separation of ions and molecules. Interactions between 
macrocycles of the present invention and ions and molecules 
are noncovalent, primarily hydrogen bonding. As a result, 
Surprising and unexpected affinities and Selectivities are 
observed for the separation of very similar molecules. For 
instance, the following Sets of anions or neutral molecules 
were Successfully separated (Example 10): 
Phenyl arsenate, benzene Sulfonate, benzoate, and phenyl 
phosphate, 
5'-Adenosine monophosphate, 5'-adenosine diphosphate and 
5'-adenosine triphosphate, 
Uridine, phenol, aniline, benzene, and 4-iodo-nitrobenzene, 
Cbz-N-protected-serine, -glutamine, -alanine, 
-phenylalanine, -tryptophan, -aspartate, and -glutamate; 
4-Fluorobiphenyl, 4,4'-difluorobiphenyl, 2,2',3,3',5,5,6,6'- 
octafluorobiphenyl, and perfluorobiphenyl, 
A mixture of polydeoxythymidylates oligomers containing 
between (12) and (18) bases; 
A mixture of polydeoxythymidylates oligomers containing 
between (19) and (24) bases; 
TCTAGA, GCATGC, and CCCGGG; 
Phthalate, isophthalate and teraphthalate; 
Benzoate, isophthalate, and 1,3,5-tricarboxybenzene, and 
Carbofuran, carbendazim, bromacil, bentazon, carboxin, 
and norflurazon. 
A method of use of the present invention comprises 
Separating a first molecule, a first anion or a first cation from 
a mixture of a first molecule, first anion or first cation, and 
other Species, using a form of Solid Support-immobilized 
calixnlpyrrole, calixmpyridinonpyrrole or calixm 
pyridine by contacting the Solid Support with the mixture to 
Separate a first molecule, first anion or first cation from a 
mixture of first molecule, first anion or first cation and other 
Species. Examples of Solid Supports include, but are not 
limited to, Silica gel, aminopropyl Silica gel, carboxylalky 
lated Silica gels, chloromethylated Silica gel, chloroalkylated 
Silica gel, other functionalized Silica gels, alumina, poly 
acrylamide polymer beads, polystyrene polmer beads, 
Sepharose, SephadeX, agarose, clays, or Zeolites coupled to 
calixnpyrroles, calixmpyridinonpyrroles or calixm 
pyridines. Examples of forms of Solid Supports include, but 
are not limited to chromatography columns, thin-layer chro 
matographic Supports, electrophoresis gels, or capillary 
electrophoresis tubes. Examples of ions or neutral molecules 
to be separated are neutral aromatic or aliphatic Species 
(polymeric, oligomeric and monomeric), a polyhalobiphenyl 
(including polychlororbiphenyl), or anionic species 
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(polymeric, oligomeric and monomeric) Such as nucleotides, 
oligonucleotides, pertechnetate, polyoxometalates or inor 
ganic phosphate. 
The inventors discovery that calixnpyrroles recognize 
and bind phosphate anions led the inventors to reason that 
Such macrocycles would be ideal for use in techniques to 
Separate and purify oligonucleotides. Data provided in 
Example 10 demonstrate that this is the case. 
The present inventors realized that for a Solid Support to 
be most useful, it must not only Separate Similar nucleotides 
and oligonucleotides from one another, it must do So rigor 
ously and correctly based on chain length or size. 
Unfortunately, prior to the present invention, there were no 
Suitable phosphate chelating agents which made this an 
achievable goal for use in either HPLC or electrophoretic 
Separation Systems. AS described in Example 10, the inven 
tors designed and constructed calixpyrrole-based Supports 
and used them to achieve the Separation of nucleotides and 
oligonucleotides, thus overcoming many of the existing 
drawbackS. 
A further utility of Such calixpyrrole-substituted materials 
is their use as tools in the removal of phosphorylated 
environmental contaminents from ground water, Soil, 
foodstuffs, and the like. They may therefore be employed to 
analyze and Separate pesticides Such as, but not limited to, 
carbofuran, carbendazim, bromacil, bentazon, carboxin and 
norflurazon. Calixpyrrole-Substituted Silica gels and col 
umns may be employed in the rapid detection and analysis 
of organophosphorus chemical warfare agents, allowing 
them to be disposed of where necessary. 
Another technical area in which Significant improvements 
could be made is in oligonucleotide analysis. For example, 
automated gene Sequencing is currently carried out using 
either radio- or fluorescent labeled nucleic acid gel electro 
phoresis. This technique is limited by the requirement for 
either Slab or tubular polyacrylamide gels. An alternative 
approach, currently being considered on a research basis, is 
to use capillary electrophoresis. Unfortunately, this is lim 
ited when it comes to achieving Separations based purely on 
electroStatics and oligomer size. A technique, Such as the 
present invention, which would allow for Such separation 
would therefore represent a Significant improvement in this 
aca. 
A method of making a Solid-Supported calixnpyrrole, 
calixmpyridinonpyrrole or calixmpyridine macrocycle 
comprising attaching the macrocycle having a functional 
ized group to a Solid Support, the Solid Support reactive with 
the functionalized group, or to a tether-functionalized Solid 
Support, the tether reactive with the functionalized group is 
a further embodiment of this invention. An exemplary 
method is described in Example 10. 
Two new derivatized Silica gels have been produced. Gel 
M is aminopropyl Silica gel linked to the attached calixpyr 
roles via a calixpyrrole meso-carbon and Gel B is amino 
propyl Silica gel linked to the appended calixpyrrole via a 
calixpyrrole B-carbon. Both gels have been demonstrated to 
Separate mixtures of anions Such as oligonucleotides (dT2 
24), nucleotide S, a romatic poly carboxylate S, 
phenyloxoanions, halides, phosphates and Sulfates in an 
HPLC column (Example 10). Additionally, the calixpyrrole 
modified Silica gels can Separate mixtures of neutral mol 
ecules Such as polyfluorobiphenyls and other aromatic Spe 
cies. Thus, the calixpyrrole modified column Supports offer 
a wide range of Separatory ability. 
The macrocycle modified solid support in the form of a 
chromatography column or capillary electrophoresis tube or 
a contacting proceSS involving the macrocycle modified 













A method of forming a complex of a calixnpyrrole or a 
calixmpyridinonpyrrole and an anion or a neutral 
molecule, comprising contacting the calixnpyrrole or the 
calixmpyridinonpyrrole with the anion or neutral mol 
ecule under conditions effective to allow the formation of the 
complex is another embodiment of this invention. 
Another embodiment of this invention is a method of 
transporting a molecular or ionic Species through a mem 
brane comprising incorporating a calixnlpyrrole or a calix 
mpyridinonpyrrole into the membrane; and contacting 
the membrane with the molecular or ionic Species in the 
presence of a gradient of the molecular or ionic Species, or 
a counter gradient of a further Species. The transporting may 
result in the purification of the molecular or ionic Species. 
Additionally binding a cation comprising contacting the 
cation with a calixnpyrrole or calixmpyridinonpyrrole 
having a cation-binding functionality, or with a calixm 
pyridinompyrrole or calixmpyridine is an embodiment of 
this invention. 
Removal of pertechnetate from pertechnetate-containing 
nuclear waste comprising contacting the waste with a calix 
npyrrole or a calixmpyridinonpyrrole to form a calix 
npyrrole- or a calixmpyridinonpyrrole-pertechnetate 
complex; and removing the complex from the waste is an 
embodiment of this invention. 
A method of removal of an environmental pollutant from 
an environmental Source, comprising contacting the envi 
ronmental Source with a calixnlpyrrole or a calixm 
pyridinonpyrrole to form a calixnpyrrole- or a calixm 
pyridinonpyrrole-pollutant complex, and removing the 
complex from the environmental Source is a further embodi 
ment of this invention. See Example 12 for examples of 
removing pertechnetate from nuclear waste. Environmental 
pollutants Such as, but not limited to nitrates, phosphates, 
polychlorobiphenyls, and fluoride are damaging to the envi 
ronment. See Example 12 for examples of removing envi 
ronmental pollutants using macrocycles. 
A Sensor comprising a Solid Support bound to a macro 
cycle of the present invention is a further embodimnt of the 
present invention. A Sensor can be made by either electropo 
lymerizing the macrocycle onto the Surface of the Solid 
Support or encapsulating the macrocycle into a membrane 
attached to the Surface of the Solid Support is envisioned to 
act as an electrochemical Sensor for ionic or molecular 
Species. 
The calixnpyrrole where n is 5, 6, 7, or 8 may be 
associated with a metal that is bound by Substituents on the 
periphery of the macrocycle. Heterocyclic macrocyles con 
taining free electron pairs chelate cations. Pyridine is known 
to coordinate to certain cations. Calixmpyridines also 
contain nitrogen atoms that are expected to donate electron 
density to cations. This donation would require that the 
cations Stay in close proximity to the pyridine units, thereby, 
binding the cations to the core of the ring. 
In Vivo Applications 
Calixnpyrroles, calixmpyridinonpyrroles or calixm 
pyridines in DNA recognition and modification. Water 
Soluble calixnpyrroles, calixmpyridinonpyrroles or 
calixmpyridines may be particularly advantageous for use 
in a number of ways, Such as in cellular recognition, 
targeting, and in the transport of biologically important 
molecules. Generally, water-Soluble calixnpyrroles are 
preferred for biomedical applications. “Water soluble” 
means soluble in aqueous fluids to about 1 mM or better. 
Anionic phosphorylated entities are ubiquitous in biology. 
They play a critical role in a variety of fundamental pro 
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ceSSes ranging from gene replication to energy transduction. 
In addition, certain phosphate-bearing nucleotide analogues, 
Such as, e.g., 9-(f-D-Xylofuranosyl)guanine-5'- 
monophosphate (Xylo-GMP), are known to display antiviral 
activity in vitro. However, xylo-GMP, like a considerable 
number of phosphorylated nucleotide analogues which 
exhibit anti-Viral activity in cell-free extracts, is inactive in 
Vivo due to its inability to croSS lipophilic cell membranes. 
The anti-herpetic agent, acyclovir (9-(2-hydroxyethoxy) 
methyl-9H-guanine), is active in Vivo. Acyclovir can enter 
the cell only in its uncharged nucleoside-like form. Once in 
the cytoplasm, it is phosphorylated, first by a viral encoded 
enzyme, thymidine kinase, and then by relatively non 
Specific cellular enzymes to produce an active ionic triph 
osphate nucleotide-like Species. There, it functions both as 
an inhibitor of the viral DNA polymerase and as a chain 
terminator for newly synthesized herpes simplex DNA. 
The biological limitations of many other potential anti 
Viral agents, including Xylo-G, arise from the fact they are 
not phosphorylated once inside the cell and are therefore 
largely or completely inactive. If, however, the active mono 
phosphorylated forms of these putative drugs could be 
transported into cells, it would be possible to fight viral 
infections with a large battery of otherwise inactive mate 
rials. If Such specific into-cell transport were to be achieved, 
it would therefore greatly augment the treatment of Such 
debilitating diseases as, for example, AIDS, herpes, hepatitis 
and measles. Given the fact that AIDS is currently a major 
World health problem of frightening proportions, and that 
Something So nominally benign as measles Still claims over 
100,000 lives per year world-wide, treatment of these dis 
eases would be particularly timely and worthwhile. 
A major aim of the inventors Studies has been therefore 
to provide a means of transporting active mono- and poly 
phosphorylated forms of these and other agents into cells. 
This would allow a wide range of otherwise inactive 
compounds, Such as antivirals, to be employed 
therapeutically, and would also create new possibilities for 
gene therapy. 
Calixnlpyrrole- or calixmpyridinonpyrrole-based 
Systems may be made effective as neutral regime carriers, 
Say, e.g., for GMP by constructing a of polytopic receptor 
System in which a nucleobase recognition unit, in this case, 
a cytosine-like group, is appended directly to a phosphate 
chelating calixnpyrrole or calixmpyridinonpyrrole 
macrocycle. Nucleobase recognition units are demonstrated 
herein for use in the Specific binding and transport of 
complementary nucleobases and nucleobase-containing 
compounds. 
To synthesize multitopic receptors, calixnpyrrole con 
jugates were developed to address the following objectives: 
(i) the independent development of molecular recognition 
Strategies for the complexation of two very different kinds of 
Substrates (charged anionic and neutral nucleobase); (ii) 
Subsequent co-combination So as to provide receptors bear 
ing both kinds of binding Subunits; and (iii) various alter 
native methods of receptor oligomerization So as to provide 
oligomeric Species bearing numerous combinations of mul 
titopic receptors. 
Pursuing these Strategies led to the development of the 
calixnpyrrole-based ditopic receptor Systems of the present 
invention, capable of recognizing both the anionic phos 
phate and the neutral portions of the nucleotide derivatives, 
Such as the purine or pyrimidine moieties. The present 
inventors envisage expanding this theme to the preparation 











multiple phosphate anions and nucleobase portions of nucle 
otide derivatives arranged in Specific Sequences. 
Ditopic receptor Systems are ideal vehicles for the intra 
cellular transport of oligonucleotides and their derivatives, 
including anti-Viral agents. The multitopic receptors, 
likewise, are contemplated to be of use in binding to 
oligonucleotides and specific sections of DNA or RNA and 
in transporting Such nucleic acid Segments into cells. 
Pharmaceutical Preparations 
For in Vivo and ex vivo uses, calixnpyrroles, calixm 
pyridinonpyrroles and calixmpyridines are provided as 
pharmaceutical preparations. A pharmaceutical preparation 
of a calixnlpyrrole, calixmpyridinonpyrrole or calixm 
pyridine may be administered alone or in combination with 
pharmaceutically acceptable carriers, in either Single or 
multiple doses. Suitable pharmaceutical carriers include 
inert Solid diluents or fillers, Sterile aqueous Solutions and 
various organic Solvents. The pharmaceutical compositions 
formed by combining a calixnpyrrole, calixmpyridinon 
pyrrole or calixmpyridine of the present invention and the 
pharmaceutically acceptable carriers are then easily admin 
istered in a variety of dosage forms. Administration may be 
intravenous, intraperitoneal, parenteral, intramuscular, 
Subcutaneous, oral, or topical, with intravenous administra 
tion being preferred. 
Solutions of the calix npyrroles, calixmpyridinon 
pyrroles or calixmpyridines in Sesame or peanut oil, aque 
ous propylene glycol, or in Sterile aqueous Solution may be 
employed. Such aqueous solutions should be suitably buff 
ered if necessary and the liquid diluent first rendered iso 
tonic with Sufficient Saline or glucose. These particular 
aqueous Solutions are especially Suitable for intravenous, 
intramuscular, Subcutaneous and intraperitoneal administra 
tion. In this connection, Sterile aqueous media which can be 
employed will be known to those of skill in the art in light 
of the present disclosure. Topical creams, emulsions, 
Solutions, and the like are contemplated for applications to 
Surface areas of the body. Topical application may also be by 
iontophoresis. 
The pharmaceutical forms Suitable for injectable use 
include Sterile aqueous Solutions or dispersions and Sterile 
powders for the extemporaneous preparation of Sterile 
injectable Solutions or dispersions. In all cases the form must 
be sterile and must be fluid to the extent that easy use with 
a Syringe exists. It must be stable under the conditions of 
manufacture and Storage and must be preserved against the 
contaminating action of microorganisms, Such as bacteria 
and fungi. The carrier can be a Solvent or dispersion medium 
containing, for example, water, ethanol, polyol (for example, 
glycerol, propylene glycol, and liquid polyethylene glycol, 
and the like), Suitable mixtures thereof, and vegetable oils. 
The proper fluidity can be maintained, for example, by the 
use of a coating, Such as lecithin, by the maintenance of the 
required particle size in the case of dispersion and by the use 
of Surfactants. The prevention of the action of microorgan 
isms can be brought about by various antibacterial and 
antifungal agents, for example, parabens, chlorobutanol, 
phenol, Sorbic acid, thimerosal, and the like. In many cases, 
it will be preferable to include isotonic agents, for example, 
SugarS Such as mannitol or dextrose or Sodium chloride. 
Prolonged absorption of the injectable compositions can be 
brought about by the use in the compositions of agents 
delaying absorption, for example, aluminum monoStearate 
and gelatin. 
Sterile injectable Solutions are prepared by incorporating 
the active compounds in the required amount in the appro 
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priate Solvent with various of the other ingredients enumer 
ated above, as required, followed by filtered Sterilization. 
Generally, dispersions are prepared by incorporating the 
various Sterilized active ingredients into a Sterile vehicle 
which contains the basic dispersion medium and the 
required other ingredients from those enumerated above. In 
the case of Sterile powders for the preparation of Sterile 
injectable Solutions, the preferred methods of preparation 
are vacuum-drying and freeze-drying techniques which 
yield a powder of the active ingredient plus any additional 
desired ingredient from a previously Sterile-filtered Solution 
thereof. 
AS used herein, "pharmaceutically acceptable carrier' 
includes any and all Solvents, dispersion media, coatings, 
permeation enhancers, antibacterial and antifungal agents, 
isotonic and absorption delaying agents and the like. The use 
of Such media and agents for pharmaceutically active Sub 
stances is well known in the art. Except insofar as any 
conventional media or agent is incompatible with the active 
ingredient, its use in the therapeutic compositions is con 
templated. Supplementary active ingredients can also be 
incorporated into the compositions. 
Calixnpyrroles, calixmpyridinonpyrroles or calixm 
pyridines may be incorporated into liposomes for use in the 
present invention. Liposomes may be prepared by any 
number of techniques that include freeze-thaw, Sonication, 
chelate dialysis, homogenization, Solvent infusion, 
microemulsification, Spontaneous formation, Solvent 
Vaporization, reverse phase, French pressure cell technique, 
or controlled detergent dialysis, for example. Preparation 
may be carried out in a Solution, Such as a phosphate buffer 
Solution, containing calixnpyrrole-, calixmpyridinon 
pyrrole or calixmpyridine-lipophilic molecule conjugates 
So that the conjugate is incorporated into the lipoSome 
membrane. Alternatively, the conjugate may be added in 
already formed liposomes. Liposomes employed in the 
present invention may be of any one of a variety of Sizes, 
preferably the less than about 100 nm in outside diameter, 
more preferably less than about 50 nm. 
Micelles may be prepared by Suspension of a calixn 
pyrrole-, calixmpyridinonpyrrole- or calixmpyridine 
lipophilic molecule and lipid compound(s) in an organic 
Solvent, evaporation of the Solvent, resuspension in an 
aqueous medium, Sonication and then centrifugation. 
Alternatively, the calixn]pyrrole-, calixmpyridinon 
pyrrole- or calixmpyridine-lipophilic molecule may be 
added to preformed micelles. 
Techniques and lipids for preparing liposomes and 
micelles are discussed in U.S. Pat. No. 5,466,438, incorpo 
rated herein by reference. 
Use of Calixnpyrroles, Calixmpyridinon 
pyrroles, or Calixmpyridines in Ex Vivo and in In 
Vivo Treatment of Body Tissues 
Use of macrocycles of the present invention includes the 
dialysis of bodily fluids. Examples of dialyzable substrates 
include, but are not limited to, phosphate-containing mol 
ecules or halide waste. Examples of conditions for treatment 
include gout, diabetes, or drug overdoses. 
Using kidney dialysis to illustrate an ex vivo treatment, 
bodily fluid would be contacted with a calixnpyrrole, a 
calixmpyridinonpyrrole, or a calixmpyridine. Phos 
phate bound by the macroycle is removed from the blood. 
The following examples are included to demonstrate 
preferred embodiments of the invention. It should be appre 











disclosed in the examples which follow represent techniques 
discovered by the inventors to function well in the practice 
of the invention, and thus can be considered to constitute 
preferred modes for its practice. However, those of skill in 
the art should, in light of the present disclosure, appreciate 
that many changes can be made in the Specific embodiments 
which are disclosed and still obtain a like or similar result 
without departing from the Spirit and Scope of the invention. 
EXAMPLE 1. 
Novel Crystal Structures of Complexed Prior-Art 
meso-Substituted Calixpyrrole Macrocycles 
The present inventors have crystallized anion- and neutral 
molecule-complexed forms of known calix4pyrrole mac 
rocycles and have Studied the coordination properties of 
calixpyrroles in Solution and in the Solid State. As a result, 
the present inventors have demonstrated unexpected crys 
talline forms of calixpyrrole macrocycles and the existence 
of a conformational change between an unbound macrocycle 
and a macrocycle bound to an anion or a neutral Substrate. 
In the Solid State, uncomplexed calix4pyrrole macrocycles 
adopt an alternate conformation where adjacent pyrrole 
rings are oriented in opposite directions. Solid-State com 
plexed calix4pyrrole macrocycles are shown herein to 
adopt a cone conformation such that the four NH protons of 
the pyrrole rings hydrogen bond to the bound Substrate 
forming a Supramolecular ensemble. In Solution, a dynamic 
equilibrium exists where the bound anionic or neutral Sub 
strate is reversibly bound to all or less than all of the pyrrole 
NH groupS. Such a conformational change would alter the 
properties of the calixpyrrole, for example, groups on the 
meso- or B-positions would be brought into closer proximity 
in the cone configuration. This conformational change may 
be taken advantage of in the design of a Sensor, for example. 
meso-Octamethylcalix4pyrrole 1 was prepared using 
prior art procedures in the following manner. Pyrrole (20g) 
and acetone (20g) were introduced into a stirred 500 mL 
round-bottomed flask fitted with a reflux condenser. Meth 
anesulfonic acid (1 mL) was added down the reflux 
condenser, causing a violent reaction. CARE-The acid 
must be added slowly. Once the acid was added, the solid 
mass formed was broken up and a further 20 mL of acetone 
was added. The mixture was then heated at reflux for 30 min. 
After this time, the mixture was allowed to cool and the 
white precipitate was filtered off. 
The white precipitate was crystallized from acetone to 
give a crude crystalline material. This was recrystallized 
from acetone, giving crystals of the product meso 
octamethylcalix4pyrrole 1, Suitable for Single crystal 
X-ray diffraction studies. 
meso-Tetraspirocyclohexylcalix4pyrrole 2 was pre 
pared according to prior art procedures as follows. A Solu 
tion of 16.2 g (0.242 mol) of pyrrole and 20 mL of absolute 
ethanol was placed in three-necked 500 mL flask. The flask, 
fitted with a reflux condenser, was placed in an ice bath. To 
the stirred solution was added dropwise 1 mL of 37% 
aqueous hydrochloric acid Solution, followed by 23.7 g 
(0.242 mol) of cyclohexanone over a period of 20 min. The 
stirrer was stopped by the Solid formed in the flask when the 
addition of cyclohexanone was complete. After Standing at 
room temperature for 1 hour, the product was washed with 
50 mL of cold water. The Solid was removed from the flask 
by partial dissolution in ether. The total yield of the crude 
synthesis was 12.86 g (9.0%). 
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Several crystallizations of the product from benzene and 
the n from he Xane gave white crystals of 
tetraspirocyclohexylcalix4pyrrole 2, m.p. 272.0-272.5. 
X-ray Crystallographic Data. Single crystals Suitable for 
X-ray crystallographic analysis were obtained by Slow 
evaporation of acetone and acetone/dichloromethane (1:1 
V/v) solutions of calixpyrroles 1 and 2, respectively. The 
crystallographic Summary for 1 is as follows. Pale yellow 
crystals, tetragonal, P4, Z2 in a cell of dimensions 
a=10.097(1) A, c=23.764(1) A, V=2422.7(4) A, p=1.18 
g cm, F(000)=928. Data were collected at 198K on a 
Siemens P4 diffractometer, equipped with a Nicolet LT-2 
low-temperature device and using graphite monochroma 
tized Mo KO. radiation ()=0.71073 A). Data were collected 
using () scans with a scan range of 1 in co. 3733 unique 
reflections, 2552 with F-4(O(F)). The final R=00556, 
R=0.132, goodness of fit=0.999 for 290 parameters. The 
crystallographic Summary for 2.(CHCl) is as follows. 
ColorleSS crystals, monoclinic, P2/c, Z=4 in a cell of 
dimensions a-10.993(2) A, b=14.250(3) A, c=23.466(4) A, 
B=97.254(14), V=3646.5(11) A, p=1.23 g cm, 
F(000)=1448. Data were collected on a Siemens P3 diffrac 
tometer. 5562 unique reflections, 2285 with Fa(O(Fo)). 
The final R=0.0762, Rw-0.141, goodness of fit=0.995 for 
424 parameters. As illustrated in FIG. 1A and FIG. 1B, 
molecules 1 and 2 adopt a 1,3-alternate conformation in the 
Solid State wherein adjacent rings are oriented in opposite 
directions similar to a previously-reported octaethyl ana 
logue. 
Crystals of anion complexes of the calixpyrroles 1 and 2 
were then prepared in order to Study the conformational 
changes from the free ligand to the complexed ligand. 
Crystals of the tetrabutylammonium chloride complex of 
calixpyrrole 1 were obtained by Slow evaporation of a 
dichloromethane Solution containing an excess of the chlo 
ride salt. The crystallographic Summary for 1...(n-BuNCI) 
CHCl is as follows: Colorless crystals, Orthorhombic, 
Pna2, Z=4 in a cell of dimensions a=21.247(3) A, b=19.937 
(2) A, c=10.691(1) A, V=4528.7(9) A p=1.16 g cm, 
F(000)=1720 6027 unique reflections, 3566 with F-4(O. 











for 478 parameters. Crystals of the tetrabutylammonium 
fluoride complex of compound 2 were obtained using a 
Similar procedure and the crystallographic Summary for 
2.(n-BuNF) is as follows. Colorless crystals, tetragonal, 
P4/nnc, Z=4 in a cell of dimensions a-15.732(1) A, 
c=20.076(1) A, V=4968.7(5) A, p=1.14 g cm, 
F(000)=1872. 3634 unique reflections, 2220 with F-4(C 
(F)). The final R=0.064, Rw-0.171, goodness of fit=1.029 
for 152 parameters. 
The structures so obtained (FIG. 2A and FIG. 2B) reveal 
that in both cases the calix4pyrrole ligand adopts a cone 
like conformation such that the four NH protons can hydro 
gen bond to the bound halide anion. While these two 
Structures are thus grossly similar, in the case of the chloride 
complex (FIG.2A) the nitrogen-to-anion distances are in the 
range of 3.264(7)–3.331(7) A, while for the corresponding 
fluoride complex they are 2.790(2) A (FIG. 2B) (the four 
pyrrole groups are equivalent by Symmetry). As a result, in 
these two complexes the chloride and fluoride anions reside 
2.319(3) A and 1.499(3) A above the N root mean square 
planes of calixpyrroles 1 and 2, respectively. Thus, fluoride 
anion appears to be more tightly bound in the Solid State. 
Expanding the range of potential guests, complexes of 
neutral Species were then prepared. Crystal complexes of 
calixpyrrole 1 and N,N-dimethylformamide (“1.2(DMF)') 
were grown by dissolution of compound 1 in DMF and 
Subsequent crystallization. The Net . . . Oor distances 
are 2.908(2) and 2.924(2) A, with associated N-H... .0 angles 
of 167(2) and 166(2), respectively. The unsaturated por 
tion of the amide lies 3.363(3) A above the plane of a third 
pyrrole ring (the planar twist angle between these two 
moieties is 7.1(1)0), Suggesting that a t-stacking interaction 
helps to stabilize 1.2(DMF). The crystallographic summary 
for 12(DMF) is as follows: colorless prisms from DMF, 
triclinic space group P1, Z=1, a =9.473(1) A, b=9.573(1) A, 
c10.316(1) A, g=66.428(4), B=80.987(5), Y=72,025(4), 
V=815.00(14) A, p=1.17 g cm, F(000)=312. Final 
R=0.0390, Rw-0.0952, GOF=1.061 for 291 parameters. The 
NH protons of 1.2(DMF) were obtained from a AF map and 
refined with isotropic thermal parameters. 
Crystal complexes of calixpyrrole 1 and methanol (“1.2 
(CHOH)”) have also been studied by X-ray crystallogra 
phy. The crystals were prepared by Slow evaporation of a 
methanol/dichloromethane Solution of the ligand. The calix 
pyrrole unit in 1.2(MeOH) was found to assume a 1 
,3-alternate conformation in the Solid State. Single molecules 
of the alcohol lie above and below the macrocycle, each one 
held in place by hydrogen bonds to two pyrrolic NH groups. 
The four symmetry-equivalent H-bonds (N. ... Oro) 
are 3.155(4) A long, a value which is very close to the 
N. . . . Oor distances (ca. 3.0–3.2 A) found in a 
methanol complex of a tetrapyrrolic “expanded porphyrin.” 
Further evidence that methanol is bound to 1, rather than 
merely occupying Space in the lattice, is given by the inward 
tilt of the pyrroles of 1.2(MeOH). This effect compresses the 
“cross ring N. . . . N, and N. . . . N distances by ca. 
0.15 A relative to those in free 1. although it is not Sufficient 
to allow for a linear alignment of the three hydrogen bonding 
atoms (N-H . . . Oor=152.1(4)). Crystal data for 
12(MeOH):yellow prisms from CH.Cl-MeOH, tetragonal 
space group I4, Z=2, a-10.383(2) A, b=10.383(2) A, 
c=13.232(5) A, V=1426.6(6) A, p=1.15 g cm', 
F(000)=536. Final R=0.0787, Rw-0.205, GOF=1.099 for 84 
parameters. The NH proton of 12(MeOH) was calculated in 
an idealized postion (N-H=0.90 A) with U set to 1.2 U. 
for the attached N atom. 
Crystal complexes of calixpyrrole 1 and dimethylsulfox 
ide (“1.(DMSO)”) have also been studied by X-ray crystal 
lography. The crystals also undergo a phase change as they 
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are cooled, at room temperature there is one crystallographi 
cally distinct calixpyrrole in the unit cell, at -75 C. there are 
two. In both phases the calixpyrrole adopts a 1,3-alternate 
conformation wherein a DMSO molecule is hydrogen 
bonded to one pyrrole NH group (at low temperature N. . 
. O=2.962, 2.985 A; H . . . O=2089, 2.024A and N-H.. 
. O=176.2 and 174.5 and at room temperature N . . . 
O=2.996 A. H. ... O =2.099A and N-H... O=174.5°). 
Crystallographic data for 1.(DMSO): There are two crystal 
lographic modifications of 1.(DMSO). The room tempera 
ture modification is monoclinic, P2/c, Z=4, in a cell of 
dimensions: a = 10.423(2), b=23.599(6), c=12.480(2) A, 
B=107.72(1), V=2924(1) A, p=1.15 g cm, F(000)= 
1096. 6720 unique reflections, 2161 with F-4(O(F)). The 
final R(F)=0.0866, Rw(F)=0.253, goodness of fit=0.981 for 
335 parameters refined on F. The low-temperature modi 
fication (-75 C.) is triclinic, P1, Z=4, in a cell of dimen 
sions: a-10.362(3), b=12.373(7), c=23.468(10) A, C-89.77 
(4), B=88.35(3), Y=72.36(4), V=2866(2) A, p=1.17 g 
cm, F(000)=1096. 10061 unique reflections, 5213 with 
F>4(O(F)). The final R(F)=0.0819, Rw(F)=0.212, good 
ness of fit=1.075 for 700 parameters refined on F. 
The complex of caliX4pyrrole 1 and N,N- 
dimethylformamide (“1.2(DMF)”) indicates that individual 
Symmetry-equivalent guests are found above and below the 
host, and that each amide is hydrogen bonded to adjacent 
pyrroles (FIG. 3B). The conformation of the calixpyrrole is 
therefore 1,2-alternate. To the present inventors knowledge, 
1.2(DMF) is the first calixpyrrole in this conformation to be 
unambiguously characterized. The complexes of 1.2 
(CHOH) (FIG. 3A) and 1.(DMSO) (FIG. 3C) both adopt 
the 1,3-alternate conformation in the Solid state. However in 
the case of 1.2(CHOH) all the pyrrole NH groups are 
involved in hydrogen bonding, whereas in the case of 
1.(DMSO) only one pyrrolic NH group hydrogen bonds to 
the calixpyrrole. 
While cone, 1,3-alternate, 1,2-alternate and partial cone 
conformations for calixpyrrole macrocycles have been pro 
posed previously, the present Studies provide the first dem 
onstration of the crystalline forms of anion-complexed mol 
ecules. Solution phase data are provided in Example 10. 
EXAMPLE 2 
Novel meso-Substituted Calix4pyrrole 
Macrocycles 
The present example provides meso-Substituted calix4 
pyrrole macrocycles that have not previously been known. 
In particular, calix4pyrrole macrocycles having functional 
groups for further derivatization have proved particularly 
useful as provided for in later examples. 
Calix4pyrrole meso-monoester 3. 4-Acetylbutyric acid 
(3.8g, 29 mmol) was dissolved in methanol (50 mL) in a 100 
mL round bottomed flask with magnetic Stirring. Concen 
trated hydrochloric acid (1 mL, 37%) was added and the 
mixture heated at reflux for 12 hr. The solvent was then 
removed in vacuo and the residue redissolved in dichlo 
romethane (50 mL). The solution was then washed with 
saturated NaHCO (aq) solution (2x50 mL) and then brine 
(1x100 mL). The organic layer was separated and then dried 
over MgSO and reduced in vacuo to give the methyl ester, 
methyl-4-acetylbutyrate, as a yellow oil (3.5g, 24.3 mmol) 
corresponding to a yield of 84%. "H NMR (CDC1) 3.64 (s, 
3, OCH), 2.49 (t, J=7.2 Hz, 2, CH), 2.32 (t, J=7.2 Hz, 2, 
CH), 2.12 (s, 3, CH), 1.86 (m, 2, CH). 'C NMR (CDC1) 












Methyl-4-acetylbutyrate (0.80g, 5.6 mmol) was dissolved 
in methanol (50 mL) in a 100 mL round bottomed flask. 
Cyclohexanone (0.55g, 5.6 mmol) and pyrrole (0.75 g, 11.1 
mmol) were added and the mixture cooled in an ice bath to 
0° C. The flask was fitted with a reflux condenser and 
magnetically stirred. MethaneSulfonic acid (20 drops) was 
added dropwise over the course of five minutes, and the 
mixture was stirred at 0° C. for 1 hr. and then at room 
temperature overnight. The Solvent was removed in vacuo. 
FAB mass spectrocopic analysis showed the presence of 
mono-, di-, tri- and tetrahook material in the crude reaction 
mixture as well as tetraspirocyclohexylcalix4pyrrole. The 
residue was purified by column chromatography on Silica 
gel using dichloromethane as eluant. This yielded the mono 
hook calixpyrrole methyl ester 3 as a white powder (211 mg, 
0.33 mmol) corresponding to a yield of 11.8%. "H NMR 
(CDC1) 7.07 (br. m, 4, NH), 5.88 (m, 8, CH(py)), 3.63 (s, 
3, OCH), 2.22 (t, J=7.2 Hz, 2, CH), 1.93 (v. br., 14, 
6CH --CH2(ne 1.56-1.35 (V. br., 23, CH2n+ 
9CH2+CCH) °C NMR (CDC1) 173.8, 137.169, 
136.5, 136.3, 130.7, 103.6, 103.5. 103.2, 53.4, 51.37, 39.7, 
39.5, 39.4, 38.5, 37.5, 37.2, 36.9, 36.8, 34.0, 26.1, 25.9, 
22.75, 22.70, 19.9. CIMS m/z (a 635 (MH). High Reso 
lution Mass Spectrum: Mass=634.4236 mDa 1.1 ppm 1.8 




Calix4pyrrole meso-monoacid 4. The calixpyrrole 
methyl ester (211 mg, 0.33 mmol) (compound 3) was 
dissolved in 20 mL ethanol in a 100 mL round bottomed 
flask with magnetic Stirring. The flask was fitted with a 
reflux condenser and the Solution heated to reflux. An 
aqueous solution of sodium hydroxide (20 mL, 2.0 M) was 
added and the mixture heated at reflux for 4 hr. The Solution 
was then allowed to cool and the ethanol present in Solution 
was removed in vacuo. The remaining aqueous Solution was 
acidified to pH 1 with perchloric acid (70%). The product 
was then extracted from this acqueous phase with dichlo 
romethane (50 mL). The dichloromethane layer was washed 
with water (100 mL) and dried over MgSO4. Removal of the 
solvent afforded the “monohook” calixpyrrole acid 3 as an 
off-white powder (187 mg, 0.30 mmol) corresponding to a 
yield of 90.6%. "H NMR (CDCL) 7.02 (br. m., 4, NH), 5.89 
(m, 8, CH), 2.26 (t, 2, CH,), 1.91 (br., 14, 6CH, 
(cyclohlexyl)--CH2(e), 1.44 (br. m., 24, 9CH2(either--CH2 
(hete--CCH)+0.5HO) C NMR (CDC1,) 179.4, 137.3, 
136.6, 136.2, 103.7, 103.6, 103.5, 103.2, 53.4, 39.7, 39.4, 
39.3, 38.5, 37.4, 37.2, 36.9, 36.8, 33.8, 26.0, 25.9, 22.7, 22.6, 
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19.5. FAB MS m/z ( 620 (MH"). High Resolution Mass 
Spectrum: Mass 620.4073 mDa 1.7 ppm 2.8 Calc. mass 
620.4090 DBE 170 CHNO. 
CH 
OH 
X-ray quality crystals of the tetrabutylammonium Salt of 
calix4pyrrole carboxylate 4 were obtained by slow evapo 
ration of a dichloromethane Solution of 4 in the presence of 
excess tetrabutylammonium fluoride trihydrate. The result 
ing crystal structure demonstrated that this anionic calix4 
pyrrole Self-assembles into dimers in the Solid State forming 
a cyclic structure. The carboxylate moiety is hydrogen 
bonded to the pyrrole array of an adjacent calix4pyrrole 
(FIG. 4). Therefore the calix4pyrrole 4 adopts a cone 
conformation in the dimer. The Separation between the root 
mean Square planes of the nitrogen atoms in each macro 
cycle is 7.41(1) A. Crystallographic summary for 
(CoH5NO2)(CHN)"-2CHCl, colorless needles 
were grown from CHCl, triclinic, P1, Z=2 in a cell of 
dimensions: a =12.682(2), b=13.127(2), c=17.871(2) A, 
C-99.913(9), B=90.527(9), Y=98.49(1), V-2896.7(6) A, 
p=1.18 g cm, F(000)=1116. A total of 11364 reflections 
were measured, 10078 unique (R=0.044) on a Siemens P4 
diffractometer using graphite monochromatized Mo KC. 
radiation ()=0.71073 A). The structure was refined on F to 
an R=0.220, with a conventional R=0.084, with a goodness 
of fit=1.031 for 661 refined parameters. The geometry of the 
interaction is: N1-H1N ... O1 (related by 1-X, 1-y, 1-z), 
N... O 2.975(5) A, H... O 2.19(4) A, N-H... O 162(4): 
N2-H2N ... O1, N... O 2.980(5) A, H... O 2.18(5) A, 
N-H... O 167(4); N3–H3N ... O1, N... O 2.950(5) 
A, H . . . O 2.14(4) A, N-H . . . O 163(4); 
N4–H4N ... O1, N... O 2.916(5) A, H... O 2.09(4) A, 
N-H... O 176(4). 
“Monohook” acid 4 is particularly useful as a synthon for 
the production of calix4pyrrole derivatives, conjugates, 
modified Silica gels and the like. Additionally the present 
inventors expect that compound 4 may be used as a ZWit 
terion binding agent as cations may coordinate to the car 
boxylate functionality and anions to the calixpyrrole core. 
Tetravinylcalix4pyrrole 5. Pyrrole (0.745 g, 11.12 
mmol) and 5-hexan-2-one (1.09 g, 11.12 mmol) were dis 
solved in methanol (100 mL). Methanesulfonic acid (0.5 
mL) was added and the reaction was stirred in the dark for 
12 hr. The Solvent was then removed in vacuo and the 
reaction mixture was purified by column chromatography on 









from the column was collected and, upon removal of the 
solvent, afforded a colorless oil (1.05 g, 64% yield). 
The product 5 is a mixture of conformers of 
tetravinylcalix4pyrrole where the groups in the meso 
positions are each in one of two orientations, with the 
bulkier alkene group either above or below the plane of the 
meso-carbon atoms (see Example 7). H NMR (CDC1): 
7.02(br. s, 4H, NH), 5.91 (m, 8H, CH), 5.71 (m, 4H, 
=CH-), 4.90 (m, 8H, =CH-), 2.22 (br. m., 16H, CHCH). 
'C NMR (CDC1-): (139.4, 139.3, 139.2), (137.83, 137.80, 
137.70, 137.63, 137.58), (114.5, 114.4, 114.35), (104.4, 
104.3, 104.26, 104.2, 104.1, 104.0), (40.02, 39.98), (39.2, 
39.0), 29.2, (26.45, 26.43, 26.23, 26.15, 26.04, 25.97). 
Calix4pyrrole 5 may prove to be particularly useful as a 
monomer for use in the Synthesis of calixpyrrole polymer 
materials. A known method uses pyrrole, a C-C Saturated 
alicyclic ketone and an acid containing Vinyl groups or triple 
bonds to form a polymerized resin. In this case, the resulting 
products are undefined Since it appears to be unknown where 
the modifying group is attached to the product. In contrast, 
the present method allows synthesis of monomer 5 which 
can then be subjected to polymerization. This method of 
forming a defined calixnpyrrole polymer is applicable for 
n=4-8. 
Meso-octabenzylcalix4pyrrole 6. Pyrrole (0.745 g, 
11.12 mmol) and 1,3-diphenylacetone (2.34g, 11.12 mmol) 
were dissolved in methanol (250 mL). Methanesulfonic acid 
(0.5 mL) was added and the reaction was stirred in the dark 
for twelve hours. The Solvent was then removed in vacuo 
and the reaction mixture was purified by column chroma 
tography. The first fraction from the column was collected 
and, upon removal of the Solvent, afforded a yellow oil. 
Acetone (10 mL) was added and the flask was swirled in 
order to dissolve the oil. After 20 min, white crystals of the 
meso-octabenzylcalix4pyrrole 6 (278 mg, 9.6% yield) had 
formed; they were collected and dried. "H NMR (CDC1): 
7.19 (m, 24H, ArH), 6.83 (m, 16H, ArH), 6.22 (br. s, 4H, 
NH), 5.62 (d. 8H, CH), 2.90 (m, 16H, ArCH. 13C 
NMR (CDC1): 138.3, 1341, 130.9, 127.7, 126.4, 106.5, 
44.7. High Resolution negative FAB calc. for C7H7N, 
(1035.53674) found 1035.4720 (1.8 ppm). 
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Crystals of octabenzylcalix4pyrrole 6 suitable for X-ray 
Study were grown from acetone. The conformation of the 
macrocycle in 6.2(acetone).acetone is 1,3-alternate (as 
in 1.2(MeOH)), but the two acetone guests are both located 
on the same face of the ligand, held in place by Single 
H-bonds (FIG. 5). One of the acetone moieties lies much 
closer to the macrocycle than the other (N. . . . 
O =2.972(6) A vs. 3.359(6) A), reflecting an almost 
colinear (177(5)) arrangement of N, H. . . ... O lyrroie 
atoms in the former case. By contrast, the N-H ... O angle 
formed with the more distant ketone measures 159(4). 
Octabenzylcalix4pyrrole may prove useful as a phase 
transfer catalyst for anions, or as a starting material for the 
Synthesis of calix4pyrrole aryl-transition metal complexes 
which could be used as catalysts for various reactions or as 
a Sensor for anions. This material is also a potential precur 
Sor to pyridine-containing Systems (Example 6). 
meso-Tetraspirotetrahydrothiopyrancalix4pyrrole 7. 
Tetrahydrothiopyran-4-one (0.50 g, 4.3 mmol) and pyrrole 
(0.288 g, 4.3 mmol) were dissolved in ethanol (30 mL) and 
10 drops of methanesulfonic acid were added. The mixture 
was stirred for 12 hours in the dark, after which time a white 
precipitate had formed. The Solvent was removed in vacuo 
and the residue purifed by column chromatography (SiO2, 
CH2Cl eluant) affording the tetra Sulfide macrocycle as a 
white powder (540 mg, 76% yield). H NMR (250 MHz, 
CD2Cl2) 8: 7.10 (s, 4H, NH), 5.97 (m, 8H, CH, ), 2.61 
(m, 12H, CH)2.28 (m, 12H, CH). CNMR (62.90 
MHz, CDC1) 8: 136.0, 105.0, 39.5, 37.9, 24.9. High 
resolution FABMS calc for C.H.N.S. 660.2449; found 











Crystals of macrocycle 7 suitable for analysis by X-ray 
diffraction techniques were grown by Slow evaporation of a 
dichloromethane solution of the macrocycle (FIG. 6). Crys 
tallographic data for 7: Colorless crystals, triclinic, P1, Z=2, 
in a cell of dimensions: a = 11.059(2), b=15.023 (3 ), 
c=15.874(3) A, C-112.21(1), B=102.64(1), Y=103.07(2), 
V-2238.9(7) A, p=1.42 g cm, F(000)=998. 3987 
unique reflections, 2991 with F>4(O(F)). The final R(F)= 
0.0545, Rw(F)=00.126, goodness of fit=1.133 for 336 
parameters refined on F. Calix(4)pyrrole 7 is a useful 
Synthon for the Synthesis of transition metal complexes on 
the periphery of the calixpyrrole which complexes are 
contemplated to be useful as Sensors. Oxidation of macro 
cycle Sulfide groups to Sulfoxide or Sulfone introduces 
further polarity into the macrocycle and renders it more 
water Soluble, thus allowing use in biomedical applications 
(see Example 11). Additionally, the present inventors envi 
Sion that analogous macrocycles containing NH, NH", 
NHCH, N(CH)", NOH, NNH and NN(CH) function 
alities instead of Sulfur will be water Soluble. 
meso-Octanonylcalix4pyrrole 8. 10-Nonadecanone 
(3.144 g, 11.12 mmol) and pyrrole (0.745 g, 11.12 mmol) 
were dissolved in a mixture of ethanol (100 mL) and 
dichloromethane (50 mL). Methanesulfonic acid (20 drops) 
was added and the mixture was stirred for 12 hours. The 
Solvent was then removed in vacuo and the product was 
purified by column chromatography on Silica gel (hexane 
eluant) affording the product as a white powder (650 mg, 
17% yield). H NMR (250 MHz, CDC1) 8: 6.99 (s, 4H, 
NH), 5.86 (s, 8H, CH), 1.77, 1.54, 1.21, 0.86 (br. multiplets, 
152H, CHCH). 'C NMR (62.90 MHz, CDC1) 8: 136.2, 
104.6, 42.4, 37.7, 31.9, 30.3, 29.78, 29.75, 29.4, 24.0, 22.7, 
14.1. High resolution FABMS calc for CHN 
1326.3034; found 1326.3015 (A1.4 ppm). 
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Due to hydrophobic alkyl groups, calixpyrrole 8 is designed 
to have particular affinity for lipid bilayer membranes and is 
expected to Serve as an insertion agent, i.e. insertion of 
macrocycle 8 is expected to allow passage of charged 
Species (Such as phosphorylated anti-viral agents) through 
cell membranes, thereby increasing the effectiveness of the 
agent (Example 11). 
meso-Tetramethyl-mesotetraferrocenylcalix 4-pyrrole 9. 
Pyrrole (0.373 g, 5.56 mmol) and acetylferrocene (1.27 g, 
5.56 mmol) were dissolved in methanol (50 mL) and stirred. 
Methanesulfonic acid (20 drops) was added and the reaction 
stirred for twelve hours. Triethylamine (30 drops) was then 
added to the reaction mixture followed by aspartic acid (2 g) 
and the solvent removed in vactio. The residue was purified 
by column chromatography (silica gel, CH2Cl eluant) 
yielding the product as a yellow foam (390 mg, 25% yield). 
"H NMR (CDC1,) 1.801–1.997 ppm (12H, m, CH), 
3.931-4,198 ppm (36H, m, CH, ), 5.625-5.927 
(8H, m), 7.929 (s, 4H, NH). C NMR (CDC1) 28.958, 
31.016, 39.841, 39.857, 67.343, 67.525, 67.818, 69.031, 
69.141, 69.356, 98.224, 104.588, 104, 932, 105.814, 
136.866, 137.348, 137,482, 137.572 
(O-O-y-Y-O (O) 
(O-ON'-(OO) 
Calix4pyrrole 9 can be used as a reporter molecule or 
Sensor for detecting anions or neutral molecules. The com 
plexation of an anion in the calixpyrrole core will perturb the 
electronic States of the ferrocene moieties, thereby causing 
a shift in the ferrocene redox potential which can be detected 
by electrochemical techniques, including, but not limited to, 
cyclic volatmmetry and Osteryoung-type Square wave Vol 
tammetry. 
While the present example demonstrates ester (3), acid 
(4), alkenyl (5), aryl (6), Sulfide (7), and alkyl (8) substitu 
ents for calix4pyrroles, one of skill in the art would be able 
to Synthesize further meso-Substituted calix4pyrrole mac 
rocycles in light of the teachings herein and using Standard 
organic chemical Synthesis reactions as described herein. 
EXAMPLE 3 
Novel B-Substituted Calix 4-pyrrole Macrocycles 
Calix4pyrrole macrocycles with functional groups in the 
f-position (i.e., on the f-carbon of a pyrrole ring), and the 
Syntheses thereof, are provided in the present example. Such 
B-Substituted calixpyrroles may have Substitution at one or 
more of the B-positions. To prepare Such compounds of the 
present invention, either meso-octamethylcalix4pyrrole 1 
is deprotonated and the Substituent to be added at the 
B-position is then reacted with the activated calixpyrrole, or 
the calixpyrrole is Synthesized from a B-Substituted pyrrole. 
Initially, Sodium hydride was tried as a base to deproto 
nate the calixpyrrole. Sodium hydride was added to a 











hylacetate was added in order to introduce an ester func 
tionality to the calixpyrrole. However, this produced no 
reaction. 
A stronger base (n-BuLi) was then tried; 4 equivalents of 
the base were added dropwise to a THF solution of the 
macrocycle at -78 C. under an argon atmosphere. After 2 
hours stirring at -78. C., 4 equivalents of bromoethylacetate 
were added and the Solution was allowed to warm up to 
room temperature over 90 minutes. The THF was then 
removed in vacuo and the residue was purified using column 
chromatography on Silica gel by eluting with CH2Cl2. Sev 
eral fractions were isolated from the column. The first 
proved to be unreacted calix4pyrrole. The Second was the 
B-monosubstituted ester 10 and the third, the B-diester 11. 
Her 
i) 4.0 BuLi, THF, -78° C. 
ii) 4.0 BrCH2COOEt 
10: R1 = CHCOOEt, R = H 
11: R1 = R2 = CHCOOEt 
Calix4pyrrole B-mono- and disubstituted ester 10 and 
11. meso-Octamethylcalix4pyrrole (1.0 g, 2.34 mmol; 
preparation described in Example 1) was dissolved with 
stirring in THF (100 mL, dry) under an argon atmosphere. 
The solution was cooled to -78 C. using a CO/acetone 
bath. n-Butyllithium (5.83 mL, 9.34 mmol, 1.6M in hexane) 
was added to the Solution dropwise. After 2 hours, ethyl 
bromoacetate (1.95 g, 11.68 mmol) was added dropwise to 
the solution. The reaction was then removed from the CO 
bath and allowed to warm to room temperature. After 90 
minutes, the solvent was removed in vacuo and EtOH (100 
mL) was added to the flask. Water (100 mL) was slowly 
added with Swirling, causing a white precipitate to form. The 
precipitate was collected by filtration, dried under high 
Vacuum and then purified by column chromatography on 
silica gel eluting with CHC1. The monoester 10 (310 mg, 
26%) and diester 11 (40 mg, 2.8%) were the second and third 
main products to be eluted from the column. Mono-ester 10: 
"H NMR (500 MHz, CDC1) 8: 8.55 (s, 1H, NH), 7.15 (s, 
1H, NH), 7.04 (s, 1H, NH), 7.00 (s, 1H, NH), 5.94-5.88 
(overlapping multiplets, 5H, CH), 5.83 (m, 1H, CH), 
5.72 (m, 1H, CH), 424 (q, J=7.15 Hz, 2H, CHCH4), 3.65 
(s, 2H, CCH), 1.62–1.47 (overlapping singlets, 24H, 
CCH), 1.33 (t, 3H, J-7.15 Hz). C (DEPT) NMR (500 
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MHz, CDC1) 8: 174.93 (C=O), 140.42 (C), 139.69 
(C), 139.31 (C), 138.92 (C), 138.50 (C), 137.98 
(C), 137.20 (C), 134.06 (C), 109.95 (CH), 107.07 
(CCHCOOEt), 103.41 (CH), 103.10 (CH), 102.90 
(CH), 102.66 (CH), 101.37 (CH), 61.40 (CH2CH3), 
37.16 (CCH), 35.50 (CCH), 35.43 (CCH), 35.17 (CCH), 
33.95 (CCH), 29.20 (CCH), 29.05 (CCH), 28.90 (CCH), 
28.68 (CCH), 14.47 (CHCH). High resolution FABMS 
calc for CHNO 514.3308; found 514.3302 (A1.2 ppm) 
Bis-ester 11: "H NMR (500 MHz, CDC1) 8: 8.61 (s, 1H, 
NH), 8.52 (s, 1H, NH), 7.20 (s, 1H, NH), 7.00 (s, 1H, NH), 
5,85-5.54 (several multiplets-overlapping, 4H, CH), 
5.63 (d. 1H, CH), 5.55 (d. 1H, CH), 4.19 (m, 4H, 
CHCH), 3.60 and 3.59 (two singlets, total 4H, CCH), 
1.58 (s, 6H, CCH), 1.52 (s, 6H, CCH), 1.49 (s, 6H, CCH), 
1.44 (s, 6H, CCH), 1.29 (t, 2H, CHCH), 1.27 (t, 2H, 
CHCH). C (DEPT) NMR (500 MHz, CDC1) 8: 175.51 
(C=O), 175.21 (C=O), 14121(C), 140.36 (C), 138.98 
(C), 137.94, (C) 137.70, (C) 137.68 (C), 134.33 
(C), 133.89 (C), 109.64 (CCH), 109.09 (CCH), 
106.73 (CH), 105.08 (CH), 103.23 (CH), 102.90 
(CH), 101.93 (CH), 100.72 (CH), 61.42 (CHCH.), 
37.21 (CCH), 36.89 (CCH), 35.52 (CCH), 35.19 (CCH.), 
33.97 (CCH), 33.93 (CCH), 29.05 (CCH), 28.90 (CCH.), 
14.41 (CHCH). High resolution FABMS calc for 
C.H.N.O. 600.3676; found 600.3663 (A2.1 ppm). This 
reaction may also be accomplished using other bases includ 
ing but not limited to aryllithium or alkyllithium or in the 
presence of a coordinating ligand Such as but not limited to 
tetramethylethylenediamine with an aryllithium or alkyl 
lithium base. Alternately other electrophiles may be attached 
to the activated calixpyrrole macrocycle (e.g. CO2, 
ethylchloroformate, acrylonitrile). B-Substituted calix4 
pyrrole esters are useful as a reagent for the Synthesis of 
other calixpyrrole derivatives as described herein. 
Calix4pyrrole B-acid 12. Compound 10 was 
de-esterified to produce calix4pyrrole f-acid 12 by reflux 
ing in a solution of NaOH in EtOH/HO. The acid was 
clarified by adding perchloric acid to the cooled reaction 




















Compound 10 (200 mg, 0.38 mmol) was stirred in 20 mL 
ethanol. The slurry was heated to reflux and NaOH. (20 
mL, 2.0 M) was added. The reaction was heated at reflux 
until all the ester had been consumed (approximately 4 
hours). The ethanol was then removed in vacuo and a further 
50 mL of cold water was added to the Solution. The Solution 
was then acidified with concentrated perchloric acid to pH1. 
The monoacid 12 then precipitated out as a white powder, 
was collected by filtration and dried under high vacuum to 
yield 146 mg (79%). H NMR (500 MHz, CDC1) 8; 7.84 
(s, 1H, NH), 7.24(s, 114, NH), 7.01 (coincident singlets, 2H, 
NH), 5.90–5.76 (overlapping multiplets, 5H, CH), 3.71 (s, 
2H, OCH), 1.51 (s, 6H, CCH), 1.50 (s, 6H, CCH), 1.48 
(s, 6H, CCH), 1.47 (s, 6H, CCH). C NMR (500 MHz, 
CD.C.) 8: 179.13 (C=O), 139.96 (C), 139.20 (C), 
139.09 (C), 138.60 (C), 138.52 (C), 137.45 (C), 
133.96 (C), 109.27 (C) 107.11 (CH), 103.21 (CH), 
103.14 (CH), 103.05 (CH), 102.91 (CH), 102.75 (CH), 
102.14 (CH), 37.20 (CCH), 35.49 (CCH), 35.40 (OCH), 
35.23 (CCH), 33.68 (CCH), 30.38 (CCH), 29.16 (CCH.), 
29.09 (CCH), 29.00 (CCH), 28.85 (CCH). High resolu 
tion FABMS calc for CHNO. 486.2989; found 
486.2995 (A1.1 ppm). 
B-substituted “monohook” calix4pyrrole 12 is particu 
larly useful for further substitution as described in Examples 
8, 9, 10, and 11. 
f-Octamethoxy-meso-tetraspirocyclohexylcalix4 
pyrrole 13. 3,4-Dimethoxypyrrole (0.568 g, 4.5 mmol) and 
cyclohexanone (437 mg, 4.5 mmol) were dissolved in gla 
cial acetic acid (10 mL), and the solution was stirred for 3 
hours in the dark under argon, forming a black Solution. The 
acid was then removed in Vactio and the residue purified by 
column chromatography (SiO2, CH2Cl eluant). The prod 
uct was collected as the Second fraction from the column 
having an R=0.33 (81 mg, 0.097 mmol) in a yield of 8.6%. 
Following chromatographic purification, the Solvent was 
immediately reduced in vacuo and the product 13 Stored 
under argon in the freezer. H NMR (300 MHz, CDC1) 8: 
6.11 (s, 4H, NH), 3.77 (s, 24H, OCH), 2.08 (s, br., 16H, 
CH), 1.45 (s, br., 24H). 'C NMR (75.42 MHz, CDC1) 8: 
136.3, 75.73, 61.1, 42.5, 35.1, 26.3, 23.9. High resolution 
FABMS calc for C.H.N.O.s 828.5037 found 828.5025 
(A1.5 ppm). 






B-Substituted calix4pyrrole 13 shows decreased anion 
binding affinity relative to compound 2 due to electron 
donating properties of the methoxy Substituents. These types 
of compounds are useful as HPLC column media since low 
affinity constants and fast complexation-decomplexation 
rates generally lead to efficient separation of Substrates (see 
Example 10). 
f-Octabromo-meso-octamethylcalix4pyrrole 14. An 
oven-dried 100 mL round-bottomed flask containing a stir 
bar was charged with meso-octamethylcalix4pyrrole (0.69 
g, 1.6 mmol) and 50 mL of dry tetrahydrofuran. With 
Stirring, N-bromosuccinimide (2.34 g., 13.1 mmol) was 
added all at once, causing the reaction mixture to turn 
yellow. A reflux condenser and argon balloon were affixed to 
the flask, which was heated to gentle reflux in the dark. After 
48 h, the clear red-brown solution was allowed to cool to 
room temperature, and the THF was removed in vacuo. The 
tan Solid which remained was triturated with 20 mL of 
dichloromethane, and the CHCl solution was flash chro 
matographed on Silica gel (1:1 CH-Cl-hexanes as eluent). 
Colorless-to-light-yellow fractions with R=0.73 were com 
bined and evaporated to afford a white solid. Drying under 
high vacuum gave 1.53 g (90%) of the desired product 14. 
H NMR (CDC1): 8 1.56 (s, 24H), 7.34 (brs, 4H). 'C 
NMR (CDC1): 625.9, 38.2, 98.6, 130.4. LRMS (FAB): 
m/z 1059, 979,901,821, 741. Elemental analysis calc. for 







Single crystals of compound 14 were grown by Slow 
evaporation of a dilute dichloromethane Solution of the 
macrocycle (FIG. 7). The structure reveals that compound 
14 exists in a chair-like flattened 1,2-alternate conformation 











rings and plane through the calixpyrrole meso-carbon atoms 
are 66.8, 5.8, -66.8 and -5.8). Crystallographic sum 
mary for CHNBrs: Large, colourleSS prisms were 
grown by Slow evaporation from CH2Cl2. Crystals were 
monoclinic, P21/n Z =2, in a cell of dimensions: a =10.819 
(4), b=12.042(4), c=12.746(4) A, B=99.01(2), V=1640.1 
(10) A, p-2.15 gem, u-98.07 cm, F(000)=1008. A 
total of 7416 reflections were measured, 3763 unique (R. 
(F)=0.091) on a Siemens P3 diffractometer using graphite 
monochromatised Mo KO. radiation ()=0.71073 A) at -75 
C. The structure was refined on Fusing SHELXTL/PC (ver 
5.03, Siemens Analytical X-ray Instruments, Madison, Wis., 
U.S.A.) to an R=0.131, with a conventional R=0.0575 
(2231 reflections with F-4O(F)), and a goodness of 
fit=1.105 for 182 refined parameters. The molecule lies on a 
crystallographic inversion centre at 0,0,0. 
B-Substituted calix4pyrrole 14 shows increased anion 
binding affinity relative to the parent calix4pyrrole 1 due 
to the electron withdrawing properties of the bromine Sub 
Stituents (see Example 10). Receptors with an increased 
anion binding ability Such as 14 are useful as anion Seques 
tering agents (e.g., in removal of phosphate and nitrate 
pollutants from aqueous environments) (see Example 12) or 
as Synthons in reactions to produce further modified calix 
4pyrroles. The present inventors envision this system will 
be useful as a precursor to a calixmpyridinonpyrrole or a 
calixmpyridine. 
While the present example describes ester (10,11), acid 
(12), alkoxy (13) and halo (14) B-substituents, one of skill in 
the art would be able to synthesize further modified 
B-Substituted molecules in the light of the present disclosure 
and using Standard organic chemical Synthesis reactions as 
described herein. 
f-Substituted calix4pyrrole macrocycles have similar 
utility to that of the meso-substituted molecules described 
herein. 
EXAMPLE 4 
Use of Calixnarene in the Synthesis of Calixn 
pyrrole, and Pseudo Dimers Thereof 
The present example provides the Synthesis of a calixn 
arene-calixnlpyrrole pseudo dimer. Reaction of p-tert 
butylcalix4larene tetramethyl ketone (0.5 g., 0.57 mmol) 
with pyrrole (0.153 g, 2.29 mmol) in a dichloromethane/ 
ethanol mixture, in the presence of methaneSulfonic acid, 
followed by column chromatography on Silica gel (CH2Cl2, 
eluant) afforded the calixpyrrole-calixarene pseudo dimer 15 
in 32% yield. Compound 15 gave spectroscopic and ana 
lytical data in accord with the assigned Structure. AS a 
consequence of this template Synthesis, the Stereochemistry 
at the calixpyrrole meso-carbons is automatically defined. 
Thus this method of Synthesis produces only one configu 
rational isomer even though all four ketone groups involved 
in the Synthesis of an individual calixpyrrole are asymmetri 
cal (see Example 7). 
Analytical and spectroscopic data for compound 15: 
Analysis for CHNO: 
Calculated C 80.86%; H 7.92%; N 5.24%. Found C 
80.57%; H 7.95%; N 5.11%. High resolution positive ion 
FABMS: Calculated (CHNO) 1068,649; Found 
1068.648 (A1.4 ppm). H NMR (CDC1) 8: 11.22 (s, 4H, 
NH), 7.22 (s, 8H, ArH), 5.83 (d. J=2.5 Hz, 8H, CH), 4.35 (d. 
J=12.5 Hz, 4H, ArCHAr), 3.80 (s, 8H, OCH), 3.37 (d. 
J=12.5 Hz, ArCHAr), 1.58 (PyCCH), 1.18.(s, 36H, tert 
Bu). CNMR (CDC1) 8: 151.3, 146.8, 137.2, 134.4,126.1, 
101.7, 90.2, 37.9, 34.1, 31.4, 29.6, 21.1. 
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Crystals were obtained by slow evaporation of a dichlo 
romethane solution of compound 15. The crystals were then 
Subject to X-ray diffraction Structural analysis. The resulting 
Structure shows the calixarene in a cone conformation. The 
pyrrole NH groups are within hydrogen bonding distance of 
the lower rim calixarene oxygen atoms (FIG. 8). 
Crystallographic Summary for 15.XCH2Cl2. Large regions 
of disordered solvent of unknown stoichiometry in this 
Structure presented difficulties with this analysis, however 
the Structure of the calixarene-calixpyrrole pseudo dimer is 
a reliable description of this unique and interesting mol 
ecule. Faintly yellow crystals, monoclinic, C2/m, Z=4 in a 
cell of dimensions a=25.836(5) A, b=20.139(3) A, c=15.46 
(2) A, B=106.0(1), V=7719(2) A. pl.: x=4; 1.21 gem; 
x=6, 1.36 gem. 9112 unique reflections of which 4121 
were observed (I>2O(I)). Data collected at -90° C. on a 
Siemens P3 diffractometer. The final R=0.148. 
The "H NMR spectrum of 15 in dichloromethane-d 
shows that the pyrrole NH protons, which are normally 
observed at around 7 ppm in other calix4pyrroles, resonate 
at 11.22 ppm (FIG. 9). This can be attributed to hydrogen 
bonding between the pyrrole NH groupS and the calixarene 
oxygen atoms. CDOD was added to the NMR solution in 
an attempt to disrupt this hydrogen bonding interaction, 
however this had a negligible effect on the "H NMR spec 
trum. Similarly, addition of 10.0 equiv. tetrabutylammonium 
fluoride (which has been shown to bind strongly to other 
calix4pyrroles) caused no changes in the NMR spectrum. 
Based on these findings, the present inventors conclude that 
the dimer is adopting a cylindrical conformation in Solution 





These types of calixarene-calixpyrrole molecular cylin 











possess a hydrophobic cavity. Additional functional groups 
could be appended to the free phenolic OH groups on the 
calixarene. These may be used to attach the molecule to a 
polymer or other Solid Support. Such Solid Supported com 
pounds may be used in column chromatography, for 
example. Alternatively, an optical or electrochemical Sens 
ing group Such as anthracene or ferrocene could be attached 
and may be able to Sense the inclusion of neutral Species in 
the cylinder and therefore act as a Sensor. These materials 
may also be able to extract toxic organic Substances (Such as 
insecticides and PCBs) from aqueous Solutions and, being 
potential receptorS for Zwitterions, aid in the purification of 
amino acids, peptides, proteins, and the like. 
In addition to a dimer cylinder, trimers and larger tubular 
polymers may be prepared. The Synthesis of a calixarene/ 






Calix4arene tetra ketones in the 1,3-alternate conformation 
may be used to make calixarene-calixpyrrole tubular poly 
mers which may have interesting properties, either alone or 




US 6,262,257 B1 
S1 
Other n-fold templates may be used around which a 
calixnpyrrole may be constructed. Examples of Such mol 
ecules include, but are not limited to, calixnarenes, 
resorcinarenes, CTV, and cyclic SugarS Such as the C, 3- or 
Y-cyclodextrins. Alternatively, benzene rings Substituted 
with ketone groups, or azacrown ethers with N-pendant 
ketone moieties may serve as templates in the Synthesis of 
the present invention. In one aspect of the invention, it is 
preferred that the ketone groups of the template all be 
pointing in the Same direction. For example, in the case of 
calixarenes, the calixarene is in a cone conformation. 
EXAMPLE 5 
Synthesis of Calixnpyrroles 
Calixnpyrroles where n is greater than 4 have not 
previously been described. The present example provides 
methods for Synthesis of higher order cyclic oligomers 
where n is 5-8. Prior art methodology for preparing calix 
4pyrroles involved the condensation of a ketone with a 
pyrrole using a Brónsted acid Such as methaneSulfonic acid 
or hydrochloric acid. This method produces exclusively 
calix4pyrrole. The present inventors have developed a 
methodology that employs Lewis acid catalysis of the con 
densation of pyrroles and ketones to yield novel calix5, 6, 
7, or 8pyrroles having high yield and purity. 
Synthesis of Calixnpyrroles where n=5, 6, 7, or 8. A 
pyrrole and a ketone may undergo Lewis acid-catalyzed 
condensation to form a generalized calixnlpyrrole having 
Structure I. The reaction conditions have been optimized for 
the preparation of higher calixnpyrroles (nd4) by varying 
pyrrole and the ketone ratioS and employing BF.Et2O as a 
catalyst. Optimal conditions for the formation of higher 
order calixnpyrroles (nd4) are a 1:1 to a 1.25:1 molar ratio 
(ketone:pyrrole) with a 10% Lewis acid catalyst. The con 
centration of Starting compounds ranged from 50 mM to 1 
mM depending on the Solvent used e.g. dichloromethane 
(dry), chloroform and acetonitrile, although it may be pos 
sible to use other solvents or Solvent mixtures to obtain 
optimum yields of a given calixnpyrrole. 
Lewis acids such as BF OEt, BF methanol, VOCl, 
TiCl, and Mn(OAc) have been used as catalysts and it has 
been found that TiCl, in dry dichloromethane produces 
higher yields of calixnlpyrroles than the other catalysts. 
Lewis acids may also be used in doped Zeolites, 
monymorillonites, clays, Silica and alumina which can pro 
vide a convenient site for calixnlpyrrole formation. 
The conditions for the preparation of calixnpyrroles 
ranging from n=4 to 10 are: acetone (0.5808 g, 10 mmol) 
and pyrrole (0.67 g, 10 mmol) were dissolved in dry 
dichloromethane (150 mL) under an argon atmosphere with 
Stirring under argon for 15 minutes. The catalyst, BF.Et2O 
(0.5 mL of 1M solution in dichloromethane, 0.5 mmol), was 
Slowly added via Syringe. The reaction mixture was Stirred 
under argon for between 24 to 48 hours. HCl (3 mL of 3%) 
was then added and the mixture stirred for 10 minutes. The 
reaction mixture was transferred to a separatory funnel and 
the organic phase was washed with water and dried over 
Sodium Sulfate. The Solvent was evaporated and the crude 
reaction mixture was filtered over a short neutral alumina 











calixnpyrrole products were purified by flash chromatog 
raphy or by preparative HPLC using dichloromethane 
hexane (3:1) a mobile phase. Yield 78%. The ratio for n is as 
follows: 1, n =4, 60%; 17, n=5, 12%; 18, n=6, 9%; 19, n=7, 
5%; 20, n=8, 3%. Separated calixnpyrroles were charac 
terized by HRMS: Cyclic pentamer: 17, n=5, For CHN 
calc. 535.367497, found. 535.367194. For MHCHN 
calc. 536.375322, found 536.374278. Cyclic hexamer: 18 
n=6 For CHN calc. 642.440996, found 642.440390. 
Cyclic heptamer: 19 n=7 For CHN, calc 749.514496, 
found 749.514133. Cyclic octamer: 20 n=8 For CH7Ns 
calc. 857.5958, found 857.5923. 
Chloroform and acetonitrile may also be used as Solvents. 
BF-MeOH was used as a catalyst with 73% overall yield. 
When 1-alkyl-, or 1-arylpyrrole were used, the reaction 
again produced cyclic Systems, N-Substituted calixn 
pyrroles where n is from 4 to 8, with the main product n=4, 
but with higher ratio for n>4 than in case of pyrrole (the ratio 
estimate is 35:12:9:7:5) for n=4-8, for 1-methylpyrrole and 
ratio 29:12:9:8:6 for 1-phenylpyrrole. 
The procedure for the use of high valent Lewis acid 
catalysts (e.g. TiCl) in calixnlpyrrole Synthesis is as fol 
lows: acetone (0.581 g, 10 mmol) and pyrrole (0.67 g, 10 
mmol) were dissolved in 100 mL of dry dichloromethane 
under argon. Titanium tetrachloride (1 mL of 1M solution in 
dichloromethane, 1 mmol) was then added to the Solution 
under argon while Stirring at room temperature. Immediately 
after addition, a precipitate was formed, which redissolved 
after 5 minutes Stirring. The reaction mixture was Stirred at 
room temperature for 20 hours, then washed with 3% HCl, 
water and dried over sodium sulfate. The product was 
purified by column chromatography on neutral alumina. 
Final Separation was performed by flash chromatography on 
Silica gel using dichloromethane-hexane 4:1. The overall 
yield was 67% with a calixnpyrrole distribution as follows: 
88 (1, n=4), 8 (17, n=5), 6 (18, n=6), 3 (19, n=7), 2 (20, n=8). 
The procedure has been repeated using analogous condi 
tions to those used with titanium tetrachloride but using 
other Lewis acids such as VOCl, Mn(OAc), SnCl, AlCls, 
or UO2(OAc) and also using a number of different Solvents. 
A variety of cation exchange resins (DoweX) were 
employed in their H rich forms, however, the product was 
exclusively the cyclic tetramer. 
Synthesis of Calixnlpyrroles using clayS. Montmorrilo 
nite K10 (Aldrich) was added to a 250 mL flask and dried 
at 120° C./0.2 Torr for 2 hours. After cooling to room 
temperature under argon, dry dichloromethane (100 mL) was 
added, followed by acetone (0.0581 g, 1 mmol) and pyrrole 
(0.067 g, 1 mmol) successively. The reaction mixture 
(Suspension) was vigorously stirred under argon for 8 hours. 
The Solid material was filtered through Celite and washed 
with dichloromethane (25 mL). The combined dichlo 
romethane filtrates were evaporated and the product was 
purified on a short neutral alumina column (dichloromethane 
eluant). The products separated by preparative HPLC on a 
Silica gel column using dichloromethane-hexane as the 
mobile phase. Overall yield was 68% with the main product 
being calix4pyrrole 1 (59%). Additionally, calix5pyrrole 
17 (6% yield and 3% of higher oligomers (nd-6)) were 
isolated. 
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Synthesis of calixnpyrroles via cyclization of 
2-(dialkylhydroxy)methylpyrrole Calixnlpyrroles may 
also be synthesized from 2-(dialkylhydroxy)methyl 
pyrroles. These molecules are cyclized using either a Brøn 
Sted acid or a Lewis acid. One approach for the preparation 
of 2-(methylalkyl)hydroxymethylpyrrole derivative is 
based on the reaction of commercially available 
2-acetylpyrrole with alkylmagnesiumbromides (Grignard 
reagents) affording the desired product 21 (R=alkyl) as a 




2-Acetylpyrrole (0.109 g, 1 mmol) was dissolved in 50 mL 
of dry THF under argon. The solution was then cooled to 
-78° C. A solution of MeMgBr (1 mL of a 1 M solution in 
diethylether) was added via Syringe while stirring. The 
reaction mixture was allowed to warm up to -15° C. for 10 
minutes. It was then cooled down and another 1.5 molar 
equivalents MeMgBr (1.5 mL of 1M solution; 1.5 mmol) 
was slowly added at -78 C. The reaction mixture was 
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stirred at that temperature for 15 minutes and then slowly 
allowed to warm up to 0° C. After stirring for two hours at 
0 C., the reaction was quenched with MeOH and evapo 
rated to dryness. The residue was redissolved in dichlo 
romethane (50 mL) and washed with a 5% solution of 
ammonium chloride and Water. The 
2-(dimethylhydroxymethyl)pyrrole was subjected to acid 
and Lewis acid catalytic macrocyclization giving mixture of 
calixnpyrroles at 65% yield with n=4-8 as the products 
with the main product being 1. The present inventors envi 
Sion this Synthesis could be extended to pyrroles with ketone 
groups in the C-position. 
f3-Octaethylcalix4pyrrole 22, 3,4-Diethylpyrrole (0.369 
g, 3 mmol) was dissolved in dry THF (30 mL) under argon 
and the solution was cooled to -78 C. A MeMgBr solution 
(3 mL of 1 M solution in diethylether, 3 mmol) was slowly 
added and stirred at that temperature for 10 minutes. The 
solution was allowed to warm up to -10° C. for 10 minutes 
and was then cooled to -78 C. At this point, 1.2 molar 
equivalents of tert-BuLi was added (3.6 mL of a 1 M molar 
Solution in hexane, 3.6 mmol) and the reaction mixture was 
kept at -78 C. for 30 minutes. The reaction mixture was 
allowed to warn up to -10° C. for 10 minutes and then 
cooled to -78°C. Acetone (0.29 g, 5 mmol) was added to the 
solution at that temperature and stirred for 30 min. at -78 
C., then allowed slowly warm up to -10° C. and kept at that 
temperature for 1 hour. The reaction was quenched by 
addition of 1 mL of Saturated water Solution of ammonium 
chloride. After evaporation of the organic Solvent, the prod 
uct 21 (R=Me, R=R=Et) was extracted into dichlo 
romethane and isolated by flash chromatography on Silica 
gel with dichloromethane as the mobile phase. Yield 78%. 
HRMS for CHNO calc. 181.146664, found 181.14781. 
2-(Dimethyl)hydroxymethyl)-3,4-diethylpyrrole 21 was 
Subjected to acid and Lewis acid catalysed cyclization. The 
mixture of calixnpyrroles was isolated in 45% net yield. 
The main product has n=422: (CHN) found 652; but a 






Pyrrole can be substituted for 3,4-diethylpyrrole in this 
procedure. 
The present inventors envision that 1-alkyl pyrrole and 
1-alkyl-3,4-diethylpyrrole and ketones could be used in a 
modification of the above procedure: 1-methylpyrrole or 
1-methyl-3,4-diethylpyrrole (3 mmol) are dissolved in dry 
THF (30 mL) under argon and cooled to -78° C. 1.2 molar 
equivalents of tert-BuLi are added (3.6 mL of a 1 M molar 











at -78 C. for 30 minutes. The reaction is warmed to -10 
C. for 10 min. and then cooled to -78 C. A general ketone 
(5 mmol) added and the reaction mixture was stirred for 30 
min. at -78 C. The solution is allowed to slowly warm up 
to -10° C. and stirred at that temperature for 1 hour. The 
reaction is quenched with 1 mL of a Saturated water Solution 
of ammonium chloride. After evaporative removal of the 
organic Solvent, the product is extracted to dichloromethane 
and isolated by flash chromatography on Silica gel using 
dichlorome thane as a eluent. The products: 
2-(dialkylhydroxy)methylpyrrole derivates were used for 
the preparation of calixnlpyrroles using the methodology 
described above. 
EXAMPLE 6 
Conversion of Calixm+npyrroles to Calixm 
pyridinonpyrrole 
A general Synthetic method for the preparation of calix 
mpyridinonpyrroles where m and n designate a number 
of pyridines and pyrroles in the macrocycle, respectively, is 
unknown to date. Calix(2pyridino 2pyrroles and calix1 
pyridino.3pyrroles have been previously Synthesized via an 
organometallic-mediated transformation using Zirconium 
and other metals. However, calixmpyridinonpyrroles 
where mid-2 have not been reported. 
The Synthetic approach provided by the present inventors 
differs from the prior art methods and provides access to a 
broad variety of calixmpyridinonpyrroles and calixm 
pyridines. The approach of the present Synthetic protocol is 
based on a non organometallic-mediated pyrrole ring expan 
Sion involving one or more of the pyrrole rings contained in 
a calixm+nlpyrrole macrocycle. 
Expansion of pyrrole within an existing calixm+n 
pyrrole involves the cycloaddition of dichlorocarbene to a 
particular pyrrolic Subunit followed by rearrangement to 
yield a corresponding pyridine. Dichlorocarbene may be 
generated under basic or neutral conditions. 
One or more pyrrolic Subunits may react in this procedure 
Specifically, varying the ratio of dichlorocarbene to calix 
m+npyrrole allows control of the extent of conversion of 
pyrrole to pyridine which, in turn, determines the ratio of 
pyridine Subunits to pyrrole Subunits in the calixmpyridino 
npyrroles. 
The present inventors have also discovered a Solvent 
dependence for the conversion of calixm+npyrroles to 
calixmpyridinonpyrroles. The use of dioxane leads 
mainly to one and two converted units, while the use of 
1,2-dimethoxyethane and prolonged reaction time provides 
for the full conversion of calixm+nlpyrroles to calixm 
pyridines. Partial conversion of calixm+npyrroles to calix 
mpyridinonpyrroles is also accomplished by the present 
methods. 
Additionally, the present inventors have found that 
dichlorocarbene generated under neutral conditions (from 
Sodium salts of trichloroacetic acid, for example) gives 
better yields than generating the dichlorocarbene under basic 
conditions (i.e. from the reaction of chloroform with sodium 
ethoxide). 
A first method utilizes dichlorocarbene generated under 
neutral conditions and achieves fully converted calixpyri 
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dine product. meso-Octamethylcalix4pyrrole (10 mmol) 
was dissolved in dry 1,2-dimethoxyethane (75 mL). Four 
molar equivalents of dry Sodium trichloroacetate were added 
per pyrrole ring. The reaction mixture was heated to reflux 
under an argon atmosphere for 20 hours. After cooling to 
room temperature, the Solution was filtered and the organic 
Solvent was evaporated in vacuo. The resulting residue was 
redissolved in dichloromethane, treated with charcoal, fil 
tered over celite and evaporated to dryneSS. The crude 
product was purified over a short neutral alumina column 
(dichloromethane eluant). Final separation was achieved by 
flash chromatography on Silica gel with dichloromethane 
and methanol (0-10%) as the mobile phase. Yield of fully 
converted product 27 is 35–50%. HRMS: For CHNIC1 
MH: calc. 613. 145933, found 613.145490. 
A second method employs a partial calix4pyrrole expan 
Sion process to form mixed calixmpyridinonpyrroles. 
Mixed Systems were obtained using 1-3 molar equivalents 
of Sodium trichloroacetate for each pyrrole ring in the 
macrocyclic System. The molar ratio of pyrrole / 
dichlorocarbene allows one to “tune” the number of pyrroles 
that are converted to pyridines. Using one molar equivalent 
of Sodium trichloroacetate for each pyrrole unit, the main 
product was calix1pyridino.3pyrrole 23 (76% yield). 
Using 2 equivalents, the main product was a mixture of the 
two calix(2pyridino.2pyrrole isomers 24 and 25 (83% 
yield). Using 3 molar equivalents, calix3pyridino1 
pyrrole 26 was obtained (56% yield). These compounds 
were isolated by flash chromatography and Separation was 
obtained on semipreparative HPLC with dichloromethane 
acetonitrile as a Solvent and a gradient of acetonitrile from 
0–5%. After column and HPLC separation, the following 
3-chloropyridine macrocyclic products were characterized 
by HRMS: Monoconversion: HRMS For CHNC calc. 
474. 255025, found 474.254.879. Bis conversion: HRMS For 
CHNICl calc. 520. 216053; found 520.215789 and 512. 
215985. For tris conversion: HRMS For CHNICl calc. 
566.177081, found 566.178902. 
Mixed molecule Systems were further obtained using a 
third procedure. Dioxane was used as a Solvent under the 
conditions described which resulted in full conversion of the 
calix4pyrrole to calix4pyridine, the main products where 
calix1pyridino.3pyrrole 23, calix2pyridino 2pyrrole 24 
and 25 and calix3pyridino1pyrrole 26. Conditions: reflux 
under argon for 15 hours, purification and Separation of 
products as above. 
Crystals of compound 24 were grown and the Structure 
elucidated by X-ray diffraction. Crystallographic data for 
24: Colorless crystals, triclinic, P1, Z=4, in a cell of dimen 
sions: a =12,544(1), b=15.406(2), c=16.770(3) A, C =63.93 
(1), B-82.957(9), Y=76.958(9), V=2835.0(9) A, p=1.23 
g cm, F(000)=1144. 4134 unique reflections, 2783 with 
F-4(O(Fo)). The final R(F)=0.113, Rw(F)=0.269, good 
ness of fit=4.30 for 668 parameters refined on F. Two 
crystallographically distinct molecules per unit cell. Dihe 
dral angles of rings to root mean Square plane through 
meso-carbons: pyrrole 118.8, pyridine 2113.20 (23.8), 
pyrrole 323.20, pyridine 467.20 (22.8), and pyrrole 1 
21.7, pyridine 269.9 (20.1), pyrrole 3161.7 (18.30), 
pyridine 4 67.0° (23.0). 
Sodium (1.15 g, 50 mmol) was dissolved in absolute 
ethanol (25 mL) in a flask fitted with a reflux condenser and 











Calix4pyrrole (15 mmol) in chloroform (5 mL) was added 
and mixture was heated to 55° C. for 18 hours. The Sodium 
chloride was filtered off, the residue was treated with char 
coal and purified on a short neutral alumina column fol 
lowed by flash chromatography on Silica gel with 
dichloromethane-methanol (from 0-5%). The main product, 




















Configurational Isomers of Calixpyrrole 
The structures of calix4pyrroles described herein are 
drawn two dimensionally. This representation obscures the 
fact that caliXpyrroles containing more than one 
asymmetrically-Substituted meso-position will be formed as 
a mixture of configurational isomers. For example, com 
pound 5 (see Example 2), contains four asymmetrically 
Substituted meSO-positions and can exist as four different 
isomers which are chemically distinct from each other and 
may be separated via HPLC chromatographic techniques. A 
two dimensional representation is as follows. 
The four possible configurational isomers of compound 5 
are as follows. 













C, C, C, f 
Cl, f, C., f: 
C, C, f, 
Therefore, as used herein, all two dimensional representa 
tions of calixpyrroles containing more than one asymmetri 
cally Substituted meso-position refer to all possible isomers 
(C.C.C.C), (C.C.O.B) (C. f.O.f3) and (C.O.?, B) unless other 
wise stated. For calix5pyrrole there will also be four 
possible configurational isomers (C.C.C.C.C.), (C.C.C.C.f3) 
(C.f3,C...f3,C) and (C.C.C.B.f3) however for n>5 the number of 
possible configuarational isomers will increase above four. 
EXAMPLE 8 
Calixnpyrrole Derivatives, Multimers, Conjugates, 
and Synthesis Thereof 
Calixnpyrrole derivatives, multimers and conjugates 
have been Synthesized. Such molecules possess useful bind 
ing properties for ion, chiral Substrate, or neutral molecule 
Separation, for Salt binding, for acting as Sensors for ions or 
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Amido-calixpyrroles 28 and 29 are particularly useful as 
anion binding agents. Additionally, they serve as model 
compounds for calixpyrrole modified Silica gels wherein the 
calixpyrrole is linked to the modified Silica gel via amide 
bonds. 5 
Mono-f-butylamidocalix4pyrrole 28. Compound 12 
(?3-hook acid) (300 mg, 0.62 mmol) was dissolved in DMF 
(20 mL, dry) under and argon atmosphere. n-Butylamine (45 
mg, 0.62 mmol) was added followed by BOPPF (327 mg, 
0.74 mmol) and triethylamine (125 mg, 1.2 mmol). The 
reaction mixture was stirred for 48 hours. The DMF was 
then removed in vacuo and the product purified by column 
chromatography (SiO, CHCl: CH-OH 99:1 eluant) 
affording compound 28 as a white foam (331 mg, 99%). "H 
NMR (250 MHz, CDC1) 8: 8.80 (s, 1H, NH), 7.24 (s, 1H, 
NH), 7.01 (coincidents, 2H, NH), 5.92–5.82 (m, 7H, 6CH, 
and NH), 5.70–5.69 (1H, d, CH), 3.51 (s, 2H, OCH), 
3.29 (q, J=6.2 Hz, 2H, CH), 1.66-1.30 (coincident 
resonances, 28H, 8CH, 2CH i), 0.96 (t, 3H, CH 
heck). C. NMR (62.9 MHz, CDC1,) 8: 173.0,140.2, 139.7, 
1O 
15 
139.2, 138.9, 138.4, 138.1, 137.4, 134.2, 110.7, 106.9, 
103.2, 103.2, 103.1, 102.7, 102.5, 101.6, 39.7, 37.1, 35.9, 
35.5, 35.4, 35.2, 32.1, 29.2, 29.0, 28.7, 20.5, 14.0. High 
resolution FABMS calc for CH-NO 541.3781; found 






Mono-meso-butylamidocalix4pyrrole 29. Compound 4 
(meso-hook acid) (268 mg, 0.43 mmol) was dissolved in 
DMF (20 mL, dry) under and argon atmosphere. 
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n-Butylamine (31.6 mg, 0.43 mmol) was added followed by 
BOPPF (230 mg, 0.52 mmol) and triethylamine (87 mg, 
0.86 mmol). The reaction mixture was stirred for 48 hours. 
The DMF was then removed in vacuo and the product 
purified by column chromatography (SiO, CHCl: CH-OH 
99:1 eluant) affording compound 29 as a white foam (118 
mg, 41%). H NMR (250 MHz, CDC1) 8: 7.26 (s, 2H, 
NH), 7.17 (s, 2H, NH), 5.93 (s. 2H, CH), 5.92 (s, 2H, 
CH), 5.90 (s.2H, CH), 5.89 (s.2H, CH), 5.46 (brt, 1H, 
NH), 3.17 (q, J=6.3 Hz, 2H, CH), 1.87 (br. coincident 
resonances, 18H, 9CH cyclohexyl), 1.45 (br. coincident 
resoances, 25H, 6CH2-tete--5CH2 +CH i), 0.92 
(t, J=7.2 Hz, 3H, CH). 'C NMR (62.90 MHz, CDC1,) 8: 
172.6, 137.6, 137.2, 137.0, 136.9, 104.0, 103.9, 103.6, 40.0, 
39.8, 39.5, 39.4, 38.8, 37.3,37.0, 36.7, 32.2, 26.4, 25.6, 23.2, 
20.9, 20.5, 14.0. High resolution FABMS calc for 
CHNO 675.4876; found 675.4879 (A1.2 ppm). 
29 
Mono-f-octadecylantidocalix4pyrrole 30. B-hook acid 
12 (250 mg, 0.51 mmol) was dissolved in DMF (20 mL, dry) 
under and argon atmosphere. Octadecylamine (139 mg, 0.51 
mmol) was added followed by BOP PF (273 mg, 0.61 
mmol) and triethylamine (105 mg, 1.03 mmol). The reaction 
mixture was stirred for 72 hours. The DMF was then 
removed in vacuo and the product purified by column 
chromatography (SiO, CHCl:CH-OH 99:1 eluant) afford 
ing the product 30 as a yellow oil (330 mg, 87%). H NMR 
(250 MHz, CD.C.) 8; 8.79 (s, 1H, NH), 7.50 (s, 1H, 
NH), 7.03 (s. 2H, NH), 5.89-5.80 (coincident multiplets, 
7H, 6CH, and NH), 5.67 (d. 1H, NH), 3.49 (s. 2H, 
CHCO), 3.26 (q, J=6.4 Hz, 2H, CH), 1.68 (m, 12H,4CH), 
1.49 (m, 12H, 4CH), 1.29 (m, 32H, CH), 0.90 (t, J=6.8 Hz, 
31H, CH). CNMR (62.90 MHz, CDC1) 8: 1730, 1402, 
139.7, 139.2, 139.0, 138.4, 138.1, 137.4, 134.3, 110.8, 
107.0, 103.3, 103.2, 102.7, 102.5, 101.7, 40.1, 37.2, 35.9, 
35.50, 35.45, 35.2, 32.4, 30.2, 30.1, 29.8, 29.2, 29.0, 28.7, 
27.4, 23.1, 14.3. High resolution FABMS calc for 
CHNO 737.5972; found 737.5957 (A2.0 ppm). The 
amide NH group of this receptor contributes to the calix4 
pyrrole anion binding process by providing a fifth hydrogen 
bond to the bound anion (see Example 10). 
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Molecules such as 30 are designed for insertion into lipid 
bilayerS and are expected to be useful for transport. 
Propyl bridged B-amidocalix4pyrrole diner 31. A calix 
pyrrole amide dimer compound 31 was formed by coupling 
1,3-diaminopropane to the calixpyrrole acid 12. Again, this 
amide was formed as a DMF complex. This type of receptor 









Compound 12 (100 mg, 0.206 mmol) and 1,3- 
diaminopropane (7.62 mg, 0.103 mg) were dissolved in 5 
mL DMF under an argon atmosphere. BOP (109 mg, 0.247 
mmol) and EtN (41 mg, 0.411 mmol) were added in 10 mL 
dry DMF, and the solution was stirred overnight. The solvent 
was then removed under high vacuum and the residue was 
purified by column chromatography (SiO, CHCl2-1.0% 
MeOH), affording the dimer 31 as a DMF complex (65 mg, 











7.93 (DMF), 7.35 (s, 2H, NH), 7.01 (s, 2H, NH), 6.35 (t, 2H, 
NH), 5.88–5.67 (overlapping multiplets, 14H, CH), 
3.51 (s, 4H, CCH), 3.25 (m, 4H, CH), 2.90 (DMF), 2.82 
(DMF). High resolution FABMS calc for CHNO 
1010.6622; found 1010.6630 (A-0.7 ppm). This methodol 
ogy can be extended to produce calixpyrrole trimers, net 
Works of calixpyrroles, linear Strings of calixpyrroles, or 
dendrimer type arrays of calixpyrroles. Additionally all 
these multimers could be Synthesized using the meso 
"monohook' acid 4 in a similar Synthetic Scheme as 
described herein for the B-substituted molecules. 
B-Amidobenzo-15-crown-5-meso-octamethylcalix4 
pyrrole 32. 4'-Aminobenzo-15-crown-5 has been coupled to 
calix4pyrrole f-monoacid 12 to produce a ditopic receptor 
which is capable of binding a whole salt (i.e. Na+Cl) (FIG. 
10) or a Zwitterionic amino acid. The calixpyrrole provides 
an anion binding site and the crown ether a cation binding 
Site, thereby providing a Salt complexing agent. 
On 
meso-Octamethylcalix4pyrrole f-monoacid 4 (281 mg, 
0.58 mmol) and 4'-aminobenzo-15-crown-5 (164 mg., 0.58 
mmol) were dissolved in dry DMF (20 mL) and stirred under 
an argon atmosphere. Benzo tria Zol-1-yloxytris 
(dimethylamino)phosphonium hexafluorophosphate (BOP 
PF) (0.306 g., 0.69 mmol) and triethylamine (116 mg) in 20 
mL DMF were added and the reaction mixture stirred 
overnight. The Solvent was then removed under high 
Vacuum and the residue purified by column chromatography 
(SiO2, CHCl2-1 to 2% MeOH) affording the amide 32 as a 
white foam containing alkali metal cations (0.463g). H 
NMR (250 MHz, CDC1) 8:8.74 (s, 1H, NH), 7.76 (s, 1H, 
NH), 7.45 (s, 1H, ArH), 7.34 (s, 1H, NH), 7.09 (s, 1H, 
NH), 7.02 (s, 1H, NH), 6.87(m, 2H, ArH), 4.10 (m, 4H, 
20CH), 3.87 (n, 4H, 20CH), 3.71 (m, 1 OH, 40CH+ 
CCH-CO), 1.59 (s, 6H, 2CH), 1.57 (s, 6H, 2CH), 1.51 (s, 
12H, 4CH). 'C NMR (62.5 MHz, CDC1) 8: 171.48, 
149.52, 145.96, 140.08, 139.56, 139.18, 138.78, 138.31, 
138.14, 137.67, 13448, 132.73, 114.66, 112.44, 109.97, 
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107.19, 106.91, 103.26, 103.13, 103.07, 102.83, 102.31, 
101.71, 70.94, 70.40, 69.73, 69.57, 69.04, 37.12, 36.82, 
35.45, 35.41, 35.19, 29.17, 28.97, 28.79. FABMS calc for 
C.H.N.O. 751.4309; found 751.4310 (A-0.2 ppm). Fur 
ther cation binding agents that may be coupled to calixn 
pyrrole include polyethers; texaphyrins and cryptands for 
example. Anion binding agents Such as Sapphyrin or other 
expanded porphyrins Such as rubyrin, rosarin, amethyrin and 
turcasarin may also be appended to produce polyanionic 
receptors. Additionally neutral binding groupS. Such as 
hydrogen bonding arrays may be appended to the calixn 
pyrrole. 
Mono-meso-ferroceneamidocalix4pyrrole 33. The syn 
thesis of new molecular devices designed to Sense and report 
the presence of a particular Substrate is an area of analytical 
chemistry which is attracting intense current interest. Fer 
rocene is a stable organometallic moiety that has been 
incorporated into meso- and f-pendant arms of calix4 
pyrrole macrocycles forming molecules which may be used 




Compound 4 (meso-hook acid) (325 mg, 0.52 mmol) 
(see Example 2) was dissolved in DMF (20 mL, dry) under 
an argon atmosphere. Methylaminoferrocene (112 mg, 0.52 
mmol) was added followed by BOPPF (278 mg, 0.63 
mmol) and triethylamine (106 mg, 1.2 mmol). The reaction 
mixture was stirred for 48 hours. The DMF was then 
removed in vacuo and the product purified by column 
chromatography (SiO, CHCl:CH-OH 99:1 eluant) afford 
ing an orange foam 33 (288 mg, 67%). H NMR (250 MHz, 
CDC1) 8: 7.24 (s, 2H, NH), 7.16 (s, 2H, NH), 5.93 (d, 4H, 
CH), 5.89 (d, 4H, CH), 5.61 (brt, 1H, NH), 4.16 (s, 
7H, FcH+FcCH), 4.13 (m, 2H, FcH), 4.07 (m, 2H, FcH), 
2.05 (t, 2H, CH), 1.94 (coincident resonances, 16H, 2CH 
hook +6CH2 ele, 1.45 (br., 23H, CH2 +CH3+9CH2 
cyclohexyl). CNMR (62.90 MHz, CDC1) 8: 1720, 137.6, 
137.1, 137.0, 136.8, 104.0, 103.9, 103.8, 103.6, 85.7, 68.9, 
68.5, 68.4, 40.0, 39.8, 39.5, 38.9, 38.8, 37.2, 37.1, 37.0, 36.9, 
36.7, 26.4, 25.6, 23.2, 23.1, 20.9. High resolution FABMS 
calc for CHNOFe 817.4382; found 817.4364 (A2.2 
ppm). 
Mono-f-ferroceneamidocalix 4-pyrrole 34. Compound 
12 (B-hook acid) (250 mg, 0.51 mmol) was dissolved in 
DMF (20 mL, dry) under an argon atmosphere. Methylami 
noferrocene (110 mg, 0.51 mmol) was added followed by 
BOPPF (273 mg, 0.61 mmol) and triethylamine (105 mg, 
1.03 mmol). The reaction mixture was stirred for 72 hours. 
The DMF was then removed in vacuo and the product 
purified by column chromatography (SiO, CHCl:CH-OH 











NMR (250 MHz, CDC1,) 8:8.52 (s, 1H, NH), 7.38 (s, 1H, 
NH), 7.06 (s, 1H, NH), 7.01 (s, 1H, NH), 6.06 (s, 1H, NH.), 
5.91 (s, 6H, CH), 5.74 (1H, d, CH), 4.21 (m, 6H, 
FcH+FcCH), 4.14 (s, 5H, 5FcH), 3.54 (s, 2H, OCH), 1.58 
(m, 12H, CH), 1.49 (m, 12H, CH). CNMR (62.90 MHz, 
CDC1) 8: 172.6, 139.9, 139.4, 139.1, 138.9, 138.4, 138.3, 
137.6, 134.3, 110.5, 107.1, 103.3, 103.2, 103.1, 102.9, 
102.6, 102.1, 85.7, 68.9, 68.4, 68.3, 39.1, 37.1, 35.9, 35.5, 
35.2, 29.2, 29.1, 29.0, 28.8. High resolution FABMS calc for 




The electrochemical behavior of these macrocycles 
includes multiple oxidation processes occurring in the calix 
pyrrole ring. The ferrocene oxidation wave is distinct from 
these macrocycle oxidations and can be followed using 
Standard electrochemical techniques (cyclic and Square 
wave) (FIG. 11). The ferrocene oxidation wave is perturbed 
upon addition of anions to the electrochemical Solution 
(FIG. 12) (Table 1). 
Table 1 Redox potentials (mV) vs Ag/AgCl of the fer 
rocene moiety in compounds 33 and 34 in the absence and 
presence of anions (perturbation is shown in brackets) from 
Square wave Voltammetry 
Compound 33 (mV) Compound 34 (mV) 
Free ligand 453 463 
HPO, 401 (-52) 430 (–33) 
F. 491 (+38) 491 (+28) 
Cl 530 (+77) 410 (-53) 
Larger perturbations are observed for the meso-compound 
33 than for the B-compound 34. It has been demonstrated 
that calixpyrroles can be incorporated into devices (in this 
case an electrochemical anion sensor) and operate Success 
fully. 
meso-Tetrakispolyethyleneglycol-meso-tetramethyl Sub 
stituted calix4pyrrole 35. A polyethylene glycol derivative 
of calix4pyrrole has been synthesized 35. 
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O O OCH3 
Reaction of 4-acetylbutyric acid with triethylene glycol 
monomethyl ether as solvent in the presence of HCl affords 
a water-Soluble triethylene glycol ketone. Pyrrole (48 mg, 
0.72 mmol) and the triethylene glycol ketone (200 mg, 0.72 
mmol)) were dissolved in methanol (5 mL) and methane 
Sulfonic acid (I drop) added. The reaction was stirred 
overnight and the Solvent then removed in vacuo affording 
the water soluble product 35 in 24% yield. 
Preparation of amidosaccharide-calix4pyrrole conjugate 
36. The coupling of protected glucosamine with calixpyrrole 
f-acid 12 derivative of calixnpyrrole produces a water 
Soluble calixpyrrole conjugate. Calixpyrrole B-acid 12 
(48.67 mg, 0.1 mmol) was dissolved in dry dichloromethane 
(50 mL) under argon and diisopropylcarbodiimide (2.5 
molar equivalents, 0.25 mmol) was added together with 1 
mg of 1-hydroxybenzotriazole. The solution was stirred for 
10 minutes at room temparature under argon. 2-Amino-2- 
deoxy-1,3,4,6-tetraacetyl-B-D-glucopyranose hydrobromide 
Salt (2 molar equivalents, 73 mg, 0.2 mmol) was added 
follwed by 0.3 mL of dry pyridine. The reaction mixture was 
stirred under argon for 3 days, diluted with dichloromethane 
(50 mL), washed with 3% hydrochloride acid, water and the 
organic phase dried over Sodium Sulfate. The product was 
isloated on short Silica gel column with dichloromethane as 
eluant. The yield of calix4pyrrole 36 2-amido-2-deoxy-1, 
3,4,6-tetra-O-acetyl-B-D-glucopyranose conjugate was 73.4 
mg (90%). HRMS for CHNO calc. 816.4184, found. 
816.4178. Deprotection of the tetraacetylated derivative was 
performed using Standard procedures by dissolution of the 
protected Sugar calix4pyrrole conjugate described above 
(50 mg) in MeOH, with catalytic amount of sodium meth 
oxide. The Solution was stirred for 8 hours at room tem 
perature. The product, calix4pyrrole 2-amido-2-deoxy-3- 
D-glucopyranose 37 conjugate, was obtained in quantitative 
























A host of hydrophilic substituents can be coupled to 
B-mono-acid and meso-mono-acid; for example, polyethyl 
ene glycols, azacrown ethers, crown ethers, phosphate 
groups, Saccarides, modified Sugars bearing amino groups, 
a mino alcohols, Sulfonyl, chito San, 
2-aminoethylhydrogensulfate, 2-aminoethylphosphoric 
acid, and the like. Additionally, water Solublizing groups, 
Such as Sulfonates, phosphates, polyalcohols, polyethers, 
hydroxyl groups, amino groups, carboxylic acid groups, 
Sulfoxide groups, and other could be incorporated into the 
molecule via attachment to the Starting ketone and pyrrole 
before formation of the macrocycle. 
Calixnpyrroles have been shown to bind phosphate 
groups in the Solid State, in Solution, and when bound to 
solid supports as described in Example 10. DNA and RNA, 
important biological molecules, contain many phosphate 
groups. A water-Soluble calixnpyrrole is expected to bind 
to DNA and RNA. Binding could have the effect of limiting 
the ability to unwind in the case of DNA, thereby hindering 
biological functions, or in the case of RNA, could prevent 
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translation. Additionally, oligonucleotides having Sequence 
complementarity to a template molecule may be attached to 
a calixnpyrrole for site-specificity. Uses include inhibition 
of replication and anti-Sense therapy. 
EXAMPLE 9 
Chiral Calixnpyrroles, Calixmpyridinon 
pyrroles, and Calixmpyridines 
The present example provides methods for inducing 
chirality in macrocycles of the present invention, and pro 
vides chiral macrocycles for recognition and Separation of 
neutral and anionic chiral molecules. One of skill in this art, 
in light of the present disclosure, would realize that the 
methods provided herein for calixpyrroles are applicable to 
calixmpyridinonpyrroles, and calixmpyridines. 
A first method is to use chiral molecules as Starting 
materials for the Synthesis of calixnlpyrroles. A second 
method is to attach optically active (chiral) groups to the 
molecule via bond formation between functional groups on 
the calixnpyrrole and the chiral auxiliary. A third method 
is based on transforming achiral Substituents into chiral 
groups by using, for instance, chiral catalysis. 
Exemplary chiral ketones that can be used to Synthesize 
chiral calixpyrroles include, but are not limited to, chiral 
ketone containing Steroid derivatives, antibiotics e.g. 
lasalocid, Synthetic chiral ketones, and binaphthal groups 
that possess an inherent chirality. Steroid analogs have the 
added advantage of forming bowl-shape cavities because of 
the natural bend in the molecule. They have well defined 





Preparation of steroidal calixnpyrroles. 4-Cholesten-3- 
one (38.4 mg., 0.1 mmol) was dissolved in 25 mL of ethanol. 
Ten molar equivalents of pyrrole was added to the Solution. 
The solution was cooled to 0° C. and 10 mg of concentrated 
HCl in 1 mL of ethanol was added to the reaction mixture 
which was then stirred for 24 hrs. at room temperature. The 
Solvent was removed in vacuo. The residue was redissolved 
in dichloromethane (25 mL) and washed with a 3% sodium 
carbonate solution. The product 38 was purified by flash 
chromatography on Silica gel using a dichloromethane 
hexane (1:1) mobile phase. Yield=12%. The main product 
was a calix4pyrrole (CHN), Calc'd Mass: 1734. 
Found: 1734. For calix5pyrrole (CH,N) Calc’d Mass: 
2167. Found: 2167. This reaction has been repeated varying 
the ratio of ketone to pyrrole and also varying the type of 
acid used. The total yields of calixnpyrroles predominantly 
but not exclusively the n=4 product, were generally in the 
10-15% range. 
Because of their many functional groups, Steroid 
Substituted calixnpyrroles containing functional groups 
capable of being attached to Solid Supports are likely to 
exhibit enantioSelective Separation of, for example, Sugars, 
Synthetic oligonucleotides, polypeptides, chiral anions, 
chiral neutral molecules, or the like. One skilled in the air, 
in the light of the present disclosure, would appreciate that 
the resulting Species would be amenable to attachment to a 
Solid Support. 
Binaphthal System also possess an inherent chirality. 
Being So close to the periphery, they could act as “directing 
groups” and influence binding of neutral and anionic species 
e.g. 39. 
38 
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A Second method for inducing chirality in a molecule is to 
attach a chiral auxiliary to the main body of the calixn 
pyrrole. This could be done, for example, by forming an 
amide bond between a carboxycalixnpyrrole and a chiral, 
amino group-containing molecule. This can include, but is 
not limited to, aminoglycosides, chiral amino alcohols, 
aminocyclodextrins and amino acids. Many different kinds 
of functional groups can be coupled to form chemical bonds 
with a calixnpyrrole and would be known in the light of the 
present disclosure. One skilled in the art, in the light of the 
present disclosure, would appreciate that the resulting spe 
cies would be ammenable to attachment to a Solid Support. 
Chiral Amide f-Substituted calix4pyrrole 40. Monoacid 
12 has been coupled to a number of different amines to 
produce chiral and dimer calixpyrrole species. (R)-(+)-O- 
methylbenzylamine is a readily available chiral amine. This 
amine was appended to the calixpyrrole skeleton by con 
ducting an amide coupling reaction between the amine and 
compound 12 in the presence of BOP and EtN in DMF 
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Chiral calixpyrroles are useful in the chiral Separation of 
racemic mixtures of Species Such as amino acids. Compound 
40 will form a diastereomeric mixture when complexed to 
fluoride (FIG. 13). 
Compound 12 (200 mg, 0.41 mmol) and (R)-(+)-C- 
methylbenzylamine (50 mg, 0.41 mmol) were dissolved in 
dry DMF (10 mL) and stirred under an argon atmosphere. 
Benzotriazol-1-yloxytris(dimethylamino)phosphonium 
hexafluorophosphate (BOP) (0.218 g., 0.494 mmol) and 
triethylamine (83 mg, 0.82 mmol) in 15 mL DMF were 
added, and the reaction mixture was stirred overnight. The 
Solvent was then removed under high Vacuum and the 
residue was purified by column chromatography (twice on 
SiO, CHCl2-2.5% MeOH), affording the chiral amide 40 
as a DMF complex (161 mg, 66% yield). H NMR (250 
MHz, CDC1,) 8:8.76 (s, 1H, NH), 7.95 (DMF), 733–728 
(m, 5H, Ph.H), 7.16 (s, 1H, NH), 6.96 (2 brs, 2H, NH), 
5.86–5.65 (overlapping multiplets, 7H, CH, ). 5.09 (m, 1H, 
PhCH), 3.50 (s, 2H, CCH), 2.90 (DMF), 2.81 (DMF), 
1.54-1.45 (overlapping singlets, 27H, CH). High resolution 
FABMS calc for CHNO 589.3781; found 589.3768 
(A2.2 ppm). 
The third method of inducing chirality is reaction of a 
non-chiral Substituent, Such as an alkene, to form a chiral 
Side chain and Subsequent anti-Selective transformation of 
the Side chain to a chiral moiety. These types of reactions 
include, but are not limited to, catalytic asymmetric 
hydrogenation, asymmetric epoxidation and Subsequent ring 
opening, asymmetric diol formation, asymmetric halogena 
tion and asymmetric amino alcohol formation. 
EXAMPLE 10 
Calixnpyrroles, Calixmpyridinonpyrroles and 
Calixmpyridines for Solution and Solid Support 
Binding, and for Separation of Ionic and Neutral 
Substrates 
Calixnpyrroles and calixmpyridinonpyrroles for 
binding and Separation possess a pyrrolic hydrogen bonding 
array capable of coordinating anions via N-H . . . anion 
hydrogen bonds. Calixmpyridines have a lone pair of 
electrons on pyridine nitrogens that are capable of donating 
electron density to a cation. Further, a protonated calixm 











anion. Anion binding properties of calixpyrroles have been 
studied in solution using 1 H NMR titration techniques and 
are provided herein. 
Stability constants for octamethylcalix4pyrrole, 1, and 
tetraspirocyclohexylcalix4pyrrole, 2, binding to various 
anions in dichloromethane were obtained and are provided 
in Table 2. 
TABLE 2 
Stability constants for compounds 1 and 2 with anionic substrates' 
Stability Constant (M. 
Calixpyrrole 1 Calixpyrrole 2 
Fluoride 17170 (+900) 3600 (+395) 
Chloride 350 (+5.5) 117 (+4.0) 
Bromide 10 (0.5) C 
Iodide &10 C 
Dihydrogen phosphate 97 (+3.9) &10 
Hydrogen sulfate &1 O C 
Anions were added as 0.1 M CDC1 solutions of their tetrabutylammo 
nium salts to receptor to 10 mM receptor solutions in CD.C., with concen 
tration changes being accounted for by EQNMR. 
Tetrabutylammonium fluoride was added as the trihydrate. 
Undetermined. 
The data of Table 2 demonstrate that calix 4-pyrroles show 
different affinity for different anions in solution, with fluo 
ride being the most tightly bound while iodide is very 
slightly bound. 
The present inventors have discovered that varying the 
Substituents on the B-position of a calixpyrrole molecule, 
however, affects the Strength with which a particular anion 
is held. The data of Table 3 shows the effect of substituting 
the ?-positions of the macrocycle with ester 10, methoxy 13, 
and bromine 14 groups and the effect that these functional 
groups have on the binding strength of calix4pyrrole to 
various anions. Additionally compound 11 has been shown 
to interact with both fluoride and chloride anions in Solution. 
TABLE 3 




1O 13 14 
Fluoride 1.0 (+0.2) x 10 1.7 (+0.2) x 10° 2.7 (+0.4) x 10' 
Chloride 47 (+1) &10 4.3 (+0.6) x 10 
Dibiphosphate 6.5 (+0.4) x 10° 410 
Anions were added as 0.03 MCDC1 solutions of their tetrabutylammo 
nium salts to 3 mM solutions of the receptor in CD.C., with concentration 
changes being accounted for by EQNMR. In determining the stability 
constants, the possible effects of ion pairing (if any) were ignored. 
Estimated value. The NH proton resonance broadened considerably dur 
ing the titration, forcing the frequency of the resonance to be noted manu 
ally. 
Not determined. 
The attachment of electron-donating Substituents (such as 
methoxy) to the B-position (carbon or C-rim of the 
calixpyrrole) decreases the Stability constants of compound 
13 relative to compound 2. However attachment of electron 
withdrawing Substituents (such as bromine) to the carbon 
rim has increased the Stability constants of compound 14 
relative to compound 1. 
While varying the electron density of the calix4pyrrole 
core increases or decreases the binding affinities towards 
anions, the present inventors also discovered that groups 
having a functional moiety at a Suitable distance from the 
macrocycle, and having Sufficient flexibility to fold back 
over the macrocycle also affects the Strength of binding as 
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discussed below. The data of Table 4 illustrate the effects of 
an amide group attached at the meso-position of the calix 
4pyrrole. 
TABLE 4 
Stability constants for compounds 28 and 29 with anionic substrates in 
CDC -SAS-12 
Stability Constants (M 
Compound 28 (B) Compound 29 (meso) 
Chloride 405 (+10) 415 (+45) 
Dihydrogen phosphate 80 (+15) 62 (+6) 
Hydrogen sulfate &10 &10 
Anions were added as 0.1 M CD.C1 solutions of their tetrabutylammo 
nium salts to 10 mM solutions of the receptor in CDC1, with concentra 
tion changes being accounted for by EQNMR. In determining the stability 
constants, the possible effects of ion pairing (if any) were ignored. 
Estimated value. The NH proton resonance broadened considerably dur 
ing the titration, forcing the frequency of the resonance to be noted manu 
ally. 
AS compared to meso-tetraspirocyclohexylcalix4 
pyrrole, 2, the meso-Substituted, amide-Substituted calix4 
pyrrole 29 shows a marked increase in binding affinities for 
chloride and phosphate when compared with the values 
obtained for tetraspirocyclohexylcalix4pyrrole (see Table 
2). The amide group contributes to the binding of the anion 
via an amide-anion hydrogen bond as shown in FIG. 14. 
This increased binding affinity towards anions was not 
observed for the B-substituted amide substituted meso 
octamethylcalix4pyrrole 28 when compared to the com 
pound 1. A possible reason is that the carboxy “tail” is not 
long enough to Swing around and contribute to the binding 
of the anion. 
TABLE 5 
Stability constants of the ferrocene-substituted calix 4-pyrroles 33 
and 34, measured in CD.C. 
Anion 33 meso-ferrocene 34 B-ferrocene 
HPO 40 + 6 M' (B-CH) 40 - 9 M' 
F 79 - 7 M-1 (B-CH) 1496 - 370 M 
206 + 51 M (NH) 
Cl 2O2 15 MT 444 - 22 M-1 
The ferrocene modified calixpyrrole binding constants with 
anions are provided in Table 5. 
Substrate Binding in Solution. The binding of neutral 
molecules to calix4pyrrole in the Solid State prompted the 
present inventors to quantify the binding affinities of calix 
4pyrrole to a number of hydrogen-binding neutral mol 
ecules. Table 6 illustrates the varying degrees of affinity to 
which calix4pyrrole binds to various hydrogen binding 
compounds. 
TABLE 6 
Association Constants for Calix4pyrrole, 1, with Neutral Substrates' 
Substrate Added Ka (M'.) 
methanol 12.7 - 1.O 
ethanol 10.7 O.7 
benzyl alcohol 9.7 O.7 
isopropyl alcohol 7.O. O.4 
sec-butanol 6.2 O.4 
N-formylglycine ethyl ester 13.3 1.O 
N,N-dimethylformamide 11.3 O.8 
N,N-dimethylacetamide 9.O. O.9 













Association Constants for Calix4pyrrole, 1, with Neutral Substrates' 
Substrate Added Ka (M'.) 
dimethyl sulfoxide 16.2 + 1.1 
1,2-dimethylimidazole 5.4 - 0.3 
acetOne 2.2 O.2 
nitromethane 
In benzene-de at 298 K. For each titration, the concentration of 1 was 
held constant (at ca. 4 x 10 M) as aliquots of the substrate in benzene 
s (ca.1 MO were added. . -w 
In this instance, the induced shifts in the NH proton(s) of 1 were too 
small (<0.15 ppm) to afford a reliable K value. 
The data in Table 6 demonstrates the ability of calixpyr 
roles to coordinate to neutral Species 
Separation rising Solid-Supported Calix4pyrroles. Fol 
lowing the discovery of the unique anion binding capabili 
ties of calix4pyrroles, the present inventors proceeded to 
attach the “monohook” of Examples 2 and 3 to a silica gel 
Solid Support. Calix4pyrrole-Substituted Silica gel chroma 
tography has demonstrated the ability to Separate anionic, 
neutral hydrogen-binding and aromatic molecular species. 
In addition to anionic Species Such as phenyl phosphate, 
calix4pyrrole Substituted Silica gel has demonstrated the 
ability to Separate polyphosphate-containing compounds 
Such as 5'-adenosine mono-, di-, and triphosphate under 
standard, isochratic HPLC conditions at pH=7. As one might 
expect, increasing the number of anionic binding Sights 
greatly increases the retention times of these types of 
molecules. 
The present approach to anionic and neutral Species 
Separation was as follows. The macrocycle, meso-tris 
Spirocyclohexyl-monohook-calix4pyrrole, 4, was 
covalently attached to 5 g, trimethyl silyl protected, amino 
propyl HPLC-grade silica gel obtained from Phase Separa 
tions (Norwalk, Conn.) to produce Gel M as shown in FIG. 
15A. In a similar fashion, B-monohook acid calix4pyrrole 
12 was attached to 5u, trimethylsilyl protected, aminopropyl 
HPLC-grade silica gel obtained from Phase Separations 
(Norwalk, Conn.) in the presence of diisopropylcarbodiim 
ide to produce Gel B as shown in FIG. 15B. The attachment 
of the “monohook” calix4pyrrole to C-1 aminopropyl 
Silica gel is achieved in a greater than 95% yield. 
The calix4pyrrole columns were packed commercially 
by Alltech (Deerfield, Ill.), and various substrates, under 
differing conditions, were eluted through the columns. All of 
the data provided in the chromatograms herein were 
obtained at room temperature under isochratic conditions. 
FIG. 16 illustrates the separation of phenyl sulfonate (3), 
phosphate (4), arsenate (1), and benzoic acid (2) on Gel M. 
Excellent Selectivity is seen among the different anions. FIG. 
17 and FIG. 18 provide further examples of separation of 
biologically-relevant Substrates by the calix4pyrrole 
Substituted Silica gel, in this case, 5'-adenosine 
monophosphate, 5'-adenosine diphosphate and 5'-adenosine 
triphosphate. The nucleotides described elute in ascending 
order according to the number of phosphate groups con 
tained within the molecule (i.e. the Substrates containing the 
more anionic groups are retained longer on the column 
relative to Substrates containing fewer anionic groups). 
Selectivity for carboxylates was also observed for carboxy 
Substituted benzenes. In two separate experiments, calix4 
pyrrole Substituted Silica gel, B, effectively separated ben 
Zoic acid, isophthallic acid, and 1,3,5-tricarboxybenzene. In 
a separate experiment, a calix4pyrrole Substituted Silica gel 
column effectively separated phthallic acid from a mixture 
of teraphthallic acid, isophthallic acid and phthallic acid. 
FIG. 20 and FIG. 21 demonstrate the separation of 
carboxybenzyl-N-protected amino acids on Gel M and Gel 
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B, respectively. These data illustrate that both hydrophobic 
contributions and hydrogen bonding interactions are 
involved in the Separation. 
FIG. 19 illustrates the separation observed between 5 
different neutral aromatic compounds: uridine (1), phenol 
(2), aniline (3), benzene (4), and 4-iodo-nitrobenzene (5) on 
Gel M. In addition to hydrogen-bonding properties, JC-TL 
interactions appear to influence Separation. It is noteworthy 
to point out that nucleotides, shown in FIGS. 17 and 18, 
require a Substantially Stronger buffer System for elution 
than the nucleoside, uridine (1), shown in FIG. 19, which 
requires a weak buffer and is eluted almost immediately. 
Further, the Separation of very Similar molecules of a class 
of molecules was carried out. Using a model System analo 
gous to the class of polychlorobiphenyls which are known 
carcinogens, the Separation of polyfluorobiphenyls, a bio 
logically inactive compound, was effected. Demonstrated in 
FIG. 22, is the separation of four polyfluorobiphenyl com 
pounds, 4-fluorobiphenyl (1), 4,4'-difluorobiphenyl (2), 2,2', 
3,3,..'5.5",6,6'-octafluorobiphenyl (3), and perfluorobiphenyl 
(4) on Gel M and in FIG. 23 on Gel B. 
With current interest in antisense oligonucleotide therapy 
and oligonucleotides as primers and probe molecules, the 
ability to effectively and efficiently purify usable quantities 
of these oligomerS is of paramount importance. One of the 
best methods for obtaining large quantities of purified oli 
gonucleotides is high pressure liquid chromatography 
(HPLC). There are a number of HPLC techniques employed 
in the purification of oligonucleotides, however, the two 
most currently used methods are reverse phase- and ion 
eXchange chromatography. These popular methods Suffer 
from practical drawbacks. Purification of medium chain 
length (12–24) oligonucleotides using reverse phase chro 
matography must be done using protected Substrates. The 
protecting groups most often used are trityl groups which 
must be subsequently removed by hydrolysis before use. 
Additionally, reverse phase chromatography Suffers from 
very long retention times which limits its applicability. 
Oligonucleotides Separated via anion eXchange 
chromatography, while not plagued by the long retention 
times or additional hydrolysis Steps, must be desalted before 
Sc. 
FIG. 24 illustrates a separation of 12 to 18 base mixture 
of deoxythymidilates (dTs) on Gel M and FIG.25 shows 
the data for Gel B. Additionally mixtures of deoxythymidi 
lates (dTe) were Successfully separated on both Gel M 
and Gel B. The calix4pyrrole-modified silica gel has some 
immediate advantages over anion eXchange columns and 
reverse phase columns. With respect to anion exchange 
chromatography, the large concentrations of Salt that is 
normally need to effect Separation is not needed, thereby 
removing the mandatory desalting Step after chromatogra 
phy of oligonucleotides before using them in biochemical 
experiments. The primary advantage that the calix4 
pyrroles has over reverse phase columns is the higher 
resolution and Shorter retention times. Additionally, reverse 
phase chromatography of oligonucleotides is done while 
they are in a “protected” state and must further be hydro 
lyzed before use. 
The ability of calix 4-pyrroles to distinguish between 
Specific Sequences of nucleotide hexamers was then exam 
ined. FIG. 26 provides the data where three different oligo 
nucleotide hexamers, GGGCCC, TCTAGA, and GCATGC, 
were eluted through Gel M resulting in Separation of the 
three hexamers. 
Mixtures of pesticides (carbofuran, carbendazim, 
bromacil, bentazon, carboxin and norflurazon) were Suc 
cessfully separated on Gel M. 
Oligonucleotide therapy has been proposed for a wide 
range of ailments. These include, but are not limited to Sickle 












basic premise of oligonucleotide therapy is to identify the 
relevant mRNA or DNA strand that is causing the specific 
problem and Synthesizing a short (s.20 bases) complemen 
tary oligonucleotide strand that will bind to the mRNA or 
DNA, thereby blocking translation or transcription of the 
genetic material. 
Table 7 illustrates the ability of calix4pyrrole silica gels 
M and B to separate tetrabutyl ammonium halides. 
TABLE 7 
Analysis of Tetrabutylammonium Halides on Calixpyrrole-Substituted 
Silica Gel 
Elution Times (minutes 
Silica Gel B SilicaGel M 
Chloride 17.9 (+0.1) 15.2 (+0.1) 
Dihydrogen phosphate 22.0 (+0.1) 20.1 (+0.1) 
Hydrogen sulfate 16.2 (+0.1) 16.2 (+0.2) 
Fluoride 16.9 (+0.1) 16.4 (+0.2) 
Times given for individual elution of tetrabutyl ammonium anions. Sepa 
ration of mixtures was not possible due to broadening of peaks. 
Anions were eluted as 1 mM CHCN solutions of their tetrabutylammo 
nium salts under the following conditions: Mobile phase, CHCN; Flow 
Rate, 0.40 mL/min.; Detection, Conductivity; Column Temperature, 25 
C.. 
The present example primarily refers to Silica-bound 
calixpyrrole, however, the Solid Support attached to the 
calix4pyrrole is not limited to Silica gel. Further Solid 
Supports include, but are not limited to, polystyrene, 
polyacrylamide, Merrifield resins, glass, Sepharose, 
Sephadex, agarose, clays, Zeolites, and the like, that can be 
functionalized to allow the formation of a calixnlpyrrole 
bonded to a Solid Support. 
Calixnpyrroles have been shown to be selective toward 
a number of different anionic Species. In examples described 
herein, calix4pyrrole has shown differing affinities for 
anionic Species including fluoride, chloride, bromide, 
iodide, phosphates, carboxylates, arsenates and Sulfates. 
Macrocycles of the present invention may be used to 
generate ion Selective electrodes in a further use embodi 
ment. Data illustrated in Table 8 for anion selective elec 
trodes Synthesized by the present inventors indicate that the 
Selectivity and preferential binding observed in Solution and 
in Separation chemistry, described in examples herein, is 
consistent with anion Selective electrode technology. 
TABLE 8 






Hydrogen Sulfate -4.4 
Dihydrogen Phosphate -1.7 
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Selectivity coefficients determined relative to fluoride, log KP", using 
the separate solution method. 
Membrane compositions: 3% (w.fw) calix4pyrrole, 22% (w.fw) PVC, 
75% (w.fw) 2-o-nitrophenyloctyl ether. Internal electrolyte was 0.1 M NaCl 
and 0.001M NaF. 
Methods of making calixnlpyrrole-ion-selective elec 
trodes include, but are not limited to, the following 
examples: attaching, or immobilizing a functionalized calix 
npyrrole to a functionalized polymer and further coating 
this polymer to an electrode that is Sensitive to changes in 
ionic strength; immobilizing the calixnpyrrole in a plasti 
cizers and encasing the mixture in a membrane Surrounding 
an electrode that is Sensitive to changes in ionic Strength; 
covalently attaching the calixnpyrroles to an electrode that 
is Sensitive to changes in ionic Strength; or coating the 
electrode with a layer of calixnpyrroles containing elec 
tropolymerizable functional groups, including but not lim 
ited to, pyrrole, thiophene or vinyl, and polymerizing the 
coating on to the electrode. 
EXAMPLE 11 
Biomedical Applications 
The anion and neutral binding properties of calixn 
pyrrole, calixmpyridinonpyrrole and calixmpyridines 
allow for a number of useful applications within the bio 
medical field. 
Applications include, but are not limited to, drug-delivery 
Systems, anion transport through membranes, Selective 
anion channel formation, dialysis, blood filtration and viral 
inhibition. 
Cystic fibrosis is the most common lethal genetic disease 
among Caucasians, affecting one out of 2,500 infants in the 
U.S. The disease is characterized by the inability to produce 
properly-functioning chloride anion channels. The calixn 
pyrroles have been demonstrated herein to bind chloride via 
hydrogen bonding. An array of calixnpyrroles or calixm 
pyridinonpyrroles could be designed to span a membrane 
requiring Selective chloride transport. Chloride anion is 
bound and released appropriately by calix4pyrrole as dem 
onstrated in Example 10. Calix4pyrrole has also demon 
Strated the ability to transport anions through an “artificial” 
dichloromethane membrane in Pressman U-tube experi 
ments. An array of calixnpyrroles is expected to transfer 
anions by “handing off the anion to the next calixn 
pyrrole. 
Calixnpyrroles can also be used to transport the anion 
through the membrane by acting as discrete carriers. Refer 
ring to the U-tube data, calix4pyrrole has demonstrated the 
ability to transfer charged molecules through organic mem 
branes. The chloride anion could be transferred through a 
cell membrane in this way thereby alleviating the problem of 
chloride transport and ultimately treating the disorder. 
Another application of anion transport is use of the 
macrocycles of the present invention as a drug delivery 
System. Many potential anti-Viral agents which display 










cies are too polar to pass through cell wall membranes and 
are thus inactive in Vivo. 
Calix4pyrrole has been shown to transport anionic spe 
cies effectively through “artificial' membranes. The present 
inventors have Synthesized a number of nucleotide conju 
gates as examples of nucleobase-substituted calixn 
pyrroles. The possibilities of nucleotide Substitution include, 
but are not limited to any of the naturally occurring purine 
or pyrimidine nucleobases. Additionally, modified versions 
include any number of purine- or pyrimidine-based Synthetic 
molecules capable of addition to a calix4pyrrole core. 
"Nucleobase,” as used herein, means a purine or pyrimidine 
base, nucleoside (Saccharide derivative), nucleotide 
(Saccharide-poly- or mono-phosphate derivative) and natu 
ral and Synthetic analogues thereof. Attachment of a nucleo 
base to the calixnlpyrrole may occur at a functional group 
of the B-position, a pyrrolic-nitrogen, or meso-position of 
the calixnpyrrole. One nucleobase may be attached, 
however, any number or diversity of nucleobases may be 
attached to the calixnpyrrole. Attachment can occur using 
methods Such as: amide bond formation, Stille coupling, 
ester formation, or the like. The nucleobase appended calix 
pyrrole will coordinate to both the phosphate group and 
nucleoside of the anti-viral drug, forming a hydrophobic 
complex which may pass through cell wall membranes and 
decomplex, releasing the drug into the interior of the cell. 
Examples of nucleobase-calix4pyrrole conjugates Syn 
thesized by the present inventors are provided as macro 
cycles 41 and 42. 
41 
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R H, Bz. 
n = 1 
Preparation of nucleobase substituted calixnpyrroles 41 
and 42. Calixpyrrole monoacid (1 mmol) was dissolved in 
dry dichloromethane (25 mL), (chloroform, acetonitrile, 
DMF, 1,2-dichloroethane can also be used). The Solution 
was activated with 2 molar equivalents (per one acid group) 
of the activating agent diisopropylcarbodiimide at room 
temperature in the presence of five molar percent of 
1-hydroxybenzotraizole and 4-dimethylaminopyridine. Two 
molar equivalents per carboxy unit of an aminoethyl nucleo 
base derivative (nucleobase protected) were added. The 
reaction mixture was stirred at room temperature for 24-36 
hours. Acetic acid (0.5 mL) was added, followed by multiple 
washings with a 3% hydrochloric acid solution, water, a 5% 
Solution of Sodium hydrogencarbonate and water. After 
drying over Sodium Sulfate the product was obtained by 
crystallization or flash chromatography on Silica gel. 
Removal of the N-protecting group was done using Standard 
procedures. The removal of trityl- and benzyl-protecting 
groups were achieved using trifluoroacetic acid for trityl and 
and ammonia in methanol for benzyl protecting groups. 
Studies have demonstrated that these nucleobase-calix4 
pyrrole conjugates are not only efficient carriers, but Selec 
tive carriers as well. Using a cytosine-calix4pyrrole con 
jugate to transport a mixture of adenosine monophosphate, 
cytidine monophosphate, guanidine monophosphate, thymi 
dine monophosphate and uridine monophosphate, a transfer 
ratio of 5:1:125:8:7 was observed. The guanidine mono 
phosphate was transported from one aqueous phase to 
another 10-100 times better across the dichloromethane 
model membrane as a result of having complementary 
binding with the cytosine of the cytosine-calix4pyrrole 
conjugate. In addition to being bound to a single nucleobase, 
calixnpyrroles could be attached to oligonucleotides using 
known technology. Calixnpyrrole-oligonucleotide conju 
gates could then be used to bind such substrates as mRNA 
or DNA preventing transcription or translation. This mode of 
binding could be used in antisense therapy, or viral inhibi 











virus would be identified and the complementary calixn 
pyrrole-oligonucleotide conjugates would be Synthesized. 
Calixnpyrroles have utility for ex vivo applications as 
well. Kidney failure is a condition that affects a significant 
portion of the people in the World due to various ailments. 
The present example provides for the use of calixnpyrroles 
and calixmpyridinonpyrroles for dialysis or filtration of 
ex vivo bodily fluids. Phosphates, chloride, and other toxins 
contained in the blood or other bodily fluids may be removed 
by exposure to macrocycles of the present invention Since 
Said macrocycles have demonstrated the ability to bind 
anionic and neutral molecules in the Solid State, in Solution 
and when attached to a Solid Support. Further, calixn 
pyrroles can be functionalized to be anion-specific. The 
present inventors have shown that under chromatographic 
conditions where anions are bound, proteins and other 
biomolecules were unhindered in passage through a column, 
for example. 
Calixnpyrroles could also be used in dialysis. Current 
dialysis employs an anion gradient to bring anions acroSS a 
membrane, thereby establishing an equilibrium. Calixn 
pyrroles could be used to bind the anions once they came 
acroSS the membrane forcing the equilibrium to shift in favor 
of additional waste anion removal by not allowing an 
equilibrium to form. The calixnpyrroles could either water 
Soluble and partioned on one Side of a membrane or bound 
to a Solid Support to prevent diffusion into the blood Supply. 
Calixnpyrrole could be attached to a biologically-inert 
solid support and used to filter toxins out of the blood. These 
toxins include, but are not limited to, drug metabolites (for 
use in drug overdoses) and anionic wastes. Another endog 
enous material that can function as toxin is urea. Its removal 
using this approach illustrated could be used in the treatment 
of gout. 
Additionally calixpyrroles could be used in imaging. 
'"Te is an high energy form of technetium used in imaging 
for the detection of tumors. '"TeO, or any other anion 
containing '"Te may be coodinated to a calixn]pyrrole and 
used as an imaging agent. 
EXAMPLE 12 
Environmental Remediation 
Radioactive waste poses a Serious problem to the envi 
ronment. Current technology generates large amounts of 
Secondary Solid waste for disposal. Separation and concen 
tration of these wastes is of paramount importance, espe 
cially due to long half-lives, and inadequate methods of 
Storage Such as Sludges or underground tanks of wastewater. 
Half-life examples for Tc-99, Ni-63, Cs-137, and Sr-90 are 
213,000 years, 100 years, 30 years and 28 years, respec 
tively. 
Certain of the radioactive metallic wastes exist in an 
oxidized anionic form and are therefore Soluble in aqueous 
Solutions. For example, technetium exists as TcO, and 
nickel, Strontium, and cesium can exist in oxidized anionic 
forms. 
Calix4pyrrole has demonstrated the ability to bind phe 
nyl arsenate in aqueous media. In addition, FIG. 16 illus 
trates the ability of calix4pyrrole to separate four different 
phenyl anions from a mixture thereof. 
In a column embodiment, Solid-Supported calixnpyrrole 
could be used to Separate out metallic anions from a stream 
passing through a column. The bound anions could then be 
eluted from the Solid Support, and the concentrated eluate is 
able to be stored in a smaller volume. 
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In a batch embodiment, Solid Support-bound calixn 
pyrrole could be mixed with a waste Solution containing an 
anion to be removed and the mixture then filtered as a 
method of extracting the waste anions out of Solution. 
Additionally, a multi-phase extraction System is envisioned 
where calixnlpyrrole in a first phase extracts anionic waste 
from another phase, and the waste then is Separated for 
Storage or disposal. 
The present inventors envision, because of the relatively 
fast “on-off rate that is observed with calix4pyrrole, that 
the radioactive waste metal could be “washed' off of the 
Solid Support for Solid Support reuse. Current technology 
uses materials with high binding constants for removal of 
metallic oxyanion waste. This procedure is efficient for 
removal of the waste from contaminated liquid, however, the 
waste is converted to Solid waste and must Still be disposed 
of. 
Molecules that can be removed from an environmental 
Source are those ions and molecular species that calixn 
pyrrole will bind as described herein. In particular, for 
application to inorganic metal oxoanions, arsenate, 
tungstenate, pertechnetate, borate, or the like, may be 
removed. Removal of pertecimetate from nuclear waste is a 
particularly preferred application of the present technology. 
Types of Solid Supports for attaching calixnpyrrole include, 
but are not limited to, those Supports provided in Example 
10. 
Eutrophication is a serious problem for bodies of water 
near agricultural lands and urban areas. The accumulation of 
phosphates and nitrates from fertilizers in lakes, rivers and 
inland waterways causes toxic algal blooms that poison the 
water. Algal blooms are also thought to be toxic for humans. 
Removal of Such anions by use of macrocycles of the present 
invention in a water-treatment plant, for example, would 
purify the water and provide it for human use and genera 
tions of the future. 
Purification of domestic water Supplies is an increasing 
necessity in densely populated areas. The macrocycles of the 
present invention would be useful in filters for attachment to 
home water Supplies for removal of anionic pollutants Such 
as, but not limited to, fluoride, phosphate and nitrate. 
All of the compositions and methods disclosed and 
claimed herein can be made and executed without undue 
experimentation in light of the present disclosure. While the 
compositions and methods of this invention have been 
described in terms of preferred embodiments, it will be 
apparent to those of skill in the art that variations may be 
applied to the composition, methods and in the Steps or in the 
Sequence of Steps of the method described herein without 
departing from the concept, Spirit and Scope of the invention. 
More specifically, it will be apparent that certain agents 
which are both chemically and physiologically related may 
be substituted for the agents described herein while the same 
or similar results would be achieved. All Such similar 
Substitutes and modifications apparent to those skilled in the 
art are deemed to be within the Spirit, Scope and concept of 
the invention as defined by the appended claims. 
What is claimed is: 
1. A calixnpyrrole macrocycle where n is 4, 5, 6, 7, or 
8, and where the macrocycle is covalently attached to a Solid 












when n is 4, p=q=r=s=0., R-R are independently Sub 
Stituents as listed in paragraphi) below, and Ra-R, are 
independently Substituents as listed in paragraph ii) 
below; 
when n is 5, p=1, q=r=s=0, R to Rao are independently 
Substituents as listed in paragraphi) below, and Ra-R 
are independently Substituents as listed in paragraph ii) 
below; 
when n is 6, p=q=1, r=s=0, R to R2 are independently 
Substituents as listed in paragraphi) below, and Ra-R 
are independently Substituents as listed in paragraph ii) 
below; 
when n is 7, p=q=r=1, S=0, R to Rs are independently 
Substituents as listed in paragraphi) below, and Ra-R 
are independently Substituents as listed in paragraph ii) 
below; 
when n is 8, p=q=r=S=1, R to R are independently 
Substituents as listed in paragraphi) below, and RA-R 
are independently Substituents as listed in paragraph ii) 
below; 
i) hydrogen, halide, hydroxyl, alkyl, alkenyl, alkynyl, 
aryl, alkylary 1, nitro, phospho, formyl, acyl, 
hydroxyalkyl, alko Xy, hydroxyalkoxy, 
hydroxyalkenyl, hydroxyalkynyl, Saccharide, 
carboxy, carboxyalkyl, carboxy amide, 
carboxyamidealkyl, amino, amido, aminoalkyl, 
phosphoalkyl, alkyl Sulfoxide, alkyl Sulfone, alkyl 
Sulfide, tetrahydropyran, tetrahydrothiapyran, 
thioalkyl, haloalkyl, haloalkenyl, haloalkynyl, alkyl 
ester, a Site-directing molecule, a catalytic group, a 
reporter group, a binding agent, or a couple that is 
coupled to a Site-directing molecule, to a catalytic 
group, to a reporter group, or to a binding agent; 
ii) hydrogen, alkyl, aminoalkyl, alkylsulfone, carboxy 
alkyl, carboxyamidealkyl, phospho alkyl, alkyl 
Sulfoxide, alkyl Sulfone, alkyl Sulfide, haloalkyl, 
aryl, N-oxide, dialkylamino, carbamate, or arylsul 
fonyl; 
wherein odd-numbered R-substituents are other than 
hydrogen. 
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